UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K

(Mark One)

☑☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended June 30, ~~2024~~2025

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

Commission File Number: 0-56615

LONGDUODUO COMPANY LIMITED

(Exact name of registrant as specified in its charter)

Nevada		37-2018431
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification Number)

G3-5-8016 Shui’an Town, Ruyi Headquarters Base

Hohhot Economic Development Zone

Inner Mongolia 010000

P.R. China

Office: +86 (0472) 510 4980

(Address, including zip code, and telephone number, including area code,

of Registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class		Trading Symbol		Name of Each Exchange on Which Registered
None		None		Not Applicable

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $0.001 par value.

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No ☑☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☑☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐☒ No ☑☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑☒ No ☐

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☑☒

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☐ Smaller reporting company ☑☒ Emerging growth company ☑☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12 b-2 of the Act). Yes ☐ No ☑☒

~~Indicate~~The aggregate ~~the~~market ~~number~~value of ~~shares~~the ~~outstanding~~voting ofstock ~~each~~ held by non-affiliates of the ~~issuer~~registrant at December 31, 2024, the last business day of the registrant’s ~~classes~~most recently completed second fiscal quarter was $79,322,230 based on the last reported sales price of the registrant’s common stock, as ofreported by the ~~latest~~Nasdaq ~~practicable~~Stock Market on that date.

As of the date of filing of this report, there were outstanding 30,~~005~~015,~~016~~036 shares of the issuer’s common stock, par value $0.001 per share.

DOCUMENTS INCORPORATED BY REFERENCE

List hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g., Part I, Part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or information statement; and (3) Any prospectus filed pursuant to Rule 424(b) or (c) under the Securities Act of 1933. The listed documents should be clearly described for identification purposes (e.g., annual report to security holders for fiscal year ended December 24, 1980).

None

TABLE OF CONTENTS

		Page
	PART I	1
Item 1.	Business	1
Item 1A.	Risk Factors	12
Item 1B	Unresolved Staff Comments	29
Item 1C	Cybersecurity	29
Item 2.	Properties.	29
Item 3.	Legal Proceedings.	29
Item 4.	Mine Safety Disclosure	29
	PART II	30
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.	30
Item 6.	[Reserved]	3130
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	31
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk.	34
Item 8.	Financial Statements and Supplementary Data.	F-1
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.	35
Item 9A.	Controls and Procedures.	35
Item 9B.	Other Information.	36
Item 9C	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.	36
	PART III	37
Item 10.	Directors, Executive Officers, and Corporate Governance.	37
Item 11.	Executive Compensation.	40
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.	41
Item 13.	Certain Relationships and Related Transactions, and Director Independence.	42
Item 14.	Principal Accountant Fees and Services.	42
	PART IV	43
Item 15.	Exhibits, Financial Statement Schedules.	43
Item 16	Form 10-K Summary	43

PART I

Cautionary Statement Regarding Forward Looking Statements

The discussion contained in this Annual Report on Form 10-K contains “forward-looking statements” within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. Any statements about our expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements are often, but not always, made through the use of words or phrases like “anticipate,” “estimate,” “plans,” “projects,” “continuing,” “ongoing,” “target,” “expects,” “management believes,” “we believe,” “we intend,” “we may,” “we will,” “we should,” “we seek,” “we plan,” the negative of those terms, and similar words or phrases. We base these forward-looking statements on our expectations, assumptions, estimates and projections about our business and the industry in which we operate as of the date of this Form 10-K. These forward-looking statements are subject to a number of risks and uncertainties that cannot be predicted, quantified or controlled and that could cause actual results to differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. Statements in this Form 10-K describe factors, among others, that could contribute to or cause these differences. Actual results may vary materially from those anticipated, estimated, projected or expected should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect. Because the factors discussed in this Form 10-K could cause actual results or outcomes to differ materially from those expressed in any forward-looking statement made by us or on our behalf, you should not place undue reliance on any such forward-looking statement. New factors emerge from time to time, and it is not possible for us to predict which will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement. Except as required by law, we undertake no obligation to publicly revise our forward-looking statements to reflect events or circumstances that arise after the date of this Form 10-K.

~~NOTE~~Item 1. ~~REGARDING REVERSE STOCK SPLIT~~Business

~~Effective on September 26, 2023, Longduoduo Company~~Corporate Limited implemented a one-for-ten reverse split of its common stock. To facilitate comparative analysis, all statements in this Report regarding numbers of shares of common stock and all references to prices of a share of common stock, if referencing events or circumstances occurring prior to September 26, 2023, have been modified to reflect the effect of the reverse stock split on a pro forma basis.Structure

~~Item~~Longduoduo Company 1Limited (“Longduoduo”) was incorporated in the State of Nevada on October 25, 2021. ~~Business~~Longduoduo’s principal corporate address is G3-5-8016, Shui’an Town, Ruyi Headquarters Base, Hohhot Economic Development District, Hohhot, Inner Mongolia, China, 010000. Our telephone number is +86 (0472) 510 4980. Our registered agent for service of process is Incorp Services, Inc., 3773 Howard Hughes Pkwy, Suite 500S, Las Vegas Nevada 89169-6014. Our website address is www.longduoduo.net. Our website and the information contained on, or that can be accessed through, the website is not deemed to be incorporated by reference in, and is not considered part of, this report, and the inclusion of our website address in this report is an inactive textual reference only. You should not rely on any such information in making your decision whether to purchase our common stock.

~~Corporate~~LONGDUODUO IS ~~Structure~~A NEVADA CORPORATION THAT FUNCTIONS EXCLUSIVELY AS A HOLDING COMPANY. ALL OF THE BUSINESS OPERATIONS THAT ARE DESCRIBED IN THIS REPORT AND REFLECTED IN THE FINANCIAL STATEMENTS CONTAINED IN THIS REPORT ARE CARRIED OUT BY SEVEN LIMITED COMPANIES ORGANIZED AND LOCATED IN THE PEOPLE’S REPUBLIC OF CHINA (“PRC”). LONGDUODUO OWNS THE SEVEN OPERATING COMPANIES THROUGH AN INTERMEDIARY HOLDING COMPANY REGISTERED IN HONG KONG.

Longduoduo Company Limited (“Longduoduo”) was incorporated in the State of Nevada on October 25, 2021. Longduoduo’s principal corporate address is G3-5-8016, Shui’an Town, Ruyi Headquarters Base, Hohhot Economic Development District, Hohhot, Inner Mongolia, China, 010000. Our telephone number is +86 (0472) 510 4980. Our registered agent for service of process is Incorp Services, Inc., 3773 Howard Hughes Pkwy, Suite 500S, Las Vegas Nevada 89169-6014. Our website address is www.longduoduo.net. Our website and the information contained on, or that can be accessed through, the website is not deemed to be incorporated by reference in, and is not considered part of, this report, and the inclusion of our website address in this report is an inactive textual reference only. You should not rely on any such information in making your decision whether to purchase our common stock.1

~~LONGDUODUO IS A NEVADA CORPORATION THAT FUNCTIONS~~The ~~EXCLUSIVELY~~following ASchart Adescribes ~~HOLDING~~our ~~COMPANY.~~current ~~ALL~~corporate OF THE BUSINESS OPERATIONS THAT ARE DESCRIBED IN THIS REPORT AND REFLECTED IN THE FINANCIAL STATEMENTS CONTAINED IN THIS REPORT ARE CARRIED OUT BY FIVE LIMITED COMPANIES ORGANIZED AND LOCATED IN THE PEOPLE’S REPUBLIC OF CHINA (“PRC”). LONGDUODUO OWNS THE FIVE OPERATING COMPANIES THROUGH AN INTERMEDIARY HOLDING COMPANY REGISTERED IN HONG KONG.structure:

1Longduoduo Company Limited (Hong Kong) (“Longduoduo HK”), was established on July 26, 2021 under the laws of Hong Kong. On October 26, 2021, Longduoduo issued 30,000,000 shares of its common stock to the original shareholders of Longduoduo HK, in exchange for 100% of the outstanding shares of Longduoduo HK.

~~The~~LDD Technology ~~following~~Limited ~~chart~~(“LDD”) ~~describes~~was ~~our~~established ~~current~~on ~~corporate~~March 18, 2024 under the laws of British Virgin Islands. On February 19, 2025, ~~structure:~~Longduoduo issued 10,020 shares of its common stock to the original shareholders of LDD, in exchange for 100% of the outstanding shares of LDD.

~~Longduoduo~~LDDJK Hong ~~Company~~Kong Limited (~~Hong Kong) (~~“~~Longduoduo HK~~LDDJK”), was established on ~~July~~April 269, ~~2021~~2024 under the laws of Hong Kong. OnLDD ~~October~~has ~~26,~~controlled ~~2021, Longduoduo issued 30,000,000 shares of its common stock to the original shareholders of Longduoduo HK, in exchange for~~ 100% of ~~the~~LDDJK since ~~outstanding~~its ~~shares of Longduoduo HK (the “Share Exchange”)~~inception.

~~Longduoduo~~Beijing Julong Health ~~Technology~~Consulting ~~Company~~Co., Limited (“~~Longduoduo Health Technology~~Julong”), awas ~~privately~~established ~~held Limited Company, registered~~ in ~~Inner Mongolia~~Beijing, China on ~~August~~July 2023, ~~2020~~2024. OnLDDJK ~~August~~has ~~16, 2021,~~controlled ~~Longduoduo HK acquired~~ 100% of ~~Longduoduo~~Julong ~~Health~~since ~~Technology~~its ~~from the original shareholders of Longduoduo Health Technology~~inception.

~~Inner~~Beijing Yihua ~~Mongolia Qingguo~~ Health Consulting ~~Company~~ Co., Limited (“~~Qingguo~~Yihua”), awas ~~privately~~established ~~held Limited Company, registered~~ in ~~Inner Mongolia~~Beijing, China on ~~June~~March 1814, ~~2020~~2024. On ~~September 8~~January 7, ~~2020~~2025, ~~Longduoduo Health Technology~~ Julong acquired ~~90%~~all ofthe ~~Qingguo~~shares ~~from~~held by the original shareholders of ~~Qingguo~~Yihua, and controlled 100% ownership of Yihua.

~~Inner Mongolia Rongbin~~ Longduoduo Health ~~Consulting~~Technology Company Limited (“~~Rongbin~~Longduoduo Health Technology”), is a privately held Limited Company, registered in Inner Mongolia, China on ~~March~~August 1820, ~~2021~~2020. On August 16, 2021, Longduoduo HK acquired 100% of Longduoduo Health Technology from the original shareholders of Longduoduo Health Technology. ~~has~~On ~~controlled~~April 802, 2025, Julong acquired 100% of ~~Rongbin~~Longduoduo ~~since~~Health ~~inception~~Technology from Longduoduo HK.

Inner Mongolia ~~Chengheng~~Qingguo Health Consulting Company Limited (“~~Chengheng~~Qingguo”), is a privately held Limited Company, registered in Inner Mongolia, China on ~~April~~June 918, ~~2021~~2020. On September 8, 2020, Longduoduo Health Technology ~~has~~acquired ~~controlled 80~~90% of ~~Chengheng~~Qingguo ~~since~~from ~~inception~~the original shareholders of Qingguo.

Inner Mongolia ~~Tianju~~Rongbin Health Consulting Company Limited (“~~Tianju~~Rongbin”), is a privately held Limited Company, registered in Inner Mongolia, China on ~~July~~March 518, 2021. Longduoduo Health Technology has controlled 5180% of ~~Tianju~~Rongbin since its inception.

2Inner Mongolia Chengheng Health Consulting Company Limited (“Chengheng”) is a privately held Limited Company, registered in Inner Mongolia, China on April 9, 2021. Longduoduo Health Technology has controlled 80% of Chengheng since its inception.

~~Considerations~~Inner Mongolia ~~Relating~~Tianju toHealth ~~Regulation~~Consulting ~~under~~Company Limited (“Tianju”) is a privately held Limited Company registered in Inner Mongolia, ~~Chinese~~China ~~Law~~on July 5, 2021. Longduoduo Health Technology has controlled 51% of Tianju since inception.

Longduoduo is not a Chinese operating company but a Nevada holding company with all of its operations conducted through five subsidiaries located in the PRC. Investors in the Company’s common stock should be aware that they will not directly hold equity interests in a Chinese operating entity, but rather are purchasing equity solely in a Nevada holding company that will be dependent upon distributions from its principal Chinese subsidiary to finance the administrative expenses of the Nevada holding company and any cash distributions by the Nevada holding company to its shareholders. Our ability to obtain contributions from the Company’s subsidiary is significantly affected by regulations promulgated by PRC authorities. Chinese regulatory authorities could prevent our principal Chinese subsidiary from making distributions to its Nevada parent, which would likely result in a material change in our operations and cause the value of our securities to significantly decline or become worthless. Any change in the interpretation by the PRC government of existing rules and regulations or the promulgation of new rules and regulations may materially affect our operations or cause the value of our securities to significantly decline or become worthless. For a detailed description of the risks facing the Company as a result of its dependence on its Chinese operating subsidiaries, please refer to “Risk Factors - Risks Relating to Doing Business in the PRC.”2

~~Exposure~~Considerations Relating to ~~potential~~Regulation ~~sanctions~~ under ~~the HFCAA~~Chinese Law

~~Pursuant~~Longduoduo is tonot ~~the~~a ~~Holding~~Chinese ~~Foreign~~operating ~~Companies~~company ~~Accountable Act~~but ~~(“HFCAA”),~~a asNevada ~~adopted~~holding bycompany ~~the~~with ~~United~~all ~~States~~of ~~Congress~~its inoperations ~~2020,~~conducted through seven subsidiaries located in the ~~Public~~PRC. Investors in the Company’s ~~Accounting~~common ~~Oversight~~stock ~~Board~~should ~~(the~~be ~~“PCAOB”) issued~~aware athat ~~Determination~~they ~~Report~~will onnot ~~December~~directly 16hold equity interests in a Chinese operating entity, ~~2021~~but ~~which~~rather ~~found~~are purchasing equity solely in a Nevada holding company that ~~the~~will ~~PCAOB~~be ~~was~~dependent ~~unable~~upon distributions from its principal Chinese subsidiary to ~~inspect~~finance orthe ~~investigate~~administrative ~~completely~~expenses ~~registered~~of the Nevada holding company and any cash distributions by the ~~public~~Nevada ~~accounting~~holding ~~firms~~company ~~headquartered~~to inits shareholders. Our ability to obtain contributions from the ~~PRC~~Company’s ~~because~~subsidiary ofis asignificantly affected ~~position~~by ~~taken~~regulations promulgated by ~~one~~PRC orauthorities. ~~more~~Chinese regulatory authorities could prevent our principal Chinese subsidiary from making distributions to its Nevada parent, which would likely result in ~~mainland~~a ~~China.~~material ~~Under~~change in our operations and cause the ~~HFCAA~~value ~~(as~~of ~~amended~~our securities to significantly decline or become worthless. Any change in the interpretation by the ~~Consolidated~~PRC ~~Appropriations~~government ~~Act~~of –existing ~~2023),~~rules and anregulations ~~issuer’s~~or ~~securities~~the promulgation of new rules and regulations may bematerially ~~prohibited~~affect ~~from~~our ~~trading~~operations onor acause ~~U.S.~~the value of our securities ~~stock~~to ~~exchange~~significantly decline or ~~facility~~become ifworthless. ~~its~~For ~~auditor~~a isdetailed ~~not~~description ~~inspected~~of bythe risks facing the ~~PCAOB~~Company ~~for~~as ~~two~~a ~~consecutive~~result ~~years~~of ~~(reduced~~its bydependence on ~~Congress~~its inChinese ~~2023~~operating ~~from~~subsidiaries, ~~three consecutive~~please ~~years~~refer to “Risk Factors - Risks Relating to Doing Business in the ~~original HFCAA)~~PRC.”

~~On August 26, 2022, the China Securities Regulatory~~Exposure Commission (“CSRC”), the Ministry of Finance of China, and the PCAOB signed a protocol governing inspections and investigations of audit firms based in China and Hong Kong. On December 15, 2022, the PCAOB issued a new Determination Report which: (1) vacated the December 16, 2021 Determination Report; and (2) concluded that the PCAOB had been able to ~~conduct~~potential ~~inspections~~sanctions ~~and~~under ~~investigations completely in~~ the PRC in 2022. The December 15, 2022 Determination Report cautions, however, that authorities in the PRC might take positions at any time that would prevent the PCAOB from continuing to inspect or investigate completely. As required by the HFCAA, if in the future the PCAOB determines it no longer can inspect or investigate completely because of a position taken by an authority in the PRC, the PCAOB will act expeditiously to consider whether it should issue a new determination. If the PCAOB is not able to fully conduct inspections of our auditor’s work papers in the PRC, our securities may be prohibited from trading on a U.S. stock exchange or facility if our auditor is not inspected by the PCAOB for two consecutive years, and this ultimately could result in our common stock being barred from listing in the United States, which would likely prevent our shareholders from being able to sell their shares until the bar was lifted.

~~Longduoduo~~Pursuant to ~~recently~~the ~~engaged~~Holding ~~Bush~~Foreign &Companies ~~Associates CPA~~Accountable ~~LLC~~Act ~~as its independent auditor~~(“HFCAA”), ~~replacing~~as ~~Michael~~adopted T.by ~~Studer~~the ~~CPA~~United ~~P.C.~~States inCongress ~~that role. Bush & Associates is headquartered~~ in 2020, the ~~State~~Public ofCompany ~~Nevada,~~Accounting ~~and~~Oversight ~~Michael~~Board ~~T. Studer CPA P.C. is headquartered in~~ (the ~~State~~“PCAOB”) ofissued ~~New~~a ~~York.~~Determination ~~The~~Report ~~PCAOB~~on isDecember ~~able to~~16, ~~and~~2021 ~~does,~~which ~~fully~~found ~~conduct~~that ~~inspections~~the ofPCAOB ~~our~~was ~~auditor’s~~unable ~~work~~to ~~papers.~~inspect ~~There~~or ~~remains~~investigate acompletely ~~risk,~~registered ~~however,~~public ~~that~~accounting ~~the~~firms ~~government~~headquartered ofin the PRC ~~might~~because inof ~~the~~a ~~future impose restrictions~~position ontaken ~~the~~by ~~communication~~one ofor ~~information~~more toauthorities ~~auditors~~in ormainland byChina. ~~auditors~~Under ofthe ~~issuers~~HFCAA ~~whose~~(as ~~operations~~amended ~~are~~by ~~located within~~ the ~~PRC,~~Consolidated inAppropriations ~~such~~Act a– ~~way that~~2023), ~~investors~~an inissuer’s ~~the~~ securities ofmay ~~such~~be ~~issuers~~prohibited dofrom ~~not~~trading ~~receive~~on ~~the~~a ~~full~~U.S. ~~benefit~~stock ofexchange ~~the~~or ~~audits.~~facility Inif ~~that~~its ~~situation,~~auditor itis ~~could~~not ~~occur~~inspected ~~that~~by the ~~SEC~~PCAOB ~~would~~for ~~bar~~two ~~trading~~consecutive ~~platforms~~years ~~subject~~(reduced toby ~~U.S.~~Congress ~~jurisdiction~~in 2023 from ~~listing~~three ~~Longduoduo’s~~consecutive ~~securities~~years ~~for~~in ~~trading. Such an occurrence would be likely to cause~~ the ~~value~~original ~~of Longduoduo’s securities to diminish significantly~~HFCAA).

3On August 26, 2022, the China Securities Regulatory Commission (“CSRC”), the Ministry of Finance of China, and the PCAOB signed a protocol governing inspections and investigations of audit firms based in China and Hong Kong. On December 15, 2022, the PCAOB issued a new Determination Report which: (1) vacated the December 16, 2021 Determination Report; and (2) concluded that the PCAOB had been able to conduct inspections and investigations completely in the PRC in 2022. The December 15, 2022 Determination Report cautions, however, that authorities in the PRC might take positions at any time that would prevent the PCAOB from continuing to inspect or investigate completely. As required by the HFCAA, if in the future the PCAOB determines it no longer can inspect or investigate completely because of a position taken by an authority in the PRC, the PCAOB will act expeditiously to consider whether it should issue a new determination. If the PCAOB is not able to fully conduct inspections of our auditor’s work papers in the PRC, our securities may be prohibited from trading on a U.S. stock exchange or facility if our auditor is not inspected by the PCAOB for two consecutive years, and this ultimately could result in our common stock being barred from listing in the United States, which would likely prevent our shareholders from being able to sell their shares until the bar was lifted.

~~Exposure~~Longduoduo recently engaged Bush & Associates CPA LLC as its independent auditor. Bush & Associates is headquartered in the State of Nevada. The PCAOB is able to, and does, fully conduct inspections of our auditor’s work papers. There remains a risk, however, that the government of the PRC might in the future impose restrictions on ~~upstream~~the ~~distributions~~communication of information to auditors or by auditors of issuers whose operations are located within the PRC, in such a way that investors in the securities of ~~profits~~such issuers do not receive the full benefit of the audits. In that situation, it could occur that the SEC would bar trading platforms subject to U.S. jurisdiction from listing Longduoduo’s securities for trading. Such an occurrence would be likely to cause the value of Longduoduo’s securities to diminish significantly.

Longduoduo is a Nevada holding company with no business operations of its own. We conduct our operations in China through five subsidiaries. We will rely on dividends paid by our principal PRC subsidiary to fund the cash requirements of Longduoduo, including the funds necessary to pay dividends and other cash distributions to our shareholders, to service any debt we may incur and to pay our operating expenses. In order for us to pay dividends to our shareholders, we will rely on payments made from our principal PRC subsidiary to Longduoduo Company Limited (Hong Kong) (“Longduoduo HK”). If Longduduo is unable to receive profits from the operations of our PRC subsidiaries through Longduoduo HK, we will be unable to pay dividends on our common stock.3

~~The PRC government also imposes controls on the~~Exposure ~~conversion~~to ofrestrictions ~~RMB into foreign currencies and the remittance of currencies out of the PRC through the Administrative Regulations of the PRC~~ on ~~Foreign~~upstream ~~Exchange~~distributions ~~(the “Foreign Exchange Regulations”), and the Notice~~ of State Administration of Foreign Exchange on Promulgation of the Provisions on Foreign Exchange Control on Direct Investments in China by Foreign Investors. Therefore, we may experience difficulties in completing the administrative procedures necessary to obtain and remit foreign currency for the payment of dividends from our profits, if any. The Foreign Exchange Regulations will present a barrier to currency transactions between our U.S. parent company and our Chinese operating subsidiary. If we raise funds in the U.S. dollars for the purpose of funding our operations in China, we will be required to obtain SAFE approval of the conversion of the dollars into Renminbi, which could be denied.

~~Current PRC regulations permit~~ Longduoduo’s ~~PRC~~is ~~subsidiaries~~a toNevada ~~pay~~holding ~~dividends~~company towith ~~Longduoduo~~no ~~and~~business ~~its~~operations ~~Hong Kong subsidiary only out~~ of ~~their~~its ~~accumulated profits, if any, determined in accordance with Chinese accounting standards and regulations~~own. InWe ~~addition,~~conduct ~~each of~~ our ~~subsidiaries~~operations in China isthrough ~~required~~seven tosubsidiaries. ~~set aside~~We atwill ~~least~~rely ~~10%~~on ofdividends ~~its~~paid ~~after-tax~~by ~~profits~~our ~~each~~principal ~~year~~PRC subsidiary to fund athe ~~statutory~~cash ~~reserve~~requirements ~~until such reserve reaches 50%~~ of ~~its~~Longduoduo, ~~registered~~including ~~capital. Our~~the ~~subsidiaries~~funds ~~in China are also required~~ necessary to ~~further~~pay ~~set~~dividends ~~aside~~and aother ~~portion~~cash ofdistributions ~~their after-tax profits~~ to ~~fund~~our ~~their employee welfare fund~~shareholders, ~~although~~ ~~the amount~~ to beservice ~~set aside, if~~ any, isdebt ~~determined~~we atmay ~~the~~incur ~~discretion~~and ofto ~~the~~pay ~~subsidiary’s~~our ~~board~~operating ~~of directors~~expenses. ~~Although the~~ ~~statutory~~In ~~reserves~~order ~~can~~for beus ~~used,~~to ~~among~~pay ~~other~~dividends ~~ways,~~ to ~~increase~~our ~~the~~shareholders, ~~registered~~we ~~capital~~will ~~and~~rely ~~eliminate~~on ~~future~~payments ~~losses~~made infrom ~~excess~~our ofprincipal ~~retained earnings of the~~ PRC subsidiary, ~~the~~to ~~reserve~~LDDJK ~~funds~~Hong ~~are~~Kong Limited ~~not~~(“LDDJK”). ~~distributable~~If asLongduoduo ~~cash~~is ~~dividends~~unable ~~except~~to inreceive ~~the~~profits ~~event~~from ofthe ~~liquidation.~~operations ~~If one or more~~ of our PRC subsidiaries ~~incurs~~through ~~debt on its own behalf in the future~~LDDJK, we ~~the~~will ~~instruments~~be ~~governing~~unable ~~the debt may restrict its ability~~ to pay dividends oron ~~make~~our ~~other~~common ~~distributions to us~~stock.

IfThe PRC ~~Longduoduo~~government isalso ~~considered~~imposes acontrols ~~PRC~~on ~~tax~~the ~~resident~~conversion of RMB into foreign currencies and the remittance of currencies out of the PRC ~~enterprise~~through ~~for~~the ~~tax~~Administrative ~~purposes~~Regulations of the PRC on Foreign Exchange (the “Foreign Exchange Regulations”), ~~any~~and ~~dividends~~the ~~its~~Notice of ~~pays~~State toAdministration ~~our~~of ~~shareholders~~Foreign ~~may~~Exchange beon ~~regarded~~Promulgation asof ~~China-sourced~~the ~~income~~Provisions ~~and,~~on asForeign aExchange ~~result~~Control on Direct Investments in China by Foreign Investors. Therefore, we may be ~~subject~~experience difficulties in completing the administrative procedures necessary to ~~PRC~~obtain ~~withholding~~and ~~tax~~remit foreign atcurrency afor ~~rate~~the payment of updividends tofrom 10our profits, if any.~~0%.~~ ~~Certain~~The ~~payments~~Foreign ~~from~~Exchange ~~Longduoduo~~Regulations ~~Health~~will ~~Technology,~~present ~~our~~a ~~principal~~barrier ~~PRC~~to ~~subsidiary,~~currency totransactions ~~Longduoduo~~between HKour ~~are~~U.S. ~~subject~~parent tocompany ~~PRC~~and ~~taxes~~our Chinese operating subsidiary. AsIf ofwe raise funds in the ~~date~~U.S. dollars for the purpose of ~~this~~funding ~~Report~~our operations in China, ~~Longduoduo~~we ~~Health~~will ~~Technology~~be ~~has~~required ~~not~~to ~~made~~obtain ~~any~~SAFE ~~transfers~~approval orof ~~distributions~~the conversion of the dollars into Renminbi, which could be denied.

~~Pursuant~~Current PRC regulations permit Longduoduo’s PRC subsidiaries to ~~the~~pay ~~Arrangement~~dividends ~~between~~to ~~Mainland~~Longduoduo ~~China~~ and ~~the~~its Hong Kong ~~Special~~subsidiary ~~Administrative~~only ~~Region~~out ~~for~~of ~~the~~their accumulated ~~Avoidance~~profits, ofif ~~Double~~any, ~~Taxation~~determined ~~and~~in ~~Tax~~accordance ~~Evasion~~with onChinese ~~Income,~~accounting orstandards ~~the~~and ~~“Double~~regulations. ~~Tax Avoidance~~In ~~Arrangement~~addition,” ~~the~~each ~~10%~~of ~~withholding~~our ~~tax~~subsidiaries in ~~rate~~China ~~may~~is berequired ~~lowered~~ to 5%set ifaside aat ~~Hong~~least ~~Kong~~10% ~~resident~~of ~~enterprise~~its ~~owns~~after-tax noprofits ~~less~~each ~~than~~year ~~25% of~~to ~~the~~fund ~~PRC~~a ~~entity~~statutory ~~during~~reserve ~~the~~until 12such ~~consecutive~~reserve ~~months~~reaches 50% ~~preceding~~of its ~~receipt~~registered ~~of the dividends~~capital. InOur ~~current~~subsidiaries ~~practice,~~in aChina ~~Hong~~are ~~Kong~~also ~~entity~~required ~~must obtain~~to afurther ~~tax~~set ~~resident~~aside ~~certificate~~a ~~from~~portion ~~the~~of ~~Hong~~their ~~Kong~~ after-tax ~~authority~~ profits to ~~apply~~fund ~~for~~their ~~the~~employee 5%welfare ~~lower~~fund, ~~PRC~~although ~~withholding~~the ~~tax~~amount ~~rate.~~to Asbe ~~the~~set ~~Hong~~aside, ~~Kong tax~~if ~~authority~~any, ~~will~~is ~~issue~~determined ~~such~~at athe ~~tax~~discretion ~~resident~~of ~~certificate~~the onsubsidiary’s board aof ~~case-by-case~~directors. ~~basis,~~Although wethe ~~cannot~~statutory ~~assure~~reserves ~~you~~can ~~that~~be weused, ~~will~~among beother ~~able~~ways, to ~~obtain the~~increase ~~tax resident certificate from~~ the ~~relevant~~registered ~~Hong~~capital ~~Kong tax authority~~ and ~~enjoy~~eliminate ~~the~~future losses ~~preferential~~in ~~withholding~~excess ~~tax rate~~ of 5%retained ~~under~~earnings of the ~~Double~~ ~~Taxation~~PRC ~~Arrangement~~subsidiary, ~~with~~the ~~respect~~reserve tofunds ~~dividends~~are tonot bedistributable ~~paid~~as bycash ~~Longduoduo~~dividends ~~Health~~except ~~Technology~~in tothe event ~~its~~of ~~immediate holding company, Longduoduo HK~~liquidation. AsIf ofone ~~the~~or ~~date~~more of ~~this~~our ~~Report,~~PRC ~~Longduoduo~~subsidiaries ~~Health~~incurs ~~Technology~~debt ~~does~~on ~~not~~its ~~plan~~own tobehalf ~~declare~~in ~~and~~the ~~pay~~future, ~~dividends~~the toinstruments ~~Longduoduo~~governing ~~HK and we have~~the ~~not~~debt ~~applied~~may ~~for~~restrict ~~the~~its ~~tax~~ability ~~resident~~to ~~certificate~~pay ~~from~~dividends ~~the~~or ~~relevant~~make ~~Hong~~other ~~Kong~~distributions ~~tax~~to ~~authority~~us.

AtIf Longduoduo ~~the~~is ~~date~~considered ofa ~~this~~PRC ~~Report,~~tax noresident ~~subsidiary~~enterprise offor ~~Longduoduo has~~tax ~~paid~~purposes, any ~~dividend~~dividends orits ~~distribution~~pays to ~~Longduoduo~~our orshareholders ~~any~~may ~~subsidiary~~be ofregarded ~~Longduoduo,~~as China-sourced ~~nor~~income ~~has~~and, ~~Longduoduo~~as ~~made~~a ~~any~~result, ~~dividend~~may orbe ~~distribution~~ subject to ~~any~~PRC Uwithholding tax at a rate of up to 10.S0%. ~~investor.~~Certain ~~There~~payments ~~has~~from ~~been~~Julong, our noprincipal ~~transfer~~PRC ofsubsidiary, ~~cash~~to orLDDJK ~~other~~are ~~assets~~subject ~~between~~to orPRC ~~among~~taxes. ~~Longduoduo~~As of the date of this Report, ~~Longduoduo~~Julong HKhas ~~and/or~~not made any ~~Chinese subsidiary~~transfers ~~of Longduoduo~~or distributions.

4Pursuant to the Arrangement between Mainland China and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax Evasion on Income, or the “Double Tax Avoidance Arrangement,” the 10% withholding tax rate may be lowered to 5% if a Hong Kong resident enterprise owns no less than 25% of the PRC entity during the 12 consecutive months preceding its receipt of the dividends. In current practice, a Hong Kong entity must obtain a tax resident certificate from the Hong Kong tax authority to apply for the 5% lower PRC withholding tax rate. As the Hong Kong tax authority will issue such a tax resident certificate on a case-by-case basis, we cannot assure you that we will be able to obtain the tax resident certificate from the relevant Hong Kong tax authority and enjoy the preferential withholding tax rate of 5% under the Double Taxation Arrangement with respect to dividends to be paid by Julong to its immediate holding company, LDDJK. As of the date of this Report, Julong does not plan to declare and pay dividends to LDDJK and we have not applied for the tax resident certificate from the relevant Hong Kong tax authority.

~~PRC~~At the ~~Government~~date ~~Oversight~~of this Report, no subsidiary of Longduoduo has paid any dividend or distribution to Longduoduo or any subsidiary of Longduoduo, nor has Longduoduo made any dividend or distribution to any U.S. investor. There has been no transfer of cash or other assets between or among Longduoduo, LDDJK and/or any Chinese subsidiary of Longduoduo.

Changes in China’s internal regulatory mandates, such as the M&A rules, Anti-Monopoly Law, and the Data Security Law, may target the Company’s corporate structure and impact our ability to conduct business in China, accept foreign investments, or list on a U.S. or other foreign exchange. Recently, the PRC government initiated a series of regulatory actions affecting business operations in China with little advance notice, including banning certain activities in the securities market, enhancing supervision over China-based companies listed overseas using variable interest entity structure, adopting new measures to extend the scope of cybersecurity reviews, and expanding its efforts in anti-monopoly enforcement. The business of our subsidiaries until now has not been subject to cybersecurity review with the Cyberspace Administration of China, or CAC, given that: (i) data processed in our business does not have a bearing on national security and thus may not be classified as core or important data by the authorities; (ii) we have not yet approached the regulatory thresholds for holding personal information in our business operations. In addition, we are not subject to merger control review by China’s anti-monopoly enforcement agency due to the level of our revenues and the fact that we currently do not expect to propose or implement any acquisition of control of, or decisive influence over, any company with revenues within China of more than RMB400 million. However, since these regulatory actions are new, it is uncertain how soon legislative or administrative regulation making bodies will respond and what existing or new laws or regulations or detailed implementations and interpretations will be modified or promulgated, and the potential impact such modified or new laws and regulations will have on our daily business operation, our ability to accept foreign investments and our ability to list our securities on an U.S. or other foreign exchange.4

~~We intend to fund the growth of our business in large part by raising capital in Longduoduo through its sale of securities outside of the~~ PRC~~. The capital markets in the U.S. that we~~ ~~might~~Government access for financing will depend in large part on our ability to secure a listing on Nasdaq, OTCQX or one of the registered securities exchanges. The Trial Administrative Measures adopted by the China Securities Regulatory Commission (“CSRC”) on March 31, 2023 require that at the time we apply to an exchange (which for this purpose will include Nasdaq, OTCQB or OTCQX), we must file an extensive application with the CSRC and await approval by CSRC of the listing. The CSRC has indicated an intent to use these applications in order to protect the PRC from foreign control of (or significant influence over) important Chinese businesses. We cannot determine what criteria the CSRC will apply for this purpose. The regulations, therefore, create for our investors a risk that our efforts to finance Longduoduo Health Technology by selling Longduoduo securities abroad will be restricted, delayed or eliminated by CSRC’s implementation of the listing requirements in the Trial Administrative Measures. That risk, if realized, could prevent us from expanding Longduoduo Health Technology’s business, which could reduce or eliminate the value of Longduoduo common stock.Oversight

~~Summary~~Changes in China’s internal regulatory mandates, such as the M&A rules, Anti-Monopoly Law, and the Data Security Law, may target the Company’s corporate structure and impact our ability to conduct business in China, accept foreign investments, or list on a U.S. or other foreign exchange. Recently, the PRC government initiated a series of ~~Addiitonal~~regulatory ~~Risk~~actions ~~Factors~~affecting ~~Pertaining~~business operations in China with little advance notice, including banning certain activities in the securities market, enhancing supervision over China-based companies listed overseas using variable interest entity structure, adopting new measures to ~~Operations~~extend the scope of cybersecurity reviews, and expanding its efforts in anti-monopoly enforcement. The business of our subsidiaries until now has not been subject to cybersecurity review with the Cyberspace Administration of China, or CAC, given that: (i) data processed in our business does not have a bearing on national security and thus may not be classified as core or important data by the authorities; (ii) we have not yet approached the regulatory thresholds for holding personal information in our business operations. In addition, we are not subject to merger control review by China’s anti-monopoly enforcement agency due to the level of our revenues and the fact that we currently do not expect to propose or implement any acquisition of control of, or decisive influence over, any company with revenues within China of more than RMB400 million. However, since these regulatory actions are new, it is uncertain how soon legislative or administrative regulation making bodies will respond and what existing or new laws or regulations or detailed implementations and interpretations will be modified or promulgated, and the potential impact such modified or new laws and regulations will have on our daily business operation, our ability to accept foreign investments and our ability to list our securities on an U.S. or other foreign exchange.

~~There~~We intend ~~are~~to ~~additional~~fund ~~risks~~the ~~associated~~growth ~~with~~of our ~~operations~~ ~~being~~business in ~~the~~large part by raising capital in Longduoduo through its sale of securities outside of the PRC. The ~~following~~capital ~~summarizes~~markets ~~certain~~in ~~additional~~the ~~risk~~U.S. ~~factors~~ that ~~are~~we ~~discussed~~might inaccess ~~detail~~for financing will depend in large part on our ability to secure a listing on Nasdaq, OTCQX or one of the ~~section~~registered ~~titled~~securities exchanges. The Trial Administrative Measures adopted by the China Securities Regulatory Commission (“~~Risk~~CSRC”) ~~Factors:~~on ~~Risks~~March ~~related~~31, 2023 require that at the time we apply to ~~Doing~~an ~~Business~~exchange (which for this purpose will include Nasdaq, OTCQB or OTCQX), we must file an extensive application with the CSRC and await approval by CSRC of the listing. The CSRC has indicated an intent to use these applications in order to protect the PRC atfrom ~~page~~foreign 17control etof ~~seq~~(or significant influence over) important Chinese businesses. We cannot determine what criteria the CSRC will apply for this purpose. The regulations, therefore, create for our investors a risk that our efforts to finance Julong by selling Longduoduo securities abroad will be restricted, delayed or eliminated by CSRC’s implementation of the listing requirements in the Trial Administrative Measures. That risk, if realized, could prevent us from expanding business of Longduoduo’s chinese subsidiary, which could reduce or eliminate the value of Longduoduo common stock.

●Summary of ~~Changes~~Additional inRisk ~~United~~Factors ~~States~~Pertaining ~~and China relations, as well as relations with other countries, and/or regulations may adversely impact our business, our operating results, our ability~~ to ~~raise~~Operations ~~capital and the market price of our shares. As a U.S.-listed public company, we may face heightened scrutiny, criticism and negative publicity~~ in ~~the PRC, which could result in a material change in our operations and the value of our common stock.~~China

●There are ~~Uncertainties~~additional ~~with~~risks ~~respect~~associated towith ~~the~~our ~~PRC~~operations ~~legal~~being ~~system,~~in ~~including~~the ~~uncertainties~~PRC. ~~regarding~~The ~~the~~following ~~enforcement~~summarizes ofcertain ~~laws,~~additional ~~and~~risk ~~sudden~~factors orthat ~~unexpected~~are discussed ~~changes~~ in ~~laws~~detail ~~and regulations~~ in ~~China~~the ~~could~~section ~~adversely~~titled ~~affect~~“Risk usFactors: ~~and~~Risks ~~limit~~related ~~the legal protections available~~ to ~~your~~Doing ~~and~~Business ~~us. The dramatic growth of China and rapid changes~~ in ~~government policies since~~ the ~~1980s~~PRC ~~cause~~at ~~change~~page in17 ~~the~~et ~~legal system that make compliance difficult and policies unpredictable~~seq.

● ~~Because~~Changes ~~our~~in ~~principal~~United ~~assets~~States ~~are~~and ~~located~~China ~~outside~~relations, ofas ~~the~~well ~~United~~as ~~States~~relations ~~and~~with ~~because~~other ~~all~~countries, ofand/or ~~our~~regulations ~~directors~~may ~~and~~adversely ~~all~~impact our ~~officers~~business, ~~reside~~our ~~outside~~operating ofresults, ~~the~~our ~~United~~ability ~~States,~~to itraise ~~may~~capital beand ~~difficult~~the ~~for~~market ~~you~~price toof ~~use~~our ~~the~~shares. ~~United~~As ~~States~~a ~~Federal~~U.S.-listed ~~securities~~public ~~laws~~company, towe ~~enforce~~may ~~your~~face ~~rights~~heightened ~~against~~scrutiny, uscriticism and ~~our~~negative ~~officers~~publicity orin tothe ~~enforce~~PRC, ~~judgments~~which ofcould ~~United~~result ~~States~~in ~~courts~~a ~~against~~material uschange orin ~~them~~our inoperations and the ~~PRC~~value of our common stock.

● ~~The~~Uncertainties ~~fluctuation~~with respect to the PRC legal system, including uncertainties regarding the enforcement of ~~RMB~~laws, ~~may~~and ~~materially~~sudden or unexpected changes in laws and regulations in China could adversely affect ~~your~~us ~~investment.~~and Iflimit the ~~Chinese~~legal ~~government~~protections ~~reduces~~available ~~the~~to ~~relative~~your ~~value~~and us. The dramatic growth of ~~the~~China ~~RMB~~and ~~compared~~rapid tochanges ~~the~~in ~~U.S.~~government ~~Dollar,~~policies since the ~~value~~1980s incause ~~Dollars~~change ofin the ~~Company~~legal ~~will~~system ~~decline~~that make compliance difficult and policies unpredictable.

● WeBecause ~~may~~our ~~become~~principal ~~subject~~assets toare alocated ~~variety~~outside of ~~laws~~the United States and ~~regulations~~because inall ~~the~~of ~~PRC~~our ~~regarding~~directors ~~privacy,~~and ~~data~~all ~~security,~~our ~~cybersecutiry,~~officers ~~and~~reside ~~data~~outside ~~protection.~~of Wethe United States, it may be ~~liable~~difficult for ~~improper~~you to use the United States Federal securities laws to enforce your rights against us and our officers or ~~appropriation~~to enforce judgments of ~~personal~~United ~~information~~States ~~provided~~courts byagainst ~~our~~us ~~customers~~or them in the PRC.

● IfThe ~~Longduoduo~~fluctuation ~~common~~of ~~stock~~RMB ~~becomes~~may ~~listed~~materially onand ~~the~~adversely ~~OTCQB~~affect oryour aninvestment. ~~exchange,~~If wethe ~~will~~Chinese begovernment ~~required~~reduces ~~to obtain~~ the ~~approval~~relative value of the ~~PRC~~RMB ~~government~~compared ~~for~~to athe ~~business~~U.S. ~~combination~~Dollar, the ~~issuance~~value ofin ~~our~~Dollars ~~common~~of ~~stock,~~the orCompany ~~maintaining~~will ~~our status as a publicly listed company outside China~~decline.

5● We may become subject to a variety of laws and regulations in the PRC regarding privacy, data security, cybersecutiry, and data protection. We may be liable for improper use or appropriation of personal information provided by our customers.

~~Our~~● ~~Business~~If Longduoduo common stock becomes listed on the OTCQB or an exchange, we will be required to obtain the approval of the PRC government for a business combination, the issuance of our common stock, or maintaining our status as a publicly listed company outside China.

Our operating subsidiaries, Longduoduo Health Technology, Qingguo, Rongbin, Chengheng and Tianju, are each engaged in the business of providing high-quality preventive healthcare solutions to customers in the Inner Mongolia Province of China. Our primary business at the present time involves our subsidiaries’ sales on a commission basis of health maintenance services provided by Inner Mongolia Honghai Health Management Co., Ltd. Our operating subsidiaries also provide customers preventive healthcare solutions that our subsidiaries purchase from one or more of five providers under contract. These preventive healthcare solutions include a wide range of comprehensive preventive healthcare services, including disease screening, healthcare treatments, healthcare products and other services. The Company mainly focuses on prevention of myocardial infarction, cerebral infarction, hemiplegia, and cardiovascular and cerebrovascular diseases.5

~~Commissioned Sales~~Our Business

~~Since June of 2023, our~~ Our operating subsidiaries ~~have~~, ~~been~~Julong, ~~primarily~~Longduoduo ~~engaged in selling health maintenance services provided by Inner Mongolia Honghai~~ Health ~~Management~~Technology, ~~Co.~~Qingguo, ~~Ltd.~~Rongbin, ~~(“Honghai”). During~~Chengheng, ~~the~~Tianju ~~year~~and ~~ended June 30~~Yihua, ~~2024~~serve, ~~over~~for ~~95%~~some ~~of our gross revenue represented commissions paid to our operating subsidiaries by Honghai.~~customers, ~~Each~~as ~~operating~~sales ~~subsidiary~~agents isfor third-party tohealthcare aservice ~~separate~~providers ~~Sales Agency Agreement with Honghai~~and, ~~each~~for ~~dated~~other ~~June 20~~customers, ~~2023~~as ~~and~~distributors ~~expiring on June 20, 2026, although the content~~ of ~~the~~services ~~five~~provided ~~Sales~~by ~~Agency~~third-party healthcare ~~Agreements~~service ~~are~~providers. ~~identical~~In ~~but~~both ~~for~~arrangements, the ~~name~~health ofcare ~~the~~providers ~~agent:~~provide ~~Longduoduo~~comprehensive ~~Health~~and ~~Technology~~high-quality preventive healthcare ~~Co.~~solutions, ~~Ltd,~~including ~~Inner~~disease ~~Mongolia Rongbin Health Consulting Co.~~screening, ~~Ltd,~~healthcare ~~Inner Mongolia Chengheng Health Consulting Co.~~treatments, ~~Ltd,~~healthcare ~~Inner~~products ~~Mongolia~~and ~~Qinguo Health~~other ~~Consulting Co~~services., ~~Ltd.~~The orCompany ~~Inner~~mainly ~~Mongolia~~focuses ~~Tianju~~on prevention ~~Health~~of ~~Consulting~~myocardial ~~Company~~infarction, ~~Limited.~~cerebral ~~Among~~infarction, ~~the~~hemiplegia, ~~principal~~and ~~terms~~cardiovascular ofand ~~the~~cerebrovascular ~~Sales Agency Agreements are:~~diseases.

~~● Honghai is responsible for developing and providing services, and our operating subsidiary (the “Agent”) is responsible for promoting and selling the services.~~ Commissioned Sales

●Since June ~~When~~of 2023, our operating subsidiaries have been primarily engaged in selling health maintenance services provided by Inner Mongolia Honghai Health Management Co., Ltd. (“Honghai”). During the year ended June 30, 2025, over 97% of our gross revenue came from commissions earned through our agency relationship with Honghai. Each operating subsidiary is party to a separate Sales Agency Agreement with ~~was~~Honghai, ~~signed~~each dated June 20, 2023 and expiring on June 20, 2026, although the ~~specific~~content ~~services~~of tothe befive ~~marketed~~Sales ~~were~~Agency Agreements are identical but for the name of the agent: ~~trioxygen~~Longduoduo ~~autotransfusion~~Health Technology Co., ~~awakening~~Ltd, ~~brain~~Inner ~~and~~Mongolia ~~dredging~~Rongbin ~~collaterals~~Health Consulting Co., ~~double~~Ltd, ~~blood~~Inner ~~purification~~Mongolia Chengheng inHealth ~~German~~Consulting ~~technology~~Co., ~~hyperbaric trioxygen~~Ltd, ~~colon~~Inner ~~hydrotherapy,~~Mongolia ~~intestinal~~Qinguo ~~flora~~Health ~~transplantation~~Consulting Co., ~~custom-made~~Ltd. ~~Juncao~~or ~~and~~Inner ~~combinations~~Mongolia ofTianju ~~these~~Health ~~services~~Consulting Company Limited. Among the principal terms of the Sales Agency Agreements are:

● If Honghai ~~develops~~is ~~new~~responsible ~~services,~~for ~~the~~developing ~~Agent~~and ~~will~~providing ~~have~~services, ~~the~~and ~~option~~our tooperating ~~market~~subsidiary (the ~~new~~“Agent”) ~~services~~is atresponsible afor ~~price~~promoting toand beselling ~~negotiated with Honghai in accordance with criteria set in~~ the ~~Sales Agency Agreement~~services.

● ~~The~~When ~~Agent~~the isSales ~~responsible~~Agency ~~for~~Agreement ~~collecting~~was ~~payment~~signed, onthe ~~each~~specific ~~sale~~services to be marketed were: trioxygen autotransfusion, awakening brain and ~~forwarding~~dredging ~~the~~collaterals, ~~payment~~double toblood ~~Honghai~~purification ~~net~~in ofGerman ~~the~~technology, ~~pre~~hyperbaric trioxygen, colon hydrotherapy, intestinal flora transplantation, custom-~~approved~~made ~~settlement~~Juncao ~~amount~~and –combinations ~~i.e.~~of ~~commission~~these services.

● If Honghai ~~bears~~develops ~~all~~new ~~responsibility~~services, ~~for~~the Agent will have the ~~quality~~option ofto market the new services ~~and~~at ~~for~~a ~~any~~price ~~liability~~ to ~~customers~~be ~~arising~~negotiated ~~from~~with Honghai in accordance with criteria set in the ~~services~~Sales Agency Agreement.

6● The Agent is responsible for collecting payment on each sale, and forwarding the payment to Honghai net of the pre-approved settlement amount – i.e. commission.

~~Principal~~● ~~Sales~~Honghai bears all responsibility for the quality of the services and for any liability to customers arising from the services.

Before we entered the Sales Agency Agreements with Honghai, our operating subsidiaries marketed healthcare services and products exclusively as principals, by purchasing and reselling services and products from third-party healthcare service providers such as hospitals to serve customers located in Hohhot, Ordos, Baotou and Ulanqab, cities in Inner Mongolia. We continue that business, although “service revenue” from these principal sales fell by almost 82% in the year ended June 30, 2024 from the service revenue recorded in the year ended June 30, 2023. Our intention, after we have built a firm foundation for our agency sales business, is to return our attention to principal sales and build a network of third-party healthcare service providers, product suppliers and our sales agents so that we can offer a broader array of products and services to potential customers.6

~~Currently, working with our third-party healthcare~~Principal ~~service providers, our operating subsidiaries provide, as principal, the preventive healthcare solutions including below:~~Sales

●Before we ~~Meridian-regulating~~entered the Sales Agency Agreements with Honghai, our operating subsidiaries marketed healthcare services and ~~Consciousness-restoring~~products ~~Iatrotechnics~~exclusively as principals, by purchasing and reselling services and products from third-party ahealthcare ~~traditional~~service ~~Chinese~~providers ~~medicine~~such ~~treatment~~as hospitals to serve customers located in Hohhot, Ordos, Baotou and Ulanqab, cities in Inner Mongolia. We continue that business, although “service revenue” from these principal sales fell by almost 63% in the year ended June 30, 2025 from the service revenue recorded in the year ended June 30, 2024. Our intention, after we have built a firm foundation for our agency sales business, is ~~anti-thrombotic~~to return our attention to ~~prevent~~principal sales and ~~treat~~build ~~cardiovascular~~a network of third-party healthcare service providers, product suppliers and ~~cerebrovascular~~our ~~diseases~~sales agents so that we can offer a broader array of products and services to potential customers.

●Currently, working ~~Double~~with ~~Blood~~our ~~Purification~~third-party –healthcare ~~treatment~~service ~~for~~providers, ~~cardiovascular~~our ~~and~~operating ~~cerebrovascular~~subsidiaries ~~diseases~~provide, ~~that~~as ~~involves~~principal, the ~~removal~~preventive ofhealthcare solutions ~~pathogens~~including ~~and toxins from the blood through physical means such as filtration.~~below:

● ~~Immunological~~Meridian-regulating ~~Ozonated~~and ~~Autohemotherapy;~~Consciousness-restoring ~~the Third~~Iatrotechnics-~~generation~~ ~~Ozone~~a ~~Therapy~~traditional ~~Device~~Chinese –medicine ~~Autologous~~treatment ~~Blood~~that ~~Immunotherapy~~is anti-thrombotic ~~prevention~~to prevent and ~~treatment~~treat of cardiovascular and cerebrovascular diseases ~~relying on the use of an ozone therapy device to remove pathogens and toxins from the blood~~.

● ~~PRP~~Double ~~(platelet-rich~~Blood ~~plasma)~~Purification – ~~prevention~~treatment for cardiovascular and ~~treatment~~cerebrovascular ofdiseases ~~joint~~that ~~inflammation~~involves the removal of pathogens and ~~injury~~toxins ~~through~~from the ~~use~~blood ofthrough ~~platelet~~physical ~~rich~~means ~~plasma~~such as filtration.

● ~~Relaxation~~Immunological ~~therapy~~Ozonated Autohemotherapy; the Third-generation aOzone ~~traditional~~Therapy ~~Chinese~~Device ~~medicine~~– Autologous Blood Immunotherapy - prevention and treatment ~~that~~of iscardiovascular ~~used~~and tocerebrovascular ~~treat~~diseases ~~joint~~relying ~~function~~on ~~limitation~~the ~~caused~~use byof ~~soft~~an ~~tissue~~ozone ~~adhesion~~therapy ~~such~~device asto ~~periarthritis~~remove ofpathogens ~~shoulder~~and toxins from the blood.

● ~~Vegetative~~PRP ~~Nerve~~(platelet-rich ~~Regulation~~plasma) -– aprevention and treatment ~~for~~of ~~neck,~~joint ~~shoulder,~~inflammation ~~back~~ and ~~leg~~injury ~~pain~~through the use of platelet rich plasma.

● ~~Microwave~~Relaxation ~~Therapy~~therapy –- ~~through~~a ~~the~~traditional ~~use~~Chinese ofmedicine ~~specific~~treatment ~~equipment,~~that ~~heat~~ is ~~provided~~used ~~deep into the skin~~ to ~~reduce~~treat ~~inflammation,~~joint ~~detumescence,~~function ~~relieve~~limitation ~~pain~~caused ~~and~~by ~~improve~~soft tissue ~~blood~~adhesion ~~circulation,~~such ~~prevent~~as ~~and cure lumbar muscle strain, arthritis,~~ periarthritis of ~~shoulders and other diseases~~shoulder.

7● Vegetative Nerve Regulation - a treatment for neck, shoulder, back and leg pain.

~~All~~● ~~medical~~Microwave ~~services~~Therapy ~~above~~– ~~are~~through ~~provided~~the byuse ~~healthcare service~~of ~~providers~~specific ~~that are licensed medical institutions~~equipment, ~~such~~heat asis ~~hospitals~~provided ordeep ~~medical~~into ~~clinics.~~the ~~These~~skin ~~medical~~to ~~services~~reduce ~~are~~inflammation, ~~provided~~detumescence, ~~directly to~~relieve ~~our~~pain ~~customer~~and byimprove ~~our~~tissue ~~healthcare~~blood ~~service providers~~circulation, prevent and ~~our~~cure ~~healthcare~~lumbar ~~service~~muscle ~~providers~~strain, ~~bear~~arthritis, ~~the~~periarthritis ~~risk~~ of ~~liability~~shoulders ~~related~~and toother ~~the medical procedures~~diseases.

~~Our operating subsidiaries have contracted with five third-party healthcare service providers. The contracts are set out below:~~7

●All medical ~~Cooperation~~services ~~Agreement,~~above ~~dated~~are ~~March~~provided ~~26, 2021 and expiring on March 31, 2026,~~ by ~~and~~healthcare ~~between~~service ~~Inner~~providers ~~Mongolia~~that ~~Qinguo~~are ~~Health~~licensed ~~Consulting~~medical ~~Co.~~institutions, ~~Ltd.~~such ~~and~~as ~~Hohhot~~hospitals ~~Aihua~~or ~~Traditional Chinese Medicine Hospital, which is located in Hohhot~~medical clinics. ~~Under~~These ~~the~~medical ~~terms~~services ofare ~~this~~provided ~~agreement,~~directly ~~Hohhot~~to ~~Aihua~~our ~~Traditional~~customer ~~Chinese~~by ~~Medicine~~our ~~Hospital~~healthcare ~~offers~~service ~~services such as “Immunological Ozonated Autohemotherapy”~~providers, ~~“Meridian-regulating~~ and ~~Consciousness-restoring~~our ~~Iatrotechnics”,~~healthcare ~~“PRP”,~~service providers ~~“Relaxation~~bear ~~therapy”,~~the ~~“Vegetative~~risk ~~Nerve~~of ~~Regulation~~liability ~~(anterior)”~~related ~~and~~to ~~other~~the ~~conventional~~medical ~~therapies~~procedures.

●Our operating ~~Leasing~~subsidiaries ~~and~~have ~~Cooperation~~contracted ~~Agreement,~~with ~~dated~~four ~~October~~third-party ~~15,~~healthcare ~~2020~~service ~~and expiring on October 15, 2025, by and between Longduoduo Health Technology Co~~providers., ~~Ltd~~The ~~and~~contracts ~~Baotou~~are ~~Jinshi~~set ~~Zhongyi~~out Nephropathy Hospital, which is located in Baotou. Under the terms of this agreement, Baotou Jinshi Zhongyi Nephropathy Hospital offers services such as “Meridian-regulating and Consciousness-restoring Iatrotechnics”, “Double Blood Purification” and “Immunological Ozonated Autohemotherapy”.below:

● Cooperation Agreement, dated ~~May~~March 2926, 2021 and expiring on ~~May~~March 2831, 2026, by and between Inner Mongolia ~~Chengheng~~Qinguo Health Consulting Co., Ltd. and ~~Zhongyi~~Hohhot ~~Hospital~~Aihua ~~Branch~~Traditional ofChinese ~~Inner~~Medicine ~~Mongolia Jiuzun Health Examination Co.~~Hospital, ~~Ltd,~~ which is located in ~~Ordos~~Hohhot. Under the terms of this agreement, ~~Zhongyi~~Hohhot ~~Hospital~~Aihua ~~Branch~~Traditional ofChinese ~~Inner~~Medicine ~~Mongolia~~Hospital ~~Jiuzun Health Examination Co., Ltd~~ offers services such as “~~the~~Immunological ~~Third~~Ozonated Autohemotherapy”, “Meridian-~~generation~~regulating ~~Ozone~~and ~~Therapy~~Consciousness-restoring ~~Device~~Iatrotechnics”, –“PRP”, ~~Autologous~~“Relaxation ~~Blood~~therapy”, ~~Immunotherapy~~“Vegetative Nerve Regulation (anterior)” and other conventional therapies.

● Leasing and Cooperation Agreement, dated ~~June~~October 2015, ~~2021~~2020 and expiring on ~~June~~October 1915, ~~2026~~2025, by and between Longduoduo Health Technology Co., Ltd and ~~Ulanqab~~Baotou ~~Mengzhong~~Jinshi ~~Rehabilitation~~Zhongyi ~~TCM~~Nephropathy Hospital ~~Co.~~, ~~Ltd,~~ which is located in ~~Ulanqab~~Baotou. Under the terms of this agreement, ~~Ulanqab~~Baotou ~~Mengzhong~~Jinshi ~~Rehabilitation~~Zhongyi ~~TCM~~Nephropathy Hospital ~~Co., Ltd~~ offers services such as “~~Immunological Ozonated Autohemotherapy”, “~~Meridian-regulating and Consciousness-restoring Iatrotechnics”, “~~PRP”,~~Double ~~“Relaxation~~Blood ~~therapy~~Purification”, ~~“Vegetative Nerve Regulation”~~ and ~~other~~“Immunological ~~conventional~~Ozonated ~~therapies~~Autohemotherapy”.

● Cooperation Agreement, dated ~~September~~November 518, ~~2021~~2024 and expiring on ~~September~~November 418, ~~2026~~2027, by and between ~~Longduoduo~~Inner Mongolia Chengheng Health ~~Technology~~Consulting Co., Ltd and ~~Ordos~~Inner ~~Xinhai~~Mongolia ~~Yihecheng~~Jiuzun ~~Mengzhongyi~~Health ~~Hospital~~Examination Co., Ltd, which is located in Ordos. Under the terms of this agreement, ~~Ordos~~Zhongyi ~~Xinhai~~Hospital ~~Yihecheng~~Branch ~~Mengzhongyi~~of ~~Hospital~~Inner ~~offers~~Mongolia ~~services~~Jiuzun ~~such~~Health asExamination ~~“Immunological~~Co., ~~Ozonated~~Ltd ~~Autohemotherapy”,~~offers ~~“2000ml~~customers ~~Immunological~~of ~~Ozonated~~Chengheng ~~Autohemotherapy”~~services ~~and~~such as “~~Meridian~~the Third-~~regulating~~generation ~~and~~Ozone ~~Consciousness-restoring~~Therapy ~~Iatrotechnics”~~Device ~~etc~~– Autologous Blood Immunotherapy”.

8● Cooperation Agreement, dated June 20, 2021 and expiring on June 19, 2026, by and between Longduoduo Health Technology Co., Ltd and Ulanqab Mengzhong Rehabilitation TCM Hospital Co., Ltd, which is located in Ulanqab. Under the terms of this agreement, Ulanqab Mengzhong Rehabilitation TCM Hospital Co., Ltd offers services such as “Immunological Ozonated Autohemotherapy”, “Meridian-regulating and Consciousness-restoring Iatrotechnics”, “PRP”, “Relaxation therapy”, “Vegetative Nerve Regulation” and other conventional therapies.

Our operating subsidiaries pay service fees to these third-party healthcare service providers based on the number of health products, medical examinations and the services they provide for our customers. We carefully select our third-party healthcare service provider based on our internal assessment of the quality of the provider’s institution and staff. We assess potential third-party healthcare service providers and chose future third-party healthcare service providers that fit our business based on the following points:8

●Our operating ~~Services:~~subsidiaries ~~whether~~pay service fees to these third-party healthcare service providers ~~offer~~based on the ~~required~~number orof ~~complementary~~health ~~services~~products, medical examinations and the ~~venue~~services &they ~~qualifications~~provide for ~~the~~our ~~cooperation~~customers. ~~programs~~We ascarefully ~~well~~select asour ~~the~~third-party ~~management~~healthcare service provider based on our internal assessment of ~~medical~~the quality &of ~~safety,~~the ~~medical~~provider’s institution and staff,. ~~medicines~~We assess potential third-party healthcare service providers and ~~consumables;~~chose future third-party healthcare service providers that fit our business based on the following points:

● ~~Location:~~Quality ~~whether~~of Services – including required and complementary services, the quality of the venue, isas ~~convenient~~well ~~for~~as ~~our~~the ~~customers.~~quality of management, medicines, consumables etc;

● ~~Price~~Location: whether the ~~medical~~venue ~~examination~~is ~~and~~convenient ~~treatment~~for ~~price~~our ~~is acceptable~~customers.

● ~~Reputation~~Price: whether the ~~providers~~medical ~~have~~examination aand ~~good~~treatment ~~reputation~~price is acceptable.

● ~~Equipment~~Reputation: whether the ~~provider~~providers ~~possess~~have ~~advanced~~a ~~medical~~good ~~equipment~~reputation.

~~Our~~● ~~Plan~~Equipment: ~~for~~whether ~~Growth~~the provider possess advanced medical equipment.

~~In the long run, by leveraging our growing network~~Our ofPlan ~~medical~~for centers, large and loyal customer base, established demographic and disease information database, we plan to expand the scope of our service offerings and ultimately establish our company as a leading health management service provider and sales agency in China. We intend to achieve our goal by implementing the following strategies:Growth

●In the ~~further~~long ~~expanding~~run, by leveraging our ~~product~~growing network of medical centers, large and loyal customer base, established demographic and disease information database, we plan to expand the scope of our service offerings; and ultimately establish our company as a leading health management service provider and sales agency in China. We intend to achieve our goal by implementing the following strategies:

● ~~continuing~~further toexpanding ~~expand~~ our ~~network~~product ~~coverage nationwide~~offerings; ~~and~~

● ~~further~~continuing ~~upgrading~~to expand our ~~service~~network ~~standards~~coverage tonationwide; ~~enhance the customer experience.~~and

~~The~~● ~~successful~~further ~~execution~~upgrading of our ~~business~~service ~~plan is~~standards ~~subject~~ to ~~risks~~enhance ~~and~~the ~~uncertainties~~customer ~~related to our business and industry, including those relating to our ability to:~~experience.

●The successful ~~maintain~~execution of our business plan is subject to risks and ~~enhance~~uncertainties ~~the~~related ~~recognition~~to our business and ~~reputation~~industry, ofincluding those relating to our ~~operating~~ability ~~subsidiaries;~~to:

● ~~compete~~maintain ~~effectively~~and enhance the recognition and reputation of our operating subsidiaries;

● ~~manage~~compete ~~our growth and execute our strategies~~ effectively;

● ~~offer~~manage ~~services~~our atgrowth ~~attractive~~and ~~prices~~execute toour ~~meet~~strategies ~~customer needs and preferences~~effectively;

● ~~manage~~provide superior customer experience and ~~expand~~offer ~~our~~services ~~relationships~~at ~~with~~attractive ~~suppliers~~prices ~~and~~to ~~third-party~~meet ~~service~~customer ~~providers;~~needs and preferences;

● ~~secure~~manage and ~~retain~~expand ~~the~~our ~~services~~relationships ofwith ~~qualified~~suppliers ~~personnel.~~and third-party service providers; and

9● secure and retain the services of qualified personnel.

We face significant competition from two main types of competitors: the medical examination departments of major public hospitals and private medical examination companies. Some of our current or future competitors may have longer operating histories, greater brand recognition, better supplier relationships, larger customer bases or greater financial, technical or marketing resources than we do. There is no assurance that we will be able to successfully compete against these larger and better funded competitors.9

~~Our~~We face ~~performance~~significant ~~will~~competition befrom ~~largely~~two ~~dependent~~main ontypes of competitors: the ~~talents~~ ~~and~~medical ~~efforts~~examination departments of ~~highly~~major ~~skilled~~public ~~individuals.~~hospitals ~~Future~~and ~~success~~private medical ~~depends~~examination oncompanies. Some of our ~~continuing~~current ~~ability~~or tofuture ~~identify,~~competitors ~~hire,~~may ~~develop,~~have ~~motivate and~~longer ~~retain~~operating ~~highly~~histories, ~~qualified~~greater ~~personnel~~brand ~~for~~recognition, better ~~all~~supplier ~~areas~~relationships, oflarger ~~our~~customer ~~organization.~~bases ~~Competition~~or ~~for~~greater ~~such~~financial, ~~qualified~~technical ~~employees~~or ismarketing ~~intense.~~resources Ifthan we do ~~not~~. ~~succeed~~There inis ~~attracting~~no ~~excellent~~assurance that ~~personnel~~we orwill inbe ~~retaining~~able orto ~~motivating~~successfully ~~them,~~compete weagainst ~~may~~these belarger ~~unable~~and tobetter ~~grow~~funded ~~effectively~~competitors.

WeOur performance ~~rely~~will onbe ~~our~~largely ~~third-party~~dependent ~~healthcare~~on ~~service providers~~the totalents ~~provide~~and ~~services~~efforts toof ~~our~~highly ~~customers~~skilled ~~under cooperation arrangements with us~~individuals. WeFuture ~~require~~success ~~and~~depends ~~expect~~on ~~these~~our ~~third-party healthcare~~continuing ~~service~~ability ~~providers~~ to ~~possess~~identify, ~~the~~hire, ~~licenses~~develop, motivate and ~~qualifications~~retain ~~that~~highly ~~are~~qualified ~~required~~personnel for ~~their~~all ~~operations~~areas ~~and~~of toour ~~adhere~~organization. toCompetition ~~certain performance~~for ~~standards~~such ~~both~~qualified inemployees ~~terms~~is ~~of customer service and the quality of the medical care that they provide~~intense. WeIf ~~generally~~we do not ~~have~~succeed ~~control~~in ~~over the~~attracting ~~quality~~excellent ofpersonnel ~~service~~ or ~~medical~~in ~~care~~retaining ~~that these third-parties provide. They may not at all times possess the permits~~ or ~~qualifications required~~motivating ~~by laws and regulations or may fail to meet other regulatory requirements for their operations. In addition~~them, ~~they~~we may ~~engage~~ inbe ~~conduct~~unable ~~which~~to ~~our~~grow ~~customers find unacceptable, including providing poor service, mishandling sensitive personal healthcare information or committing medical malpractice~~effectively.

~~Operating~~We rely ~~Licenses~~on our third-party healthcare service providers to provide services to our customers under cooperation arrangements with us. We require and expect these third-party healthcare service providers to possess the licenses and qualifications that are required for their operations and to adhere to certain performance standards both in terms of customer service and the quality of the medical care that they provide. We generally do not have control over the quality of service or medical care that these third-parties provide. They may not at all times possess the permits or qualifications required by laws and regulations or may fail to meet other regulatory requirements for their operations. In addition, they may engage in conduct which our customers find unacceptable, including providing poor service, mishandling sensitive personal healthcare information or committing medical malpractice.

~~Our products and services are subject to regulation~~Operating by governmental agencies in the PRC and Inner Mongolia Province. Business and company registrations are certified on a regular basis and must be in compliance with the laws and regulations of the PRC and provincial and local governments and industry agencies, which are controlled and monitored through the issuance of licenses. Our licenses include:Licenses

●Our products ~~Longduoduo~~and ~~Health~~services ~~Technology’s~~are ~~operating~~subject ~~license~~to ~~enables~~regulation itby togovernmental ~~undertake~~agencies ~~medical~~in ~~information~~the ~~consulting~~PRC ~~services,~~and ~~corporate~~Inner ~~management~~Mongolia ~~consulting,~~Province. ~~health~~Business ~~management~~and ~~consulting~~company registrations ~~services~~are certified on a regular basis and somust ~~on.~~be ~~The~~in ~~registration~~compliance ~~number~~with isthe ~~91150104MA0QTDXG5T,~~laws ~~which~~and isregulations ~~valid~~of ~~from~~the ~~August~~PRC ~~20,~~and ~~2020,~~provincial and local ~~expires~~governments onand ~~August~~industry 19agencies, ~~2050~~which are controlled and monitored through the issuance of licenses. Our licenses include:

● ~~Qingguo~~Longduoduo Health Technology’s operating license enables it to undertake ~~sales~~medical ofinformation ~~food~~consulting services, ~~health~~corporate management consulting ~~services~~, ~~and~~health ~~medical~~management ~~information~~ consulting services and so on. The registration number is ~~91150104MA13Q5X152~~91150104MA0QTDXG5T, which is valid from ~~June~~August 1820, 2020, ~~with~~and noexpires ~~expiration~~on ~~date~~August 19, 2050.

● ~~Rongbin~~Qingguo’s operating license enables it to undertake ~~medical~~sales ~~information~~of ~~consulting services~~food, ~~corporate~~health management consulting services, and ~~health~~medical ~~management~~information consulting services. The registration number is ~~91150207MA13UKC301~~91150104MA13Q5X152, which is valid from ~~March~~June 18, ~~2021~~2020, ~~and~~with ~~expires~~no onexpiration ~~March 17, 2051~~date.

● ~~Chengheng~~Rongbin’s operating license enables it to undertake medical information consulting services, corporate management consulting, and health management consulting services. The registration number is ~~91150602MA7YN4JE2Q~~91150207MA13UKC301, which is valid from ~~April~~March 0918, 2021, and expires on ~~April~~March 0817, 2051.

● ~~Tianju~~Chengheng’s operating license enables it to undertake ~~sales of class I~~ medical ~~equipment,~~information ~~pre-packaged~~consulting ~~food~~services, ~~hygiene~~corporate ~~products,~~management ~~cosmetics~~consulting, and ~~disinfection products;~~ health management consulting services; medical information consulting services; software development; biotechnology promotion services; beauty services (excluding medical beauty), technical services, and technology Consultation; leasing of medical equipment. The registration number is ~~91150902MA7YPWL408~~91150602MA7YN4JE2Q, which is valid from ~~July~~April 509, 2021, toand ~~July~~expires 4on April 08, 2051.

10● Tianju’s operating license enables it to undertake sales of class I medical equipment, pre-packaged food, hygiene products, cosmetics, and disinfection products; health management consulting services; medical information consulting services; software development; biotechnology promotion services; beauty services (excluding medical beauty), technical services, and technology Consultation; leasing of medical equipment. The registration number is 91150902MA7YPWL408, which is valid from July 5, 2021 to July 4, 2051. ● Julong’s Business License enables us to undertake health management consulting services (excluding medical services) and other related services. The registration number is 91110112MADR3N7X9U, which is valid from July 23, 2024, with no expiration date. ● Yihua’s Business License enables us to undertake health management consulting services (excluding medical services) and other related services. The registration number is 91110112MADEPYKMXX, which is valid from March 14, 2024, with no expiration date.

The PRC legal system is based on written statutes. Prior court decisions may be cited for reference but have limited precedential value. In 1979, the PRC government began to promulgate a comprehensive system of laws and regulations governing economic matters in general, such as foreign investment, corporate organization and governance, commerce, taxation and trade. However, since the PRC legal system continues to evolve rapidly, the interpretations of many laws, regulations and rules are not always uniform and enforcement of these laws, regulations and rules involves uncertainties, which may limit legal protections available to us. Uncertainties due to evolving laws and regulations could also impede the ability of a China-based company, such as Longduoduo Health Technology, to obtain or maintain permits or licenses required to conduct business in China. In the absence of required permits or licenses, governmental authorities could impose material sanctions or penalties on us or could revoke our authority to carry on business. In addition, some regulatory requirements issued by certain PRC government authorities may not be consistently applied by other PRC government authorities (including local government authorities), thus making strict compliance with all regulatory requirements impractical, or in some circumstances impossible.10

~~Competition~~The PRC legal system is based on written statutes. Prior court decisions may be cited for reference but have limited precedential value. In 1979, the PRC government began to promulgate a comprehensive system of laws and regulations governing economic matters in general, such as foreign investment, corporate organization and governance, commerce, taxation and trade. However, since the PRC legal system continues to evolve rapidly, the interpretations of many laws, regulations and rules are not always uniform and enforcement of these laws, regulations and rules involves uncertainties, which may limit legal protections available to us. Uncertainties due to evolving laws and regulations could also impede the ability of a China-based company, such as Longduoduo Health Technology, to obtain or maintain permits or licenses required to conduct business in China. In the absence of required permits or licenses, governmental authorities could impose material sanctions or penalties on us or could revoke our authority to carry on business. In addition, some regulatory requirements issued by certain PRC government authorities may not be consistently applied by other PRC government authorities (including local government authorities), thus making strict compliance with all regulatory requirements impractical, or in some circumstances impossible.

We face significant competition from two main types of competitors: the medical examination departments of major public hospitals and private medical examination companies. The private medical examination market is further segmented into (i) large national companies; (ii) regional providers; (iii) numerous local independent medical examination centers located in nearly every city in China; and other sales agencies of health services.Competition

We face ~~believe~~significant ~~our~~competition ~~primary~~from ~~competitive~~two ~~advantages over~~main ~~our~~types ~~competitors~~of ~~include~~competitors: the medical examination departments of major public hospitals and private medical examination companies. The private medical examination market is further segmented into (i) large national companies; (ii) regional providers; (iii) numerous local independent medical examination centers located in nearly every city in China; and other sales agencies of health services.

●We believe ~~strong~~our ~~sales~~primary ~~and~~competitive ~~marketing~~advantages ~~efforts;~~over ~~and~~our competitors include:

● ~~the~~strong ~~innovation~~sales ~~of the market business idea~~ and ~~flexible~~marketing ~~management mechanism.~~efforts;

We● ~~believe~~our ~~that~~innovative weapproach ~~are well-positioned~~ to ~~effectively compete on~~ the ~~basis~~health ofcare ~~the~~market; factors listed above. However, some of our current or future competitors may have longer operating histories, greater brand recognition, better supplier relationships, larger customer bases or greater financial, technical or marketing resources than we do. There is no assurance that we will be able to successfully compete against these larger and ~~better funded competitors.~~

~~Income~~● ~~Taxes~~Our flexible management mechanism.

~~United~~We believe ~~States~~that we are well-positioned to effectively compete on the basis of the factors listed above. However, some of our current or future competitors may have longer operating histories, greater brand recognition, better supplier relationships, larger customer bases or greater financial, technical or marketing resources than we do. There is no assurance that we will be able to successfully compete against these larger and better funded competitors.

~~Longduoduo Company Limited is subject to a tax~~Income ~~rate of 21% in the United States of America.~~ Taxes

~~Hong Kong~~United States

Longduoduo ~~HK was incorporated in Hong Kong~~ ~~and~~Company isLimited ~~subject to Hong Kong profits tax. Longduoduo HK~~ is subject to ~~Hong~~a ~~Kong taxation on its activities conducted in Hong Kong and income arising in or derived from Hong Kong. The applicable statutory~~ tax rate isof ~~16.5~~21%. ~~The~~in ~~Company did not have any income (loss) subject to~~ the ~~Hong~~United ~~Kong~~States ~~profits~~of ~~tax~~America.

~~China~~Hong Kong

Longduoduo HK and ~~Health~~LDDJK ~~Technology~~were incorporated in Hong Kong and ~~subsidiaries~~ is subject to Hong Kong profits tax. They are subject to aHong ~~25%~~Kong ~~standard~~taxation ~~enterprise~~on ~~income~~its activities ~~tax~~conducted in ~~the~~Hong ~~PRC.~~Kong ~~The~~and ~~Company~~income ~~accrued~~arising ~~$523,207~~in ~~and~~or ~~$10,246~~derived offrom ~~PRC~~Hong ~~income~~Kong. The applicable statutory tax ~~for~~rate ~~the~~is ~~years~~16.5%. The ~~ended~~Company ~~June~~has ~~30,~~not ~~2024~~had ~~and~~any ~~2023~~income (loss) subject to the Hong Kong profits tax.

~~Employees~~China

~~The~~Julong and ~~Company~~its ~~has~~subsidiaries 49are ~~full-time~~subject ~~employees.~~to Ofa ~~those 49,~~25% ~~Qingguo~~standard ~~has~~enterprise 10income ~~full-time~~tax ~~employees,~~in ~~Rongbin~~the ~~has~~PRC. 12The ~~full-time~~Company ~~employees~~accrued $222,268 ~~Chengheng~~and ~~has 7 full-time employees~~$523,207 ~~Tianju~~of ~~has~~PRC income 4tax ~~full-time employees~~for ~~and~~the ~~Longduoduo~~years ~~Health~~ended ~~Technology~~June ~~has~~30, 162025 ~~full-time~~and ~~employees~~2024.

~~The Company’s employees include 10 with management responsibilities, 20 with administrative and operations responsibilities, and 19 responsible for customer services.~~Employees

~~All~~The Company ofhas ~~our~~52 full-time employees. ~~are~~Of ~~located~~those in49, ~~the~~Qingguo ~~PRC.~~has ~~None~~10 full-time employees, Rongbin has 14 full-time employees, Chengheng has of6 ~~our~~full-time employees, ~~are~~Tianju ~~represented~~has by6 afull-time ~~labor~~employees ~~union~~and orLongduoduo ~~similar~~Health ~~collective~~Technology ~~bargaining~~has ~~organization~~16 full-time employees.

11The Company’s employees include 10 with management responsibilities, 19 with administrative and operations responsibilities, and 23 responsible for customer services.

~~Item~~All of 1Aour employees are located in the PRC. ~~Risk~~None ~~Factors~~of our employees are represented by a labor union or similar collective bargaining organization.

An investment in our common stock involves a high degree of risk. You should carefully consider the following risk factors and other information in this 10K before deciding to invest in our Company. If any of the following risks actually occur, our business, financial condition and results of operations could be seriously harmed. As a result, the trading price of our common stock could decline and you could lose all or part of your investment.11

~~Risks~~Item 1A. ~~Related~~Risk ~~to Our Business~~Factors.

~~95%~~An investment ofin our ~~revenue~~common ~~during~~stock involves a high degree of risk. You should carefully consider the ~~year~~following ~~ended June~~risk ~~30,~~factors ~~2024~~and ~~came~~other ~~from~~information in athis ~~single~~10K ~~source:~~before ~~Inner~~deciding ~~Mongolia~~to ~~Honghai~~invest ~~Health~~in ~~Management~~our CoCompany., ~~Ltd.~~If ~~Termination~~any of the following risks actually occur, our ~~relationship~~business, ~~with~~financial ~~Honghai~~condition ~~would~~and ~~likely~~results ~~have~~of ~~serious~~operations ~~adverse~~could ~~effects~~be onseriously harmed. As a result, the trading price of our ~~financial~~common ~~results~~stock could decline and you could lose all or part of your investment.

~~In June 2023 each of our operating subsidiaries~~Risks ~~entered~~Related ~~into identical Sales Agency Agreements with Inner Mongolia Honghai Health Management Co., Ltd. (“Honghai”), pursuant~~ to ~~which~~Our our operating subsidiaries serve as sales agents for services provided by Honghai and receive commissions on the sales they initiate. During the year ended June 30, 2024, commissions from sales on behalf of Honghai represented over 95% of our Company’s revenues, while revenues from principal sales, our focus before engaging with Honghai, fell by almost 82%.Business

~~The~~97% of ~~Sales~~our ~~Agency~~revenue ~~Agreements~~during ~~terminate~~the inyear ended June ~~2026~~ 30, ~~and~~2025 ~~there~~came isfrom noa ~~certainty~~single ~~that~~source: ~~our~~Inner ~~relationship~~Mongolia ~~with~~ Honghai ~~will~~Health ~~continue~~Management ~~past that date In addition~~Co., ~~any~~Ltd. ~~number~~ Termination of ~~factors could interfere with~~ our relationship with Honghai: ~~adverse~~would ~~events~~likely inhave ~~Honghai’s~~serious ~~business could make our sales efforts unprofitable; Honghai could decide to engage competitive or replacement sales agents; licensing problems or~~ adverse ~~government~~effects ~~regulation~~on ~~could interfere with Honghai’s business or~~ our ~~ability to market Honghai’s services. In the event that any of these risks was realized, our~~ financial ~~results~~ ~~could be significantly less profitable unless and until we were able to replace Honghai as the primary source of our revenue~~results.

~~COVID-19 has~~In June ~~adversely~~2023 ~~impacted~~each of our operating subsidiaries entered into identical Sales Agency Agreements with Inner Mongolia Honghai Health Management ~~business~~Co., ~~and~~Ltd. ~~may~~(“Honghai”), ~~further~~pursuant ~~impact~~to which our ~~business,~~operating ~~financial~~subsidiaries ~~results~~serve ~~and~~as ~~liquidity~~sales agents for anservices ~~unknown~~provided ~~period~~by Honghai and receive commissions on the sales they initiate. During the year ended June 30, 2025, commissions from sales on behalf of ~~time~~Honghai represented over 97% of our Company’s revenues, while revenues from principal sales, our focus before engaging with Honghai, fell by almost 63%.

The ~~COVID-19 pandemic~~ Sales ~~has~~Agency ~~led~~Agreements ~~government and~~terminate ~~other~~in ~~authorities~~June to2026, ~~impose~~and ~~measures~~there ~~intended~~is tono ~~control~~certainty ~~its~~that ~~spread,~~our ~~including~~relationship ~~restrictions~~with onHonghai ~~freedom~~will ofcontinue ~~movement,~~past ~~gatherings of~~that ~~large~~date ~~numbers~~In ~~of people~~addition, ~~and~~any ~~temporary~~number ~~closure~~ of ~~business~~factors ~~operations.~~could ~~With~~interfere ~~respect~~with toour ~~the~~relationship ~~Longduoduo~~with ~~business,~~Honghai: ~~the~~adverse ~~primary~~events ~~adverse~~in ~~result~~Honghai’s business ofcould ~~the COVID-19 pandemic~~make ~~has~~our ~~been~~sales aefforts ~~serious~~unprofitable; ~~interruption~~Honghai ~~from~~could ~~time~~decide to ~~time~~engage ~~caused~~competitive byor ~~temporary~~replacement ~~closure~~sales ofagents; ~~business~~licensing ~~operations,~~problems ~~especially~~or ~~the~~adverse ~~third-party~~government ~~healthcare~~regulation ~~service~~could ~~providers~~interfere ~~who~~with ~~were~~Honghai’s ~~required~~business or our ability to ~~temporarily~~market ~~close~~Honghai’s services. In the ~~particular,~~event asthat ~~our~~any ~~third-party~~of ~~healthcare service~~these ~~provider~~risks ~~are~~was ~~the~~realized, ~~key~~our tofinancial ~~patients’~~results ~~treatment,~~could ~~our~~be ~~inability~~significantly toless ~~supply~~profitable ~~third-party~~unless ~~healthcare~~and ~~services~~until ~~due~~we were able to ~~COVID-19~~replace ~~restrictions seriously~~Honghai ~~delayed~~as the ~~growth~~primary source of our ~~business~~revenue.

InWe rely ~~response~~on ~~to COVID-19,~~third weparty ~~took~~providers ~~steps~~ to ~~reduce~~ ~~operating~~provide ~~costs~~our ~~and~~offered ~~improve~~services ~~efficiency,~~and ~~including~~could ~~slowing~~be ~~down~~liable ~~our~~and ~~business~~suffer ~~plan.~~reputational ~~The~~harm ~~interruption~~if ofa ~~our~~ third-party ~~healthcare~~service ~~services~~provider ~~supply~~provides ~~and~~inferior ~~the~~service ~~steps~~or weharms ~~took~~a tocustomer, ~~reduce~~which ~~the~~may ~~risk~~have toa ~~our~~material ~~employees~~adverse ~~from~~effect ~~COVID-19~~on ~~both negatively impacted~~ our ~~schedule~~business, ~~for~~financial ~~achieving~~condition, ~~development~~results of ~~our~~operations ~~business~~and prospects.

~~Since~~We rely ~~December~~on ~~2022,~~our ~~many~~third-party ofhealthcare ~~the~~service ~~restrictive~~providers ~~measures~~to provide services to our customers under cooperation arrangements with us. We ~~previously~~require ~~adopted~~and byexpect these third-party healthcare service providers to possess the ~~PRC~~licenses ~~governments~~and atqualifications ~~various~~that ~~levels~~are required for their operations and to ~~control~~adhere to certain performance standards both in terms of customer service and the ~~spread~~quality of the ~~COVID-19~~medical ~~virus~~care that they provide. We generally do not have ~~been~~control ~~revoked~~over the quality of service or ~~replaced with~~medical ~~more~~care ~~flexible~~that ~~measures~~these third-parties provide. ~~The~~They ~~revocation~~may not orat ~~replacement~~all oftimes possess the ~~restrictive~~permits ~~measures~~or qualifications required by laws and regulations or may fail to ~~contain~~meet ~~the~~other ~~COVID-19~~regulatory ~~pandemic~~requirements for their operations. In addition, they may engage in conduct which our customers find unacceptable, including providing poor service, mishandling sensitive personal healthcare information and committing medical malpractice. We could ~~have~~be exposed to reputational harm and possible liability as a ~~positive~~result of our having serviced a customer through a third-party service provider that performs unsatisfactorily, ~~impact~~which may result in a materially adverse effect on ~~the~~our ~~Company’s~~business, ~~normal~~financial condition, results of operations and prospects.

We are unable to predict the extent to which the pandemic and related impacts may adversely impact our business operations, financial performance, consolidated results of operations and consolidated financial position in the future or interfere with the achievement of our strategic objectives.12

~~We rely on third party providers to provide~~A ~~our~~computer ~~offered~~system ~~services~~failure, ~~and~~security ~~could~~breach beor ~~liable and suffer reputational harm if~~ a ~~third-party~~breach ~~service~~of ~~provider~~data ~~provides~~privacy ~~inferior service~~ or ~~harms a~~security ~~customer,~~obligations ~~which~~ may ~~have~~disrupt aour ~~material~~business, ~~adverse~~damage ~~effect on~~ our ~~business,~~reputation and ~~financial~~adversely ~~condition,~~affect our results of operations, financial condition and ~~prospects~~cash flows.

We rely on ~~our~~computer ~~third-party~~and ~~healthcare~~information ~~service providers~~systems toand ~~provide~~internet ~~services~~and tonetwork ~~our~~connectivity ~~customers~~to ~~under~~conduct ~~cooperation~~a ~~arrangements~~large ~~with~~portion ~~us.~~of Weour ~~require~~business ~~and~~operations. This ~~expect~~includes ~~these~~the ~~third-party~~need ~~healthcare service providers~~ to ~~possess~~securely ~~the~~store, ~~licenses~~process and ~~qualifications~~transmit ~~that~~confidential ~~are~~information, ~~required~~including ~~for~~personal ~~their~~information. ~~operations~~In ~~and~~many ~~to adhere to certain performance~~cases ~~standards~~this ~~both~~also inincludes ~~terms~~transmission ~~of customer service~~ and ~~the~~processing ~~quality~~to ofor ~~the~~through ~~medical~~commercial ~~care~~customers, ~~that~~business ~~they~~partners ~~provide.~~and Wethird-party ~~generally~~service ~~do not have control over~~providers. ~~the~~The ~~quality~~introduction of ~~service~~new ortechnologies, ~~medical~~computer ~~care~~system ~~that~~failures, ~~these third~~cyber-~~parties~~crime ~~provide.~~attacks ~~They~~or ~~may~~security ~~not at all times possess the permits~~ or ~~qualifications required~~privacy bybreaches ~~laws and regulations or~~ may ~~fail~~materially todisrupt our ~~meet~~business ~~other regulatory requirements for their~~ operations~~. In addition~~, ~~they~~damage ~~may engage in conduct which~~ our ~~customers find unacceptable~~reputation, ~~including~~result ~~providing~~in ~~poor~~regulatory ~~service, mishandling sensitive personal healthcare information~~ and ~~committing~~litigation ~~medical~~exposure, ~~malpractice.~~investigation ~~We could be exposed to reputational harm~~ and ~~possible~~remediation ~~liability as a result of our having serviced a customer through a third-party service provider that performs unsatisfactorily~~costs, ~~which may result in a~~ and materially ~~adverse~~and ~~effect~~adversely onaffect our ~~business,~~ ~~financial condition,~~ results of operations, financial condition and ~~prospects~~cash flows.

12The information security risk that we face includes the risk of malicious outside forces using public networks and other methods, including social engineering and the exploitation of targeted offline processes, to attack our systems and information. It also includes inside threats, both malicious and accidental. For example, human error and lack of sufficiently automated processing can result in improper information exposure or use. We also face risk in this area due to our reliance in many cases on third-party systems, all of which may face cyber and information security risks of their own. Third-party administrators or distribution partners used by us or our subsidiaries may not adequately secure their own information systems and networks, or may not adequately keep pace with the dynamic changes in this area. Potential bad actors that target us and our applicable third parties may include, but are not limited to, criminal organizations, foreign government bodies, political factions, and others. There is no guarantee that the measures that we take will be sufficient to stop all types of attacks or mitigate all types of information security or privacy risks.

AIf we ~~computer~~fail ~~system~~to ~~failure,~~maintain ~~security~~adequate ~~breach~~processes and controls or if we or our business partners fail to comply with relevant laws and regulations, policies and procedures, misappropriation or aintentional ~~breach~~or unintentional inappropriate disclosure or misuse of ~~data~~personal ~~privacy~~information or other confidential information could occur. Such control inadequacies or ~~security~~non-compliance ~~obligations~~could ~~may~~cause ~~disrupt~~disrupted ~~our~~operations ~~business~~and misstated or unreliable financial data, materially damage our reputation ~~and~~or ~~adversely~~lead ~~affect~~to increased regulatory scrutiny or civil or criminal penalties or litigation, which, in turn, could have a material adverse effect on our business, financial condition and results of operations. In addition, we analyse personal information and customer data to better manage our business, subject to applicable laws and regulations and other restrictions. It is possible that additional regulatory or other restrictions regarding the use of such techniques may be imposed. Such restrictions and obligations could have material impacts on our business, financial ~~condition~~conditions and/or ~~cash~~results ~~flows~~of operations.

We ~~rely on computer and information systems and~~ ~~internet~~operate ~~and~~in ~~network connectivity to conduct~~ a ~~large~~competitive ~~portion~~environment ~~of our business operations. This includes the need to securely store, process~~ and ~~transmit~~competing ~~confidential~~facilities ~~information, including personal information. In many cases this also includes transmission~~ and ~~processing~~services ~~to or~~could ~~through~~harm commercial customers, business partners and third-party service providers. The introduction of new technologies, computer system failures, cyber-crime attacks or security or privacy breaches may materially disrupt our business ~~operations~~, ~~damage~~financial ~~our reputation~~condition, ~~result in regulatory and litigation exposure, investigation and remediation costs, and materially and adversely affect our~~ results of operations, ~~financial condition~~ and ~~cash flows~~prospects.

~~The~~There are ~~information~~numerous ~~security~~hospitals ~~risk~~and ~~that~~private weclinics ~~face~~providing ~~includes~~ medical examination services and, at the ~~risk~~high end of ~~malicious~~the ~~outside~~market, ~~forces~~many ~~using~~Chinese ~~public~~hospitals have ~~networks~~VIP ~~and~~wards ~~other~~that ~~methods,~~cater ~~including~~to ~~social~~affluent ~~engineering~~customers. ~~and~~We ~~the~~face ~~exploitation~~significant competition from two main types of ~~targeted offline~~competitors: ~~processes,~~the tomedical ~~attack~~examination departments ~~our~~of ~~systems~~major public hospitals and ~~information~~private medical examination companies. ItThe ~~also~~private ~~includes~~preventive ~~inside~~healthcare ~~threats,~~market ~~both~~is ~~malicious~~further segmented ~~and~~into ~~accidental.~~large ~~For~~franchise ~~example~~companies, ~~human~~ ~~error~~regional providers and ~~lack~~numerous oflocal ~~sufficiently~~independent ~~automated~~medical ~~processing~~examination ~~can~~centers ~~result~~located in ~~improper~~nearly every ~~information~~city ~~exposure~~in ~~or use~~China. We ~~also~~compete ~~face~~primarily ~~risk~~on inthe ~~this area~~basis ~~due~~of toprice, ~~our~~quality ~~reliance~~of inservice, ~~many~~convenience, ~~cases~~location, onbrand ~~third-party~~recognition ~~systems,~~and ~~all~~reputation. We ofdo ~~which~~not ~~may~~have ~~face~~the ~~cyber~~same ~~and~~level ~~information~~of ~~security~~brand ~~risks~~recognition as some of ~~their~~the ~~own. Third-party~~medical ~~administrators~~examination orcenters ~~distribution~~of ~~partners~~large ~~used~~public byhospitals, usand orin some regional markets our ~~subsidiaries~~brand ~~may~~is not ~~adequately~~as ~~secure~~established ~~their~~and ~~own~~our ~~information~~geographical ~~systems and~~coverage ~~networks,~~is ornot ~~may~~as ~~not~~extensive ~~adequately~~as ~~keep~~that ~~pace~~of ~~with~~our private competitors. Furthermore, we lack the ~~dynamic~~equipment ~~changes~~necessary infor ~~this~~certain ~~area.~~highly ~~Potential~~technical ~~bad~~medical ~~actors~~tests. ~~that~~Many ~~target~~competing ushospitals ~~and~~that ~~our~~are ~~applicable~~government-owned ~~third~~are ~~parties~~exempt ~~may~~from ~~include,~~income ~~but~~taxes ~~are~~on ~~not~~their ~~limited~~medical toincome, ~~criminal~~which ~~organizations,~~provides ~~foreign~~them ~~government~~with ~~bodies,~~a ~~political~~significant ~~factions,~~competitive ~~and~~advantage ~~others~~over us. Furthermore, ~~There~~competing ishospitals, noclinics ~~guarantee~~or ~~that~~other ~~the~~facilities ~~measures~~may ~~that~~commence wenew ~~take~~operations ~~will~~or beexpand ~~sufficient~~existing tooperations, ~~stop~~which ~~all~~would ~~types~~increase oftheir competitive ~~attacks~~position orand ~~mitigate~~potentially ~~all~~erode ~~types~~our ofbusiness, ~~information security~~financial orcondition, ~~privacy~~results ~~risks~~of operations and prospects.

If we fail to maintain adequate processes and controls or if we or our business partners fail to comply with relevant laws and regulations, policies and procedures, misappropriation or intentional or unintentional inappropriate disclosure or misuse of personal information or other confidential information could occur. Such control inadequacies or non-compliance could cause disrupted operations and misstated or unreliable financial data, materially damage our reputation or lead to increased regulatory scrutiny or civil or criminal penalties or litigation, which, in turn, could have a material adverse effect on our business, financial condition and results of operations. In addition, we analyse personal information and customer data to better manage our business, subject to applicable laws and regulations and other restrictions. It is possible that additional regulatory or other restrictions regarding the use of such techniques may be imposed. Such restrictions and obligations could have material impacts on our business, financial conditions and/or results of operations.13

We may ~~operate~~not inbe aable ~~competitive~~to ~~environment and~~effectively ~~competing~~control ~~facilities~~ and ~~services~~manage ~~could harm~~ our ~~business,~~planned ~~financial condition, results of operations and prospects~~growth.

~~There are numerous hospitals and private clinics~~We ~~providing~~have ~~medical~~limited ~~examination~~operational, ~~services~~administrative and, atfinancial ~~the high end of the market~~resources, ~~many~~which ~~Chinese~~may ~~hospitals~~be ~~have~~inadequate ~~VIP wards that cater~~ to ~~affluent customers.~~sustain ~~We face significant competition from two main types of competitors:~~ the ~~medical~~growth ~~examination~~we ~~departments~~want ofto ~~major~~achieve. ~~public hospitals~~If ~~and~~our ~~private~~business ~~medical~~and ~~examination~~markets ~~companies.~~grow ~~The~~and ~~private~~develop, ~~preventive~~it ~~healthcare~~will ~~market~~be isnecessary ~~further~~for ~~segmented~~us ~~into~~to ~~large~~finance ~~franchise companies, regional providers~~ and ~~numerous~~manage ~~local~~expansion ~~independent medical examination centers located in nearly every city in China~~accordingly. WeIn ~~compete primarily on the basis of price~~addition, ~~quality~~we ~~of service, convenience, location, brand recognition and reputation. We do not have the same level of brand~~may ~~recognition~~face aschallenges ~~some of the medical examination centers of large public hospitals, and~~ in ~~some~~managing ~~regional markets~~ our ~~brand~~expanding isservice ~~not~~offerings. asSuch ~~established and~~growth ~~our~~would ~~geographical~~place ~~coverage~~increased isdemands ~~not~~on ~~as extensive as that of~~ our ~~private~~existing ~~competitors. Furthermore~~management, ~~we lack the equipment necessary for~~employees ~~certain~~and ~~highly technical medical tests~~facilities. ~~Many~~Our ~~competing~~failure ~~hospitals~~to ~~that~~meet ~~are~~these ~~government-owned~~demands ~~are~~could ~~exempt~~interrupt ~~from~~or ~~income~~adversely ~~taxes~~affect onour ~~their~~operations ~~medical income,~~and ~~which~~cause ~~provides~~administrative ~~them with a significant competitive advantage over us~~inefficiencies. ~~Furthermore~~ Additionally, ~~competing~~failure ~~hospitals,~~to ~~clinics~~execute orour ~~other~~planned ~~facilities may~~growth ~~commence~~strategy ~~new~~could ~~operations~~have ora ~~expand~~material ~~existing~~adverse ~~operations,~~effect ~~which~~on ~~would increase their competitive position and potentially erode~~ our ~~business,~~ financial condition, ~~results~~and results of ~~operations and prospects~~operation.

13Expansion of our healthcare services could be affected by the expansion of government-sponsored social medical insurance available to the Chinese population that is not available now.

WeMost government-sponsored ~~may~~social medical insurance in China does not becover ~~able~~medical examinations. In certain locations where government-sponsored social medical insurance covers medical examinations, we have cooperating hospitals that are qualified institutions under such insurance coverage. Currently, most of our individual customers pay directly for medical examinations. If government-sponsored social medical insurance is further expanded to ~~effectively~~cover ~~control~~medical examinations in more geographical locations, and Longduoduo does not become a qualified institution for such coverage, certain of our customers may discontinue or terminate their relationship with us, and ~~manage~~certain individual customers may opt to use other medical institutions covered by such medical insurance rather than pay for our ~~planned~~services. ~~growth~~As a result, the expansion of government-sponsored social medical insurance could materially and adversely affect our business, financial condition and results of operations.

~~We have limited operational~~Additional capital, ~~administrative~~if ~~and financial resources~~needed, ~~which~~ may not be ~~inadequate~~available toon ~~sustain~~acceptable ~~the~~terms, ~~growth~~if weat ~~want to achieve. If our business and markets grow and develop~~all, ~~it will be necessary for us to finance~~ and ~~manage~~any ~~expansion~~additional ~~accordingly.~~financing ~~In addition, we~~ may ~~face~~be ~~challenges in managing our expanding service offerings. Such growth would place increased demands~~ on ~~our~~terms ~~existing~~adverse ~~management, employees and facilities. Our failure~~ to ~~meet these demands~~your ~~could interrupt or adversely affect our operations and cause administrative inefficiencies~~interests. ~~Additionally, failure to execute our planned growth strategy could have a material adverse effect on our financial condition and results of operation.~~

~~Expansion~~We may ofneed additional cash to fund our ~~healthcare~~operations. ~~services~~Our ~~could~~capital needs will depend on numerous factors, including market conditions and our profitability. We cannot be ~~affected~~certain bythat ~~the~~we ~~expansion~~will ofbe ~~government-sponsored~~able ~~social~~to ~~medical~~obtain ~~insurance~~additional ~~available~~financing toon ~~the~~favorable ~~Chinese~~terms, ~~population~~if ~~that~~at all. If additional financing is not available when required or is not available on acceptable terms, we may be unable to fund expansion, successfully promote ~~now~~our brand name, develop or enhance our services, take advantage of business opportunities, or respond to competitive pressures or unanticipated requirements, any of which could seriously harm our business and reduce the value of your investment.

~~Most~~If we ~~government-sponsored~~are ~~social~~able ~~medical~~to ~~insurance in~~raise ~~China~~additional ~~does~~funds ~~not~~if ~~cover~~and ~~medical~~when ~~examinations.~~needed Inby ~~certain~~issuing ~~locations~~additional ~~where~~equity ~~government-sponsored~~securities, ~~social~~you ~~medical~~may ~~insurance~~experience ~~covers~~significant ~~medical~~dilution ~~examinations,~~of weyour ~~have~~ownership ~~cooperating~~interest ~~hospitals~~and ~~that~~holders ~~are~~of ~~qualified~~these ~~institutions~~new ~~under~~securities ~~such~~may ~~insurance~~have ~~coverage.~~rights ~~Currently,~~senior ~~most~~to ofyours ~~our~~as ~~individual customers~~a ~~pay~~holder ~~directly~~of ~~for~~our ~~medical~~common ~~examinations~~stock. If ~~government-sponsored social medical insurance is further expanded to cover medical~~we ~~examinations~~obtain inadditional ~~more~~financing ~~geographical~~by ~~locations,~~issuing ~~and~~debt ~~Longduoduo does not become a qualified institution for such coverage~~securities, ~~certain~~the terms of ~~our customers~~those ~~may~~securities ~~discontinue~~could restrict or ~~terminate~~prevent ~~their relationship with~~ us, ~~and~~from ~~certain~~declaring ~~individual customers may opt to use other medical institutions~~dividends ~~covered~~and bycould ~~such~~limit ~~medical~~our ~~insurance~~flexibility ~~rather~~in ~~than~~making ~~pay~~business ~~for our services~~decisions. AsIn athis ~~result~~case, the ~~expansion~~value of ~~government-sponsored~~your ~~social~~investment ~~medical insurance~~ could ~~materially~~be ~~and adversely affect our business, financial condition and results of operations~~reduced.

~~Additional~~There is ~~capital,~~no ifassurance ~~needed,~~that ~~may~~we ~~not~~will be ~~available~~ onable ~~acceptable~~to ~~terms,~~obtain additional funding if atit ~~all~~is needed, ~~and~~or ~~any~~that ~~additional~~such ~~financing~~funding, ~~may~~if available, will be obtainable on terms ~~adverse~~and conditions favorable to ~~your~~or ~~interests~~affordable by us. If we cannot obtain needed funds, we may be forced to curtail our activities.

We may need additional cash to fund our operations. Our capital needs will depend on numerous factors, including market conditions and our profitability. We cannot be certain that we will be able to obtain additional financing on favorable terms, if at all. If additional financing is not available when required or is not available on acceptable terms, we may be unable to fund expansion, successfully promote our brand name, develop or enhance our services, take advantage of business opportunities, or respond to competitive pressures or unanticipated requirements, any of which could seriously harm our business and reduce the value of your investment.14

~~If we are able to raise additional funds if and~~Risks ~~when~~Relating ~~needed by issuing additional equity securities, you may experience significant dilution of your ownership interest and holders of these new securities may have rights senior~~ to ~~yours as a holder of~~ our common stock. If we obtain additional financing by issuing debt securities, the terms of those securities could restrict or prevent us from declaring dividends and could limit our flexibility in making business decisions. In this case, the value of your investment could be reduced.Management

~~There~~The loss isof nothe ~~assurance~~services ~~that~~of weany ~~will~~of beour ~~able~~officers ~~to obtain additional funding if it is needed,~~ or ~~that~~our ~~such~~failure ~~funding,~~to iftimely ~~available,~~identify ~~will~~and beretain ~~obtainable~~competent onpersonnel ~~terms~~could ~~and~~negatively ~~conditions favorable to~~impact orour ~~affordable~~ability ~~by us. If we cannot obtain needed funds, we may be forced~~ to ~~curtail~~develop our ~~activities~~products and sales.

14The development of our business will continue to place a significant strain on our limited personnel, management, and other resources. Our future success depends upon the continued services of our executive officers, Xu Huibo, our President and Chairman of the Board of Director, Zhou Hongxiao, Chief Executive Officer (CEO), Secretary and director, and our Chief Financial Officer, Kang Liping. They are developing our business, which will depend on our ability to identify and retain competent employees with the skills required to execute our business objectives. The loss of the services of any of our officers or our failure to timely identify and retain competent personnel could negatively impact our ability to develop our products and services, which could adversely affect our financial results and impair our growth.

~~Risks~~If we ~~Relating~~are unable to ~~our~~hire, ~~Management~~retain or motivate qualified personnel, consultants, independent contractors, and advisors, we may not be able to grow effectively.

~~The~~Our performance ~~loss~~will ofbe largely dependent on the ~~services~~talents and efforts of ~~any~~highly skilled individuals. Future success depends on our continuing ability to identify, hire, develop, motivate and retain highly qualified personnel for all areas of our ~~officers~~organization. Competition for such qualified employees is intense. If we do not succeed in attracting excellent personnel or in retaining or motivating them, we may be unable to grow effectively. In addition, all future success depends largely on our ~~failure~~ability to ~~timely~~retain ~~identify~~key consultants and advisors. We cannot assure that any skilled individual will agree to become an employee, consultant, or independent contractor of Longduoduo Company Limited. Our inability to retain ~~competent~~their ~~personnel~~services could negatively impact our business and our ability to ~~develop~~execute our ~~products~~business ~~and sales~~strategy.

~~The development of our business will continue to place a significant strain on our limited personnel, management, and other resources.~~ Our ~~future success depends upon the continued~~ ~~services~~internal ofcontrols ~~our~~over ~~executive~~financial ~~officers,~~reporting Xumay ~~Huibo,~~not ~~our~~be ~~President~~effective and ~~Chairman of the Board of Director, Zhou Hongxiao, Chief Executive Officer (CEO), Secretary and director, and~~ our ~~Chief~~independent ~~Financial~~registered ~~Officer,~~public ~~Kang~~accounting ~~Liping.~~firm ~~They~~may ~~are~~not ~~developing~~be ~~our business, which will depend on our~~able ~~ability~~ to ~~identify~~certify ~~and~~as ~~retain competent employees with the skills required~~ to ~~execute~~their ~~our~~effectiveness, ~~business~~which ~~objectives. The loss of the services of any of our officers or our failure to timely identify and retain competent personnel~~ could ~~negatively~~have ~~impact~~a ~~our~~significant ~~ability to develop our products~~ and ~~services,~~adverse ~~which~~effect ~~could~~on ~~adversely affect~~ our ~~financial~~business ~~results~~ and ~~impair our growth~~reputation.

IfAs a new public reporting company, we ~~are~~will ~~unable~~be toin ~~hire~~a continuing process of developing, ~~retain~~establishing, orand ~~motivate~~maintaining internal controls and ~~qualified~~procedures ~~personnel~~that will allow our management to report on, ~~consultants~~and our independent registered public accounting firm to attest to, our internal controls over financial reporting if and when required to do so under Section 404 of the Sarbanes-Oxley Act of 2002. Although our independent registered ~~contractors~~public accounting firm is not required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act until the date we are no longer an emerging growth company, our management will be required to report on our internal controls over financial reporting under Section 404. If we fail to achieve and ~~advisors~~maintain the adequacy of our internal controls, we would not be able to conclude on an ongoing basis that we have effective internal controls over financial reporting in accordance with Section 404. At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our controls are documented, designed or operating. Moreover, our testing, or the subsequent testing by our independent registered public accounting firm that must be performed may reveal other material weaknesses or that the material weaknesses have not been fully remediated. If we do not remediate our material weaknesses, or if other material weaknesses are identified or we are not able to ~~grow~~comply ~~effectively~~with the requirements of Section 404 in a timely manner, our reported financial results could be materially misstated or could subsequently require restatement, we could receive an adverse opinion regarding our internal controls over financial reporting from our independent registered public accounting firm and we could be subject to investigations or sanctions by regulatory authorities, which would require additional financial and management resources, and the market price of our stock could decline.

Our performance will be largely dependent on the talents and efforts of highly skilled individuals. Future success depends on our continuing ability to identify, hire, develop, motivate and retain highly qualified personnel for all areas of our organization. Competition for such qualified employees is intense. If we do not succeed in attracting excellent personnel or in retaining or motivating them, we may be unable to grow effectively. In addition, all future success depends largely on our ability to retain key consultants and advisors. We cannot assure that any skilled individual will agree to become an employee, consultant, or independent contractor of Longduoduo Company Limited. Our inability to retain their services could negatively impact our business and our ability to execute our business strategy. 15

~~Our internal controls over financial reporting~~Limitations ~~may~~on ~~not~~director ~~be effective~~ and ~~our~~officer ~~independent~~liability ~~registered~~and ~~public~~indemnification ~~accounting~~of ~~firm~~our ~~may~~Company’s ~~not~~officers beand ~~able~~directors toby ~~certify~~us asmay todiscourage ~~their effectiveness, which~~shareholders ~~could~~from ~~have~~bringing a ~~significant~~lawsuit ~~and~~against ~~adverse~~an ~~effect~~officer onor ~~our business and reputation~~director.

~~As a new public reporting company, we will be~~Our inCompany’s acertificate ~~continuing process~~ of ~~developing,~~incorporation ~~establishing,~~ and ~~maintaining~~bylaws ~~internal controls and procedures that will allow our management to report on~~provide, ~~and~~with ~~our~~certain ~~independent~~exceptions ~~registered~~as ~~public~~required ~~accounting~~by ~~firm~~governing tostate ~~attest to~~law, ~~our~~that ~~internal~~a ~~controls over financial reporting if and when~~director ~~required~~or toofficer doshall sonot ~~under~~be ~~Section~~personally ~~404~~liable ~~of the Sarbanes-Oxley Act of 2002. Although our independent registered public accounting firm is not required~~ to ~~attest~~us toor ~~the effectiveness of~~ our ~~internal~~shareholders ~~control~~for ~~over~~breach ~~financial reporting pursuant to Section 404(b)~~ of ~~the~~fiduciary ~~Sarbanes-Oxley Act~~duty ~~until~~as ~~the~~a ~~date~~director weor ~~are no longer an emerging growth company~~officer, ~~our~~except ~~management will be required to report on our internal controls over~~for ~~financial~~acts ~~reporting~~or ~~under~~omissions ~~Section~~which ~~404.~~involve Ifintentional wemisconduct, ~~fail~~fraud toor ~~achieve~~knowing ~~and~~violation ~~maintain the adequacy~~ of ~~our internal controls~~law, weor ~~would~~unlawful ~~not~~payments beof ~~able to conclude on an ongoing basis that we have effective internal controls over financial reporting in accordance with Section 404~~dividends. AtThese ~~such~~provisions ~~time,~~may ~~our~~discourage ~~independent~~shareholders ~~registered~~from ~~public~~bringing ~~accounting~~a ~~firm~~lawsuit ~~may~~against ~~issue~~ a ~~report~~director ~~that is adverse in the event it is not satisfied with the level at which our controls are documented, designed~~ or ~~operating.~~officer ~~Moreover,~~for ~~our~~breach ~~testing,~~of orfiduciary ~~the~~duty ~~subsequent~~and ~~testing by our independent registered public accounting firm that must be performed~~ may ~~reveal~~reduce ~~other material weaknesses or that~~ the ~~material weaknesses have not been fully~~likelihood ~~remediated.~~of Ifderivative welitigation dobrought ~~not~~by ~~remediate~~shareholders ~~our~~on ~~material weaknesses, or if other material weaknesses are identified or we are not able to comply with~~ the ~~requirements~~Company’s ofbehalf ~~Section~~against ~~404 in~~ a ~~timely~~director ~~manner, our reported financial results could be materially misstated~~ or could subsequently require restatement, we could receive an adverse opinion regarding our internal controls over financial reporting from our independent registered public accounting firm and we could be subject to investigations or sanctions by regulatory authorities, which would require additional financial and management resources, and the market price of our stock could declineofficer.

15Our management has limited experience managing a public company.

~~Limitations~~At the onpresent ~~director~~time, our management has limited experience in managing a public company. This may hinder our ability to establish effective controls and ~~officer~~systems ~~liability~~and comply with all applicable requirements associated with being a public company. If compliance problems result, these problems could have a material adverse effect on our business, financial condition or results of operations. As a public company, we will incur significant legal, accounting and ~~indemnification~~other expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act of ~~our~~2002, ~~Company’s~~or ~~officers~~Sarbanes-Oxley Act, and ~~directors~~the Dodd-Frank Act of 2010, as well as rules subsequently implemented by usthe ~~may~~SEC, ~~discourage~~have ~~shareholders~~imposed various ~~from~~requirements ~~bringing~~on public companies, including requiring changes in corporate governance practices. Our management and other personnel will need to devote a ~~lawsuit~~substantial ~~against~~amount anof time to our new compliance requirements. Moreover, these requirements will increase our legal, accounting and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect it will be difficult and expensive for us to obtain director and officer liability insurance. These requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or ~~director~~as executive officers.

~~Our Company’s certificate of incorporation~~We ~~and~~may ~~bylaws~~have ~~provide,~~difficulty ~~with~~establishing ~~certain~~adequate ~~exceptions as required by governing state law~~management, ~~that~~legal a director or officer shall not be personally liable to us or our shareholders for breach of fiduciary duty as a director or officer, except for acts or omissions which involve intentional misconduct, fraud or knowing violation of law, or unlawful payments of dividends. These provisions may discourage shareholders from bringing a lawsuit against a director or officer for breach of fiduciary duty and ~~may~~financial ~~reduce~~controls ~~the~~in ~~likelihood of derivative litigation brought by shareholders on~~ the ~~Company’s behalf against a director or officer~~PRC.

~~Our~~We may have difficulty in hiring and retaining a sufficient number of qualified employees to serve as our management ~~has~~staff. ~~limited~~As a result of these factors, we may experience ~~managing~~difficulty in establishing management, legal and financial controls, collecting financial data and apreparing ~~public~~financial ~~company~~statements, books of account and corporate records and instituting business practices that meet western standards. Therefore, we may, in turn, experience difficulties in implementing and maintaining adequate internal controls as will be required under Section 404 of the Sarbanes Oxley Act of 2002.

At the present time, our management has limited experience in managing a public company. This may hinder our ability to establish effective controls and systems and comply with all applicable requirements associated with being a public company. If compliance problems result, these problems could have a material adverse effect on our business, financial condition or results of operations. As a public company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act of 2002, or Sarbanes-Oxley Act, and the Dodd-Frank Act of 2010, as well as rules subsequently implemented by the SEC, have imposed various requirements on public companies, including requiring changes in corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to our new compliance requirements. Moreover, these requirements will increase our legal, accounting and financial compliance costs and will make some activities more time-consuming and costly. For example, we expect it will be difficult and expensive for us to obtain director and officer liability insurance. These requirements could also make it more difficult for us to attract and retain qualified persons to serve on our board of directors, our board committees or as executive officers.16

~~We may have difficulty establishing adequate~~Risks ~~management,~~Related ~~legal~~to ~~and~~Doing ~~financial~~Business ~~controls~~ in the PRC.

~~We may have difficulty in hiring and retaining~~Changes ~~a sufficient number of qualified employees to serve as our management staff. As a result of these factors, we may experience difficulty~~ in ~~establishing~~United ~~management,~~States ~~legal~~ and ~~financial~~China ~~controls~~relations, ~~collecting~~as ~~financial~~well ~~data~~as ~~and~~relations ~~preparing~~with ~~financial~~other ~~statements~~countries, ~~books of account~~ and/or ~~corporate~~regulations ~~records~~may ~~and~~adversely ~~instituting~~impact ~~business~~our ~~practices that meet western standards. Therefore~~business, our weoperating ~~may~~results, inour ~~turn,~~ability ~~experience~~to ~~difficulties in~~raise ~~implementing~~capital and ~~maintaining adequate internal controls as will be required under Section 404 of~~ the ~~Sarbanes~~market ~~Oxley~~price ~~Act~~ of ~~2002~~our shares.

16The U.S. government, including the SEC, has made statements and taken certain actions that led to changes to United States and international relations, and will impact companies with connections to the United States or China, including imposing several rounds of tariffs affecting certain products manufactured in China, imposing certain sanctions and restrictions in relation to China and issuing statements indicating enhanced review of companies with significant China-based operations. It is unknown whether and to what extent new legislation, executive orders, tariffs, laws or regulations will be adopted, or the effect that any such actions would have on companies with significant connections to the U.S. or to China, our industry or on us. Any unfavorable government policies on cross-border relations and/or international trade, including increased scrutiny on companies with significant China-based operations, capital controls or tariffs, may affect our ability to raise capital and the market price of our shares.

~~Risks~~Furthermore, the SEC has issued statements primarily focused on companies with significant China-based operations, such as us. For example, on July 30, 2021, Gary Gensler, Chairman of the SEC, issued a Statement on Investor Protection Related to ~~Doing~~Recent ~~Business~~Developments in China, pursuant to which Chairman Gensler stated that he has asked the ~~PRC~~SEC staff to engage in targeted additional reviews of filings for companies with significant China-based operations. The statement also addressed risks inherent in companies with a Variable Interest Entity, or a VIE structure. We do not have a VIE structure and are not in an industry that is subject to foreign ownership limitations by China. Further, we believe that we have robust disclosures relating to our operations in China, including the relevant risks noted in Chairman Gensler’s statement. However, it is possible that the Company’s periodic reports and other filings with the SEC may be subject to enhanced review by the SEC and this additional scrutiny could affect our ability to effectively raise capital in the United States.

~~Changes~~In response into ~~United~~the ~~States~~SEC’s ~~and~~July 30 statement, the China ~~relations~~Securities Regulatory Commission (CSRC) announced on August 1, 2021, that “it asis ~~well~~our asbelief ~~relations~~that Chinese and U.S. regulators shall continue to enhance communication with ~~other~~the ~~countries,~~principle of mutual respect and~~/or~~ ~~regulations~~cooperation, and ~~may~~properly ~~adversely~~address ~~impact~~the ~~our~~issues ~~business,~~related ~~our~~to ~~operating~~the ~~results,~~supervision ~~our~~of ~~ability~~China-based companies listed in the U.S. so as to ~~raise~~ ~~capital~~form stable policy expectations and create benign rules framework for the market.” ~~price~~While the CSRC will continue to collaborate “closely with different stakeholders including investors, companies, and relevant authorities to further promote transparency and certainty of ~~our~~policies ~~shares~~and implementing measures,” it emphasized that it “has always been open to companies’ choices to list their securities on international or domestic markets in compliance with relevant laws and regulations.”

~~The U.S. government, including the SEC, has made~~If ~~statements~~any and taken certain actions that led to changes to United States and international relations, and will impact companies with connections to the United States or China, including imposing several rounds of tariffs affecting certain products manufactured in China, imposing certain sanctions and restrictions in relation to China and issuing statements indicating enhanced review of companies with significant China-based operations. It is unknown whether and to what extent new legislation, executive orders, tariffs, laws and/or regulations ~~will be~~are ~~adopted~~implemented, orif ~~the~~existing ~~effect~~trade ~~that~~agreements ~~any~~are ~~such~~renegotiated or ~~actions~~if ~~would have on companies with significant connections to~~ the U.S. or toChinese ~~China,~~governments ~~our~~take ~~industry or~~retaliatory onactions ~~us.~~due ~~Any~~to ~~unfavorable~~the ~~government~~recent ~~policies on cross~~U.S.-~~border~~China ~~relations~~tension, ~~and/or~~such ~~international~~changes ~~trade,~~could ~~including~~have ~~increased~~an ~~scrutiny~~adverse effect on ~~companies with~~our ~~significant~~business, ~~China-based~~financial ~~operations,~~condition ~~capital~~and ~~controls~~results orof ~~tariffs~~operations, ~~may affect~~ our ability to raise capital and the market price of our shares.

~~Furthermore, the SEC has issued statements primarily~~The ~~focused~~operations onof ~~companies~~our ~~with~~subsidiaries ~~significant~~in China~~-based operations~~, ~~such~~ as ~~us.~~well ~~For~~as ~~example,~~our onfinancial ~~July~~operations ~~30,~~in ~~2021,~~the ~~Gary~~U.S. ~~Gensler,~~to ~~Chairman of~~ the ~~SEC,~~ ~~issued~~extent athat ~~Statement~~they onaffect ~~Investor~~our ~~Protection Related to Recent Developments~~ subsidiaries in China, ~~pursuant~~will tobe ~~which~~subject ~~Chairman Gensler stated that he has asked the SEC staff~~ to ~~engage~~a inhigh ~~targeted~~level ~~additional reviews~~ of ~~filings~~control ~~for~~by ~~companies~~the ~~with~~national ~~significant~~and ~~China-based~~provincial ~~operations. The~~bureaucracies ~~statement also addressed risks inherent~~ in ~~companies~~the ~~with a Variable Interest Entity, or a VIE structure~~PRC. WeExercise doby ~~not have a VIE structure~~government ~~and~~authorities ~~are~~of ~~not in an industry~~ that iscontrol ~~subject~~could tosignificantly ~~foreign~~interfere ~~ownership~~with ~~limitations~~our byability ~~China. Further, we believe that we have robust disclosures relating~~ to conduct our operations in ~~China, including~~ the ~~relevant~~best ~~risks~~interests ~~noted~~of inour ~~Chairman~~company and ~~Gensler’s~~its ~~statement. However~~shareholders, itwhich iscould ~~possible that~~cause the ~~Company’s~~value ~~periodic~~of ~~reports~~our ~~and~~common ~~other~~stock ~~filings with the SEC may be subject~~ to ~~enhanced~~decline ~~review by the SEC~~ and ~~this~~limit ~~additional scrutiny~~or ~~could~~prevent ~~affect~~ our ~~ability~~efforts to ~~effectively~~finance ~~raise~~the ~~capital~~operations of inour ~~the~~Chinese ~~United States~~subsidiaries.

InThe government ~~response~~of to the ~~SEC’s~~PRC ~~July~~is 30highly ~~statement~~bureaucratized, ~~the~~ ~~China~~as ~~Securities~~are ~~Regulatory~~the ~~Commission~~provincial ~~(CSRC)~~governments ~~announced~~in onChina. ~~August~~Whereas 1,the ~~2021,~~authority ~~that~~of ~~“it~~agencies isin ~~our belief that Chinese and~~ the U.S. ~~regulators shall~~government ~~continue~~is restricted to ~~enhance~~a ~~communication~~stated ~~with~~mandate ~~the~~by ~~principle~~principles ofand ~~mutual~~regulations ~~respect~~of ~~and~~administrative ~~cooperation~~law, ~~and~~agencies ~~properly~~of ~~address~~ the ~~issues~~PRC ~~related~~government tohave ~~the~~broad ~~supervision~~authority ofto ~~China-based~~impose ~~companies~~and ~~listed~~administer inregulations, ~~the~~and ~~U.S. so as~~ to ~~form~~collect ~~stable~~information, ~~policy~~as ~~expectations~~they ~~and~~deem ~~create~~in ~~benign~~the ~~rules~~best ~~framework for~~interests of the ~~market~~nation.” As ~~While~~a ~~the~~result, ~~CSRC~~our ~~will~~Company’s ~~continue~~Board toof ~~collaborate~~Directors ~~“closely~~may ~~with~~find ~~different~~its ~~stakeholders~~ability ~~including~~to ~~investors,~~develop ~~companies,~~ and ~~relevant~~implement ~~authorities~~a tobusiness ~~further~~plan ~~promote~~constrained ~~transparency~~by ~~and~~the regulatory ~~certainty~~activities of ~~policies~~government ~~and~~agencies ~~implementing~~in ~~measures~~the PRC,” itwhich ~~emphasized~~are ~~that it~~able ~~“has~~to ~~always~~exert ~~been~~substantial ~~open~~and towide-ranging ~~companies’~~control ~~choices~~over toour ~~list~~Company’s operations, ~~their~~both ~~securities~~those onof ~~international~~our orChinese ~~domestic~~subsidiaries, ~~markets~~and inthe ~~compliance with~~financial ~~relevant~~operations ~~laws~~of ~~and regulations~~Longduoduo.”

If any new legislation, executive orders, tariffs, laws and/or regulations are implemented, if existing trade agreements are renegotiated or if the U.S. or Chinese governments take retaliatory actions due to the recent U.S.-China tension, such changes could have an adverse effect on our business, financial condition and results of operations, our ability to raise capital and the market price of our shares.17

The ~~operations of our subsidiaries in China,~~ asPRC ~~well~~agencies ~~as our financial operations in the U.S. to the extent~~ that ~~they affect our subsidiaries in China,~~ will beexercise ~~subject~~significant ~~to a high level of~~ control byover ~~the national and provincial bureaucracies in the PRC. Exercise by government authorities of that control could significantly interfere with~~ our ~~ability~~Company’s ~~to conduct our~~ operations in the best interests of our company and its shareholders, which could cause the value of our common stock to decline and limit or prevent our efforts to finance the operations of Longduoduo Health Technology.include:

~~The~~● ~~government~~China ofSecurities ~~the~~Regulatory ~~PRC~~Commission ~~is highly bureaucratized~~(“CSRC”), as ~~are~~which ~~the~~since ~~provincial~~March ~~governments~~2023 inhas ~~China.~~imposed ~~Whereas~~extensive ~~the~~reporting ~~authority~~requirements ofand ~~agencies~~other inregulations ~~the~~on ~~U.S.~~companies ~~government~~structured isas ~~restricted~~ours: tooffshore aholding ~~stated~~companies ~~mandate by~~with ~~principles~~operations ~~and~~based ~~regulations~~in ofChina. ~~administrative~~The ~~law,~~CSRC ~~agencies~~now ofrequires ~~the~~that ~~PRC~~such ~~government~~companies ~~have~~obtain ~~broad~~pre-approval ~~authority~~of tooffshore ~~impose~~securities ~~and~~listings ~~administer regulations,~~ and tooffshore ~~collect~~securities ~~information~~offerings, asand ~~they~~the ~~deem~~CSRC, in ~~the~~reviewing ~~best~~such ~~interests~~filings, ofhas ~~the~~broad ~~nation.~~discretion Asto alimit ~~result,~~or ~~our~~prevent ~~Company’s~~offshore ~~Board~~financing ofactivities ~~Directors~~that ~~may find~~CSRC ~~its~~believes ~~ability~~put tothe ~~develop~~interests ~~and~~of ~~implement~~China aat ~~business~~risk, ~~plan~~including ~~constrained~~risks byattendant ~~the~~to ~~regulatory~~indirect ~~activities~~offshore ofinvestment ~~government agencies~~ in ~~the~~companies ~~PRC, which~~that ~~are~~control ~~able~~significant todata, ~~exert~~personal ~~substantial~~or otherwise, and ~~wide-ranging~~companies ~~control~~involved ~~over~~in ~~our~~a ~~Company’s~~wide ~~operations,~~range ~~both those~~ of ~~Longduoduo~~industries ~~Health~~that ~~Technology, our~~CSRC ~~principal~~deems ~~Chinese~~essential ~~subsidiary,~~to ~~and~~ the ~~financial operations of Longduoduo~~PRC.

17● State Administration of Foreign Exchange (“SAFE”), which governs inflows and outflows of capital with respect to the PRC, and has broad authority to regulate or restrict, by registration requirements or prohibitions, cross-border transactions and currency exchange as needed to protect the interests of the PRC.

~~The~~● Cyberspace Administration of China (“CAC”), which has broad authority to regulate conduct within the PRC ~~agencies~~and offshore as it relates to cyberspace activities touching on the PRC. Among the proposed regulations under review by the CAC are a requirement that ~~will~~China-based ~~exercise~~enterprises ~~have~~holding significant ~~control~~ ~~over~~user ~~our~~data ~~Company’s~~be ~~operations~~required ~~include:~~to undergo review and approval by CAC before soliciting offshore investment.

● ~~China~~Ministry ~~Securities~~of ~~Regulatory~~Commerce ~~Commission~~ (“~~CSRC~~MOFCOM”), which ~~since March 2023~~ has ~~imposed~~broad ~~extensive~~regulatory ~~reporting~~authority ~~requirements~~over ~~and~~commercial ~~other~~activity ~~regulations~~in onthe ~~companies~~PRC, ~~structured~~with asparticular ~~ours:~~focus ~~offshore~~on ~~holding~~foreign-invested ~~companies~~commercial ~~with operations based in China~~activity. ~~The~~Among ~~CSRC~~MOFCOM’s ~~now~~activities ~~requires~~is ~~that~~reviewing ~~such companies obtain pre-approval of~~ offshore ~~securities~~investments ~~listings and offshore securities offerings, and the CSRC,~~ in ~~reviewing~~Chinese ~~such~~enterprises ~~filings, has broad discretion~~ to ~~limit~~assure ~~or prevent offshore financing activities that CSRC believes put~~ the ~~interests~~capital ofis ~~China~~used atfor ~~risk,~~purposes ~~including risks attendant to indirect offshore investment in companies~~ that ~~control~~fall ~~significant~~within ~~data,~~the ~~personal~~pre-approved orbusiness ~~otherwise,~~plan ~~and companies involved in a wide range~~ of ~~industries that CSRC deems essential to~~ the ~~PRC~~Chinese recipient.

●Investors considering ~~State~~investment ~~Administration~~in Longduoduo, therefore, should understand that the control of ~~Foreign~~our ~~Exchange~~Board ~~(“SAFE”),~~of ~~which~~Directors ~~governs~~over ~~inflows~~the plans and ~~outflows~~ operations of ~~capital~~our ~~with~~Company ~~respect~~will be subject to the ~~PRC,~~extensive control that the government of China may exercise over both our Chinese subsidiaries and ~~has~~the ~~broad~~activities ~~authority~~of toits ~~regulate~~U.S. orparent ~~restrict~~company as they involve our Chinese subsidiaries. Our Board may find, at times, that actions it considers in the best interests of our Company and its shareholders are restricted or prevented by ~~registration~~policies ~~requirements~~of one or ~~prohibitions~~more Chinese government agencies. These restrictions, ~~cross-border~~in ~~transactions~~turn, may make our public securities less valuable and ~~currency~~interfere ~~exchange~~with asour ~~needed~~efforts to ~~protect~~raise capital for the ~~interests~~operations of ~~the~~our ~~PRC~~Chinese subsidiaries.

●The government ~~Cyberspace Administration~~ of China ~~(“CAC”),~~will ~~which~~make ~~has~~a ~~broad~~direct ~~authority~~intervention tointo ~~regulate conduct within~~ the ~~PRC~~operations ~~and~~of ~~offshore~~a asChina-based itcompany ~~relates~~and totake ~~cyberspace~~control ~~activities~~of ~~touching~~its onoperations ~~the~~or significantly ~~PRC.~~restrict ~~Among~~its ~~the~~operations ~~proposed~~if ~~regulations under review by~~ the ~~CAC~~government ~~are~~believes asuch ~~requirement~~action ~~that~~is ~~China-based~~in ~~enterprises~~the ~~holding~~best ~~significant~~interests ~~user~~of ~~data~~the beChinese ~~required to undergo review and approval by CAC before soliciting offshore investment~~nation.

●The Chinese ~~Ministry~~government may intervene or influence our operations at any time, or may exert control over operations of ~~Commerce~~our ~~(“MOFCOM”)~~business, which could ~~has~~result ~~broad~~in ~~regulatory~~a ~~authority~~material change in our operations and/or the value of our securities. Any actions by the Chinese government to exert more oversight and control over ~~commercial~~offerings ~~activity~~that are conducted overseas and/or foreign investment in China-based issuers could significantly limit or completely hinder our ability to offer or continue to offer securities to investors and cause the value of such securities to significantly decline or be worthless. The government of the PRC is not bound by principles of substantive due process similar to those binding on the U.S. government. Therefore, the government of the PRC considers itself charged with ~~particular~~unrestricted ~~focus~~responsibility onfor ~~foreign~~the well-~~invested~~being ~~commercial~~of ~~activity.~~its ~~Among~~nation, ~~MOFCOM’s~~and ~~activities~~will isintervene ~~reviewing~~in ~~offshore~~the ~~investments~~economy of the PRC in general or in the affairs of an individual enterprise within the PRC, as it deems appropriate to protect the well-being of the PRC. Such intervention can take the form of restrictions on the operations of the enterprise, denial of approvals required under Chinese ~~enterprises~~law to ~~assure~~conduct the ~~capital~~business isof ~~used~~the ~~for~~enterprise, ~~purposes~~influence ~~that~~exerted ~~fall~~on ~~within~~the appointment of management, and has in some cases involved government seizure of the ~~pre-approved~~assets of an enterprise. A U.S. investor in Longduoduo will be at risk of an intervention by the PRC government in the Chinese medical services business ~~plan~~in general or the business of our Chinese subsidiaries in particular, as well as the risk that the PRC government will impose new restrictions on the ability of Longduoduo to fund the operations of our Chinese ~~recipient~~subsidiaries, such as restrictions on the use of offshore sources to fund the operations of our Chinese subsidiaries. Any such intervention by the PRC government in the operations of our Chinese subsidiaries could undermine our business plan and cause the value of an investment in Longduoduo to significantly decline or become worthless.

Investors considering investment in Longduoduo, therefore, should understand that the control of our Board of Directors over the plans and operations of our Company will be subject to the extensive control that the government of China may exercise over both Longduoduo Health Technology, our principal Chinese subsidiary, and the activities of its U.S. parent company as they involve Longduoduo Health Technology. Our Board may find, at times, that actions it considers in the best interests of our Company and its shareholders are restricted or prevented by policies of one or more Chinese government agencies. These restrictions, in turn, may make our public securities less valuable and interfere with our efforts to raise capital for the operations of Longduoduo Health Technology.18

~~The government of China will make a direct~~Failure to comply ~~intervention~~with ~~into~~any ~~the~~PRC ~~operations of a China-based company~~ laws and regulations ~~take~~may ~~control~~adversely ofaffect ~~its~~our ~~operations~~business, orinvestments and results ~~significantly restrict its operations if the government believes such action is in the best interests~~ of ~~the Chinese nation~~operations.

~~The Chinese government may intervene or influence~~Our ~~our~~China operations atare ~~any~~subject to ~~time,~~PRC laws and regulations including orbut ~~may~~not ~~exert~~limited ~~control~~to ~~over~~the ~~operations~~laws ofand ~~our~~regulations on ~~business~~taxation, ~~which~~employment ~~could result in a material change in our operations~~ and~~/or~~ ~~the~~social ~~value~~welfare, ofproduct ~~our~~quality ~~securities. Any actions by the Chinese government to exert more oversight~~ and ~~control~~consumer ~~over~~protection, ~~offerings that are conducted overseas and/or~~ foreign investment, inforeign ~~China-based~~exchange, ~~issuers~~online ~~could significantly limit or completely hinder our ability to offer~~trading orand ~~continue~~E-commerce, tofood ~~offer~~business ~~securities to investors~~ and ~~cause~~so ~~the value of such securities to significantly decline or be worthless. The government of the PRC is not bound by principles of substantive due process similar to those binding~~ on ~~the U~~.S. ~~government.~~Compliance ~~Therefore, the government of the PRC considers itself charged~~ with ~~unrestricted responsibility for the well-being of its nation~~, and monitoring ~~will intervene in the economy~~ of ~~the PRC in general or in the affairs of an individual enterprise within the PRC~~, asapplicable ~~it deems appropriate to protect the well-being~~laws and regulations may ofbe ~~the PRC. Such intervention can take the form of restrictions on the operations of the enterprise~~difficult, ~~denial~~time ~~of approvals required under Chinese law to conduct the business of the enterprise, influence exerted on the appointment of management,~~ consuming and ~~has in some cases involved government seizure of the assets of an enterprise~~ costly. A ~~U.S.~~failure to comply ~~investor~~with inapplicable ~~Longduoduo~~laws ~~will be at risk of an intervention by the PRC government in the Chinese medical services business in general~~ or ~~the business of Longduoduo Health Technology in particular~~ regulations, as ~~well as the risk~~interpreted and applied, ~~that~~could ~~the~~have ~~PRC~~a ~~government~~material ~~will~~adverse ~~impose~~effect ~~new restrictions~~ on the ability of Longduoduo to fund the operations of Longduoduo Health Technology, such as restrictions on the use of offshore sources to fund the operations of Longduoduo Health Technology. Any such intervention by the PRC government in the operations of Longduoduo Health Technology could undermine our business ~~plan~~ and results ~~cause the value~~ of ~~an investment in Longduoduo to significantly decline or become worthless~~operations.

18Changes in the policies of the PRC government could have an adverse effect on our business.

~~Failure to comply~~Policies of ~~with~~the ~~any~~PRC government can have significant effects on the economic conditions in the PRC. Although the PRC government has been pursuing ~~laws~~ economic reform policies and ~~regulations~~ transitioning to a market-oriented economy, there is no assurance that the government will continue to pursue such policies or that such policies may ~~adversely~~not ~~affect~~be ~~our~~significantly altered, especially in the event of a change in leadership, social or political disruption, or other circumstances affecting the PRC’s political, economic and social conditions. Further, regulatory agencies in China may periodically, and sometimes abruptly with little to no advance notice, change their enforcement practices. Therefore, prior enforcement activity, or lack of enforcement activity, is not necessarily predictive of future actions. Our business could be adversely affected by changes in PRC government policies, ~~investments~~ including but not limited to changes in policies relating to taxation, currency conversion, imports and ~~results~~ exports, and ownership of ~~operations~~private enterprises.

~~Our China operations are subject to PRC laws and regulations including~~Uncertainties ~~but~~with ~~not~~respect ~~limited~~ to the ~~laws~~PRC ~~and~~legal ~~regulations on taxation~~system, ~~employment~~including ~~and~~uncertainties ~~social~~regarding ~~welfare,~~the ~~product~~enforcement ~~quality~~of ~~and consumer protection~~laws, ~~foreign investment, foreign exchange, online trading~~ and ~~E-commerce,~~sudden ~~food~~or ~~business~~unexpected ~~and~~changes ~~so on. Compliance with, and monitoring of, applicable~~in laws ~~and regulations may~~ ~~be difficult, time consuming~~ and ~~costly.~~ Aregulations ~~failure to comply~~in ~~with~~China ~~applicable laws~~could ~~or regulations,~~adversely asaffect ~~interpreted~~ us and ~~applied,~~ ~~could~~limit ~~have~~the alegal ~~material~~protections ~~adverse~~available ~~effect~~to onyou ~~our business~~ and ~~results of~~ ~~operations~~us.

~~Changes~~Our operating insubsidiaries are incorporated under and governed by the ~~policies~~laws of the PRC. The PRC legal system is based on written statutes. Prior court decisions may be cited for reference but have limited precedential value. In 1979, the PRC government began to promulgate a comprehensive system of laws and regulations governing economic matters in general, such as foreign investment, corporate organization and governance, commerce, taxation and trade. As a significant part of our business is conducted in China, our operations are principally governed by PRC laws and regulations. However, since the PRC legal system continues to evolve rapidly, the interpretations of many laws, regulations and rules are not always uniform and enforcement of these laws, regulations and rules involves uncertainties, which may limit legal protections available to us. Uncertainties due to evolving laws and regulations could also impede the ability of a China-based company, such as our company, to obtain or maintain permits or licenses required to conduct business in China. In the absence of required permits or licenses, governmental authorities could impose material sanctions or penalties on us. In addition, some regulatory requirements issued by certain PRC government authorities may not be consistently applied by other PRC government authorities (including local government authorities), thus making strict compliance with all regulatory requirements impractical, or in some circumstances impossible. For example, our PRC subsidiary may have anto ~~adverse~~resort ~~effect~~to administrative and court proceedings to enforce the legal protection that we enjoy either by law or contract. However, since PRC administrative and court authorities have discretion in interpreting and implementing statutory and contractual terms, it may be more difficult to predict the outcome of administrative and court proceedings and the level of legal protection we enjoy than in more developed legal systems. Furthermore, the PRC legal system is based in part on government policies and internal rules, some of which are not published on a timely basis or at all and may have retroactive effect. As a result, we may not be aware of our violation of these policies and rules until sometime after the violation. Such uncertainties, including uncertainty over the scope and effect of our contractual, property (including intellectual property) and procedural rights, could materially and adversely affect our business and impede our ability to continue our operations.

~~Policies of the PRC government can have significant~~Intellectual ~~effects~~property onrights ~~the~~and ~~economic~~confidentiality ~~conditions~~protections in ~~the~~China ~~PRC.~~may ~~Although~~also ~~the~~not ~~PRC~~be ~~government~~as ~~has~~effective ~~been~~as ~~pursuing~~in ~~economic~~the ~~reform~~United ~~policies~~States ~~and~~or ~~transitioning to~~other acountries. ~~market-oriented economy~~In addition, ~~there~~we iscannot nopredict ~~assurance that~~ the ~~government~~effects ~~will~~of ~~continue~~future todevelopments ~~pursue~~in ~~such~~the ~~policies~~PRC orlegal ~~that~~system ~~such~~on ~~policies~~our ~~may not~~business ~~be significantly altered~~operations, ~~especially~~including in the ~~event~~ promulgation of anew ~~change in leadership~~laws, ~~social~~ or ~~political~~changes ~~disruption,~~to orexisting ~~other~~laws ~~circumstances affecting~~or the ~~PRC’s~~interpretation ~~political,~~or ~~economic~~enforcement ~~and social conditions~~thereof. ~~Further,~~These ~~regulatory~~uncertainties ~~agencies~~could inlimit ~~China~~the ~~may~~legal ~~periodically, and sometimes~~protections ~~abruptly~~available ~~with little~~ to nous ~~advance~~and ~~notice~~our investors, ~~change~~including ~~their enforcement practices~~you. ~~Therefore~~Moreover, ~~prior~~any ~~enforcement~~litigation ~~activity,~~in orChina ~~lack~~may ~~of enforcement activity, is not necessarily predictive of future actions. Our business could~~ be ~~adversely~~protracted ~~affected~~and byresult ~~changes~~ in ~~PRC~~substantial ~~government policies,~~costs ~~including~~and ~~but~~diversion ~~not~~of ~~limited~~our toresources ~~changes in policies relating to taxation, currency conversion, imports~~ and ~~exports,~~management ~~and ownership of private enterprises~~attention.

Uncertainties with respect to the PRC legal system, including uncertainties regarding the enforcement of laws, and sudden or unexpected changes in laws and regulations in China could adversely affect us and limit the legal protections available to you and us.19

~~Our~~The PRC ~~operating~~government ~~subsidiaries~~has ~~are~~significant ~~incorporated~~oversight ~~under~~ and ~~governed~~discretion byover the ~~laws~~conduct of ~~the~~our ~~PRC.~~business ~~The~~and ~~PRC~~may ~~legal~~intervene ~~system~~or isinfluence ~~based~~our onoperations as ~~written~~the ~~statutes.~~government ~~Prior~~deems ~~court~~appropriate ~~decisions~~to ~~may~~further beregulatory, ~~cited~~political ~~for~~and ~~reference but~~societal ~~have limited precedential value~~goals. InThe ~~1979, the~~ PRC government ~~began~~has torecently ~~promulgate~~published ~~a comprehensive system of laws and regulations governing~~new ~~economic~~policies ~~matters~~that insignificantly affected ~~general,~~certain industries such as ~~foreign~~the ~~investment,~~education ~~corporate organization~~ and ~~governance,~~internet ~~commerce~~industries, ~~taxation~~ and ~~trade.~~we Ascannot arule ~~significant~~out the ~~part~~possibility ofthat ~~our~~it ~~business~~will ~~is conducted~~ in ~~China,~~the ~~our~~future ~~operations~~release ~~are~~regulations ~~principally~~or ~~governed~~policies byregarding ~~PRC~~our ~~laws~~industry ~~and~~that ~~regulations.~~could ~~However,~~adversely ~~since~~affect ~~the~~our ~~PRC~~business, ~~legal~~financial ~~system~~condition ~~continues~~and toresults ~~evolve~~of ~~rapidly~~operations. Furthermore, the ~~interpretations~~PRC ofgovernment ~~many~~has ~~laws,~~recently ~~regulations~~indicated ~~and~~an ~~rules~~intent ~~are~~to ~~not~~exert ~~always~~more ~~uniform~~ oversight and ~~enforcement of~~control ~~these~~over ~~laws,~~securities ~~regulations~~offerings and ~~rules~~other ~~involves~~capital ~~uncertainties,~~markets ~~which~~activities ~~may~~that ~~limit~~are ~~legal~~conducted ~~protections~~overseas ~~available to us. Uncertainties due to evolving laws~~ and ~~regulations~~foreign ~~could~~investment ~~also~~in ~~impede the ability of a~~ China-based companies. ~~company,~~Any such asintervention ~~our~~in ~~company,~~or toinfluence ~~obtain~~on orour ~~maintain~~business ~~permits~~operations or ~~licenses required~~action to ~~conduct~~exert ~~business~~more inoversight ~~China.~~and Incontrol ~~the~~over ~~absence of required permits or licenses, governmental authorities could impose material~~securities ~~sanctions~~offerings orand ~~penalties~~other oncapital ~~us.~~markets ~~In addition~~activities, ~~some~~once ~~regulatory~~taken ~~requirements issued~~ by ~~certain~~the PRC government ~~authorities may not be consistently applied by other PRC government authorities (including local government authorities)~~, ~~thus~~could ~~making~~adversely ~~strict~~affect ~~compliance with all regulatory requirements impractical, or in some circumstances impossible. For example, our PRC subsidiary may have to resort to administrative and court proceedings to enforce~~ the ~~legal protection that we enjoy either by law or contract. However~~business, ~~since~~financial ~~PRC administrative and court~~condition ~~authorities have discretion in interpreting~~ and ~~implementing~~results ~~statutory and contractual terms, it may be more difficult to predict the outcome~~ of ~~administrative~~operations and ~~court proceedings and~~ the ~~level~~value of ~~legal protection we enjoy than in more developed legal systems. Furthermore, the PRC legal system is~~ China-based ~~in part on government policies and internal rules~~companies, ~~some~~or ofsignificantly ~~which~~limit ~~are~~or ~~not~~completely ~~published~~hinder onour aability ~~timely~~to ~~basis~~offer or atcontinue ~~all~~to ~~and~~offer ~~may~~securities ~~have~~to ~~retroactive~~investors ~~effect. As a result, we may not be aware of our violation of these policies~~ and ~~rules~~cause ~~until sometime after~~ the ~~violation.~~value ~~Such~~of ~~uncertainties,~~such ~~including~~securities ~~uncertainty~~to ~~over~~significantly ~~the~~decline ~~scope~~or ~~and~~in ~~effect~~extreme ~~of our contractual~~cases, ~~property (including intellectual~~become ~~property) and procedural rights, could materially and adversely affect our business and impede our ability to continue our operations~~worthless.

~~Intellectual property rights and confidentiality~~PRC ~~protections~~regulation inof ~~China~~loans ~~may~~to, ~~also~~and ~~not~~direct beinvestments ~~as effective as~~ in ~~the United States or other countries. In addition~~, wePRC ~~cannot~~entities ~~predict~~by ~~the~~offshore ~~effects of~~holding ~~future~~companies ~~developments~~may indelay ~~the~~or ~~PRC~~prevent ~~legal~~us ~~system~~from onusing our capital ~~business~~reserves ~~operations, including the promulgation of new laws, or changes~~ to ~~existing laws~~make orloans ~~the interpretation~~ or ~~enforcement~~additional ~~thereof.~~capital ~~These~~contributions ~~uncertainties could limit the legal protections available~~ to ~~us and~~ our ~~investors, including~~PRC ~~you.~~operating ~~Moreover, any litigation in China may be protracted and result in substantial costs and diversion of our resources and management attention~~subsidiaries.

19As an offshore holding company with PRC subsidiaries, we may transfer funds to our PRC subsidiaries or finance our operating entity by means of loans or capital contributions. Any capital contributions or loans that we, as an offshore entity, make to our Company’s PRC subsidiaries, are subject to PRC regulations. Any loans to our PRC subsidiaries, which are foreign-invested enterprises, cannot exceed statutory limits based on the difference between the amount of our investments and registered capital in such subsidiaries, and shall be registered with SAFE, or its local counterparts. Furthermore, any capital increase contributions we make to our PRC subsidiaries, which are foreign-invested enterprises, are subject to the requirement of making necessary filings in FICMIS, and registration with other government authorities in China. We may not be able to obtain these government registrations or approvals on a timely basis, if at all. If we fail to obtain such approvals or make such registration, our ability to make equity contributions or provide loans to our Company’s PRC subsidiaries or to fund their operations may be negatively affected, which may adversely affect their liquidity and ability to fund their working capital and expansion projects and meet their obligations and commitments. As a result, our liquidity and our ability to fund and expand our business may be negatively affected.

~~The PRC government has significant oversight and~~Because ~~discretion over the conduct of~~ our ~~business~~principal ~~and~~assets ~~may~~are ~~intervene~~located oroutside ~~influence~~of ~~our operations as~~ the ~~government~~United ~~deems~~States ~~appropriate to further regulatory, political~~ and ~~societal~~because ~~goals.~~all ~~The~~of ~~PRC~~our ~~government~~directors ~~has recently published new policies that significantly affected certain industries such as the education~~ and ~~internet~~all ~~industries,~~our ~~and~~officers wereside ~~cannot rule out the possibility that it will~~ in ~~the future release regulations or policies regarding our industry that could adversely affect our business~~China, ~~financial condition and results of operations. Furthermore,~~ ~~the~~it ~~PRC~~may ~~government~~be ~~has~~difficult ~~recently~~for ~~indicated~~you ~~an intent~~ to ~~exert~~use ~~more~~the ~~oversight~~United ~~and~~States ~~control~~Federal ~~over~~ securities ~~offerings~~laws ~~and~~to ~~other~~enforce ~~capital~~your ~~markets activities~~rights ~~that~~against ~~are~~us ~~conducted overseas~~ and ~~foreign investment in China-based companies. Any such intervention in or influence on~~ our ~~business operations~~officers or ~~action~~ to ~~exert more oversight and control over securities offerings and other capital markets activities, once taken by~~ ~~the~~enforce ~~PRC~~judgments ~~government, could adversely affect the business, financial condition and results~~ of ~~operations~~United ~~and~~States ~~the~~courts ~~value~~against ofus ~~China-based companies,~~ or ~~significantly~~them ~~limit~~in ~~or completely hinder our ability to offer or continue to offer securities to investors and cause~~ the ~~value of such securities to significantly decline or in extreme cases, become worthless~~PRC.

~~PRC~~Our Company ~~regulation~~conducts substantially all of ~~loans~~its tooperations in China, and ~~direct~~substantially ~~investments~~all of the assets reflected on our balance sheet are located in China. In addition, all members of our board of directors and all of our senior executive officers reside within China and are PRC ~~entities~~nationals. byAs ~~offshore~~a ~~holding~~result, ~~companies~~it may ~~delay~~be ordifficult ~~prevent~~for usour ~~from~~shareholders ~~using~~to ~~our~~effect ~~capital~~service ~~reserves~~of toprocess ~~make~~upon ~~loans~~those orpersons ~~additional~~inside ~~capital~~China. ~~contributions~~In addition, China does not have treaties providing for the reciprocal recognition and enforcement of judgments of courts with the United States. Therefore, recognition and enforcement in China of judgments of a court in the United States in relation to ~~our~~any ~~PRC~~matter ~~operating~~not ~~subsidiaries~~subject to a binding arbitration provision may be difficult or impossible.

AsShareholder claims anthat ~~offshore~~are ~~holding~~common ~~company~~in ~~with~~the ~~PRC~~United ~~subsidiaries~~States, we ~~may~~including ~~transfer~~securities ~~funds~~law toclass ~~our~~actions ~~PRC~~and ~~subsidiaries~~fraud orclaims, ~~finance~~generally ~~our~~are ~~operating~~difficult ~~entity~~to bypursue as ~~means~~a matter of ~~loans~~law or ~~capital~~practicality ~~contributions~~in China. ~~Any~~For ~~capital contributions or loans that we~~example, asin ~~an offshore entity~~China, ~~make~~there ~~to our Company’s PRC subsidiaries,~~ are ~~subject~~significant tolegal ~~PRC~~and ~~regulations.~~other ~~Any loans~~obstacles to ~~our~~obtaining ~~PRC subsidiaries, which are foreign-invested enterprises, cannot exceed statutory limits based on the difference between~~information ~~the~~needed ~~amount~~for ofshareholder ~~our~~investigations ~~investments~~or ~~and~~litigation ~~registered~~outside ~~capital~~China inor ~~such~~otherwise ~~subsidiaries, and shall be registered~~ with ~~SAFE,~~respect ~~or its local counterparts. Furthermore, any capital increase contributions we make~~ to ~~our PRC subsidiaries, which are~~ foreign~~-invested~~ ~~enterprises,~~entities. ~~are~~Although ~~subject to~~ the ~~requirement~~local ~~of making necessary filings in FICMIS, and registration with other government~~ authorities in China. We may ~~not~~establish ~~be able to obtain these government registrations or approvals on~~ a ~~timely~~regulatory ~~basis,~~cooperation ifmechanism atwith ~~all.~~the Ifsecurities weregulatory ~~fail~~authorities toof ~~obtain~~another ~~such~~country ~~approvals~~ or ~~make~~region ~~such registration, our ability~~ to ~~make equity contributions or provide loans to our Company’s PRC subsidiaries or to fund their operations may be negatively~~ ~~affected,~~implement ~~which~~cross-border ~~may~~supervision ~~adversely affect their liquidity~~ and ~~ability~~administration, tosuch ~~fund~~regulatory ~~their~~cooperation ~~working~~with ~~capital~~the ~~and~~securities ~~expansion~~regulatory ~~projects~~authorities ~~and~~in ~~meet their obligations~~the ~~and~~Unities ~~commitments.~~States Ashave anot ~~result,~~been ~~our~~efficient ~~liquidity~~in ~~and~~the ~~our~~absence ~~ability~~of toa ~~fund~~mutual and ~~expand~~practical ~~our~~cooperation ~~business may be negatively affected~~mechanism.

Because our principal assets are located outside of the United States and because all of our directors and all our officers reside in China, it may be difficult for you to use the United States Federal securities laws to enforce your rights against us and our officers or to enforce judgments of United States courts against us or them in the PRC.20

~~Our~~The recent ~~Company~~joint ~~conducts~~statement ~~substantially~~by ~~all~~the ofSEC ~~its operations~~and inPCAOB ~~China,~~ and ~~substantially~~the ~~all~~Holding ofForeign ~~the~~Companies ~~assets~~Accountable ~~reflected~~Act oncalls ~~our~~for ~~balance~~additional ~~sheet~~and ~~are~~more ~~located~~stringent criteria into ~~China.~~be Inapplied ~~addition,~~to ~~all~~emerging ~~members of~~market ~~our~~companies ~~board~~upon ofassessing ~~directors~~the ~~and~~qualification ~~all~~ of ~~our~~their ~~senior~~auditors, ~~executive~~especially ~~officers~~the ~~reside~~non-U.S. ~~within~~auditors who ~~China~~are ~~and~~not ~~are~~inspected ~~PRC~~by ~~nationals~~the PCAOB. AsFurthermore, ain ~~result~~2023, itthe ~~may~~U.S. beCongress ~~difficult for~~passed, ~~our~~and ~~shareholders~~the toPresident ~~effect~~signed, ~~service~~the ofAccelerating ~~process~~Holding Foreign ~~upon~~Companies ~~those~~Accountable ~~persons~~Act, ~~inside~~which ~~China.~~amended Inthe ~~addition,~~HFCA ~~China~~Act ~~does~~and ~~not~~requires ~~have~~the ~~treaties~~SEC ~~providing for~~to ~~the~~prohibit ~~reciprocal~~an ~~recognition~~issuer’s ~~and~~securities ~~enforcement~~from oftrading on ~~judgments~~any ofU.S. ~~courts~~stock ~~with~~exchanges ~~the~~if ~~United~~its ~~States.~~auditor ~~Therefore,~~is ~~recognition~~not ~~and~~subject ~~enforcement~~to ~~in China~~PCAOB ofinspections ~~judgments~~for oftwo aconsecutive ~~court~~years in(instead ~~the~~of ~~United~~three ~~States~~mandated in the ~~relation~~HFCAA). toThese ~~any~~developments ~~matter~~could ~~not~~add ~~subject~~uncertainties to aour ~~binding~~business ~~arbitration provision may be difficult or impossible~~operations.

~~Shareholder~~Pursuant to ~~claims~~the ~~that~~Holding ~~are~~Foreign ~~common~~Companies inAccountable ~~the~~Act ~~United States~~(“HFCAA”), ~~including~~as ~~securities~~adopted ~~law~~by ~~class~~the ~~actions~~United ~~and~~States ~~fraud~~Congress ~~claims~~in 2020, ~~generally~~the ~~are~~Public Company ~~difficult~~Accounting toOversight ~~pursue~~Board as(the a“PCAOB”) ~~matter~~issued ofa ~~law~~Determination orReport ~~practicality in~~on ~~China.~~December ~~For example~~16, in2021 ~~China,~~which ~~there~~found ~~are~~that ~~significant~~the PCAOB ~~legal~~was ~~and~~unable ~~other obstacles~~ to ~~obtaining~~inspect ~~information~~or ~~needed~~investigate ~~for~~completely ~~shareholder~~registered ~~investigations or~~public ~~litigation~~accounting ~~outside~~firms ~~China~~headquartered orin ~~otherwise~~the ~~with~~PRC ~~respect~~because toof ~~foreign~~a ~~entities.~~position taken ~~Although~~by ~~the~~one ~~local~~or more authorities in mainland China. ~~may~~Under ~~establish~~the aHFCAA ~~regulatory cooperation~~(as ~~mechanism~~amended ~~with~~by the ~~securities~~Consolidated ~~regulatory~~Appropriations ~~authorities~~Act of– ~~another~~2023), an ~~country~~issuer’s orsecurities ~~region~~may tobe ~~implement~~prohibited ~~cross-border~~from ~~supervision~~trading ~~and administration,~~on ~~such~~a ~~regulatory~~U.S. ~~cooperation~~stock ~~with~~exchange ~~the~~or ~~securities~~facility ~~regulatory~~if ~~authorities~~its inauditor is not inspected by the PCAOB ~~Unities~~for ~~States~~two ~~have~~consecutive ~~not~~years ~~been~~(reduced ~~efficient~~by Congress in ~~the~~ ~~absence~~2023 offrom athree ~~mutual~~consecutive ~~and~~years ~~practical~~in ~~cooperation~~the ~~mechanism~~original HFCAA).

20On August 26, 2022, the China Securities Regulatory Commission (“CSRC”), the Ministry of Finance of China, and the PCAOB signed a protocol governing inspections and investigations of audit firms based in China and Hong Kong. On December 15, 2022, the PCAOB issued a new Determination Report which: (1) vacated the December 16, 2021 Determination Report; and (2) concluded that the PCAOB had been able to conduct inspections and investigations completely in the PRC in 2022. The December 15, 2022 Determination Report cautions, however, that authorities in the PRC might take positions at any time that would prevent the PCAOB from continuing to inspect or investigate completely. As required by the HFCAA, if in the future the PCAOB determines it no longer can inspect or investigate completely because of a position taken by an authority in the PRC, the PCAOB will act expeditiously to consider whether it should issue a new determination. If the PCAOB is not able to fully conduct inspections of our auditor’s work papers in the PRC, our securities may be prohibited from trading on a U.S. stock exchange or facility if our auditor is not inspected by the PCAOB for two consecutive years, and this ultimately could result in our common stock being barred from listing in the United States, which would likely prevent our shareholders from being able to sell their shares until the bar was lifted.

~~The~~Longduoduo recently ~~recent~~engaged ~~joint~~Bush ~~statement~~& byAssociates CPA LLC as its independent auditor. Bush & Associates is headquartered in the ~~SEC~~State ~~and~~of Nevada. The PCAOB ~~and~~is ~~the~~able ~~Holding~~to, ~~Foreign~~and ~~Companies~~does, ~~Accountable~~fully ~~Act~~conduct ~~calls~~inspections ~~for~~of ~~additional~~our ~~and~~auditor’s ~~more~~work ~~stringent~~papers. ~~criteria~~There toremains bea ~~applied~~risk, tohowever, ~~emerging~~that ~~market~~the ~~companies~~government ~~upon~~of ~~assessing~~ the ~~qualification~~PRC ofmight ~~their~~in ~~auditors,~~the ~~especially~~future impose restrictions on the ~~non-U.S.~~communication ~~auditors~~of ~~who~~information ~~are~~to ~~not~~auditors ~~inspected~~or by ~~the~~auditors ~~PCAOB.~~of ~~Furthermore,~~issuers inwhose ~~2023,~~operations ~~the~~are ~~U.S.~~located ~~Congress~~within ~~passed~~the PRC, ~~and~~in ~~the~~such ~~President~~a ~~signed,~~way that investors in the ~~Accelerating~~securities ~~Holding~~of ~~Foreign~~such ~~Companies~~issuers ~~Accountable~~do ~~Act,~~not ~~which~~receive ~~amended~~the full benefit of the ~~HFCA~~audits. ~~Act~~In ~~and~~that ~~requires~~situation, ~~the~~it ~~SEC~~could tooccur ~~prohibit~~that anthe ~~issuer’s~~SEC ~~securities~~would ~~from~~bar trading onplatforms ~~any~~subject to U.S. ~~stock~~jurisdiction ~~exchanges~~from iflisting ~~its auditor is~~Longduoduo’s ~~not~~securities ~~subject to PCAOB inspections~~ for ~~two~~trading. ~~consecutive~~Such ~~years~~an ~~(instead~~occurrence ofwould ~~three~~be ~~mandated~~likely into cause the ~~HFCAA).~~value ~~These~~of ~~developments~~Longduoduo’s ~~could~~securities ~~add uncertainties~~ to ~~our~~diminish ~~business operations~~significantly.

Pursuant to the Holding Foreign Companies Accountable Act (“HFCAA”), as adopted by the United States Congress in 2020, the Public Company Accounting Oversight Board (the “PCAOB”) issued a Determination Report on December 16, 2021 which found that the PCAOB was unable to inspect or investigate completely registered public accounting firms headquartered in the PRC because of a position taken by one or more authorities in mainland China. Under the HFCAA (as amended by the Consolidated Appropriations Act – 2023), an issuer’s securities may be prohibited from trading on a U.S. stock exchange or facility if its auditor is not inspected by the PCAOB for two consecutive years (reduced by Congress in 2023 from three consecutive years in the original HFCAA).21

~~On August 26~~However, ~~2022,~~ the ~~China~~recent ~~Securities~~developments ~~Regulatory Commission~~would ~~(“CSRC”),~~add ~~the~~uncertainties ~~Ministry~~to ofour ~~Finance~~situation ~~of China,~~ and ~~the~~we ~~PCAOB~~cannot ~~signed~~assure ayou ~~protocol~~whether ~~governing~~regulatory ~~inspections~~authorities ~~and~~would ~~investigations~~apply ofadditional ~~audit~~and ~~firms~~more ~~based~~stringent incriteria ~~China~~to ~~and~~us ~~Hong~~after ~~Kong. On~~considering ~~December 15, 2022,~~ the ~~PCAOB~~effectiveness ~~issued~~of aour ~~new~~auditor’s ~~Determination~~audit ~~Report~~procedures ~~which:~~and ~~(1) vacated~~quality ~~the~~control ~~December 16~~procedures, ~~2021~~adequacy ~~Determination~~of ~~Report;~~personnel and ~~(2)~~training, ~~concluded~~or ~~that~~sufficiency ~~the~~of ~~PCAOB~~resources, ~~had~~geographic ~~been~~reach ~~able~~or toexperience ~~conduct~~as ~~inspections~~it ~~and~~relates ~~investigations completely~~to in the ~~PRC~~audit inof ~~2022.~~our ~~The~~financial ~~December~~statements. ~~15,~~It ~~2022~~remains ~~Determination~~unclear ~~Report~~what ~~cautions, however, that authorities in~~ the ~~PRC~~SEC’s ~~might~~implementation ~~take~~process ~~positions~~related ~~at any~~to ~~time that would prevent~~ the ~~PCAOB~~June ~~from~~2021 ~~continuing~~interim final toamendments ~~inspect~~will entail or ~~investigate~~what ~~completely.~~further Asactions ~~required by~~ the ~~HFCAA,~~SEC ifor in the ~~future the~~ PCAOB ~~determines~~will ittake noto ~~longer~~address ~~can~~these ~~inspect~~issues orand ~~investigate~~what ~~completely~~impact ~~because~~those ofactions will ahave ~~position~~on ~~taken~~U.S. bycompanies anthat ~~authority~~have significant operations in the PRC, ~~the~~and ~~PCAOB will~~have ~~act~~securities ~~expeditiously~~listed toon ~~consider~~a ~~whether~~U.S. itstock ~~should~~exchange ~~issue~~ (including a ~~new~~national ~~determination.~~securities Ifexchange or over-the-counter ~~PCAOB~~stock ismarket). ~~not~~In ~~able~~addition, tothe ~~fully~~June ~~conduct~~2021 ~~inspections of~~interim ~~our~~final ~~auditor’s~~amendments ~~work~~and ~~papers~~any inadditional actions, ~~the PRC~~proceedings, ~~our~~or ~~securities~~new ~~may~~rules beresulting ~~prohibited~~ from ~~trading~~these onefforts ato increase U.S. ~~stock~~regulatory ~~exchange~~access orto ~~facility~~audit ifinformation ~~our~~could create ~~auditor~~some isuncertainty ~~not~~for ~~inspected~~investors, by the ~~PCAOB~~market ~~for~~price ~~two~~of ~~consecutive~~our ~~years,~~common ~~and~~stock ~~this~~could ~~ultimately~~be ~~could~~adversely ~~result~~affected, inand ~~our~~we ~~common~~could ~~stock~~be ~~being~~delisted ~~barred~~if ~~from~~we and ~~listing~~our inauditor ~~the~~are ~~United~~unable ~~States,~~to ~~which~~meet ~~would~~the ~~likely~~PCAOB ~~prevent~~inspection ~~our~~requirement ~~shareholders~~or ~~from~~ being ~~able~~required to ~~sell~~engage ~~their~~a ~~shares~~new ~~until~~audit ~~the~~firm, ~~bar~~which ~~was~~would ~~lifted~~require significant expense and management time.

~~Longduoduo recently engaged Bush & Associates~~Restrictions ~~CPA~~contained ~~LLC as its independent auditor, replacing Michael T. Studer CPA P.C.~~ in ~~that~~Chinese ~~role.~~law ~~Bush~~on ~~& Associates is headquartered in~~ the ~~State of~~ability ~~Nevada, and Michael T. Studer CPA P.C. is headquartered in the State~~ of ~~New~~overseas ~~York.~~securities ~~The~~regulators ~~PCAOB is able~~ to, ~~and~~collect ~~does, fully conduct inspections of our auditor’s work papers. There remains a risk, however, that the government of the PRC might in the future impose restrictions on the communication of~~ information ~~to auditors or by auditors of issuers whose operations are located within the PRC,~~ in ~~such~~China amay ~~way~~deny ~~that~~ investors in ~~the~~our ~~securities of such issuers do not receive~~ Company the ~~full~~benefits ~~benefit~~ of ~~the audits. In that situation, it could occur that the SEC would bar trading platforms subject to~~ U.S. ~~jurisdiction from listing Longduoduo’s~~ securities ~~for trading~~regulation. ~~Such an occurrence would be likely to cause the value of Longduoduo’s securities to diminish significantly.~~

21China has often restricted U.S. regulators’ access to information and limited regulators’ ability to investigate or pursue remedies with respect to China-based issuers, generally citing to state secrecy and national security laws, blocking statutes, or other laws or regulations. In addition, according to Article 177 of the PRC Securities Law, which became effective in March 2020, no overseas securities regulator can directly conduct investigations or evidence collection activities within the PRC and no entity or individual in China may provide documents and information relating to securities business activities to overseas regulators without Chinese government approval. The SEC, U.S. Department of Justice, and other U.S. authorities face substantial challenges in bringing and enforcing actions against China-based issuers and their officers and directors. As a result, investors in our Company may not benefit from a regulatory environment that fosters effective enforcement of U.S. federal securities laws.

~~However, the recent developments would add uncertainties~~According to ~~our~~Article 177, ~~situation~~there ~~and~~are weuncertainties ~~cannot~~as ~~assure you whether regulatory authorities would apply additional and more stringent criteria~~ to ~~us after considering~~ the ~~effectiveness of our auditor’s audit~~ procedures and ~~quality~~requisite ~~control~~timing ~~procedures,~~for ~~adequacy of personnel and training, or sufficiency of resources, geographic reach or experience as it relates to~~ the ~~audit of our financial statements~~U.S. Itsecurities regulatory ~~remains unclear~~agencies ~~what the SEC’s implementation process related~~ to ~~the~~conduct ~~June~~investigations ~~2021~~and ~~interim~~collect ~~final~~evidence ~~amendments~~within ~~will entail or what further actions~~ the ~~SEC~~ or territory of the ~~PCAOB will take to address these issues and what impact those actions will have on U~~ PRC.S. ~~companies~~If ~~that have significant operations in~~ the ~~PRC and have securities listed on a~~ U.S. ~~stock exchange (including a national~~ securities ~~exchange or over-the-counter stock market).~~ regulatory Inagencies ~~addition,~~are ~~the~~unable ~~June~~to ~~2021~~conduct ~~interim~~such ~~final amendments and any additional actions~~investigations, ~~proceedings,~~there orexists ~~new~~a ~~rules~~risk ~~resulting~~that ~~from~~they ~~these~~may ~~efforts to~~determine ~~increase U.S. regulatory access~~ to ~~audit~~suspend ~~information~~or ~~could~~de-register ~~create some uncertainty for investors, the market price of~~ our ~~common stock~~registration ~~could~~with bethe ~~adversely~~SEC ~~affected,~~ and wemay ~~could~~also bedelist ~~delisted if we and~~ our securities from ~~auditor~~OTC ~~are~~Markets ~~unable to meet the PCAOB inspection requirement~~ or ~~being required~~other toapplicable ~~engage~~trading amarket ~~new~~within ~~audit~~the ~~firm, which would require significant expense and management time~~US.

~~Restrictions contained in Chinese law on~~Governmental ~~the~~control ~~ability~~ of ~~overseas~~currency ~~securities~~conversion ~~regulators to collect information in China~~ may ~~deny~~affect ~~investors in our Company~~ the ~~benefits~~value of ~~U.S.~~your ~~securities regulation~~investment.

~~China~~The People’s ~~has~~Republic ~~often~~of ~~restricted~~China ~~U.S.~~(PRC) ~~regulators’ access~~government toimposes ~~information~~controls ~~and~~on ~~limited~~the ~~regulators’~~convertibility ~~ability~~of toRenminbi ~~investigate~~(RMB) orinto ~~pursue~~foreign ~~remedies~~currencies ~~with~~and, in ~~respect~~certain ~~to China-based issuers~~cases, ~~generally citing~~the toremittance ~~state~~of ~~secrecy~~currency ~~and~~out ~~national~~of ~~security~~the ~~laws,~~PRC. ~~blocking~~We ~~statutes,~~receive orsubstantially ~~other~~all ~~laws~~of orour ~~regulations.~~revenues Inin ~~addition~~RMB, ~~according~~which tois ~~Article~~currently ~~177~~not ofa ~~the~~freely ~~PRC~~convertible ~~Securities~~currency. ~~Law,~~Shortages ~~which~~in ~~became~~the ~~effective~~availability inof ~~March~~foreign ~~2020,~~currency nomay ~~overseas~~restrict ~~securities~~our ~~regulator~~ability ~~can~~to ~~directly~~remit ~~conduct~~sufficient ~~investigations~~foreign currency to pay dividends, or ~~evidence~~otherwise ~~collection~~satisfy ~~activities~~foreign ~~within~~currency ~~the~~dominated obligations. Under existing PRC ~~and~~foreign noexchange ~~entity~~regulations, payments orof ~~individual~~current inaccount ~~China~~items, ~~may~~including ~~provide~~profit ~~documents~~distributions, interest payments and ~~information~~expenditures ~~relating~~in toconnection with a commercial ~~securities~~transaction, ~~business~~can ~~activities~~be tomade ~~overseas~~in ~~regulators~~foreign currencies without ~~Chinese~~prior ~~government~~ approval. ~~The~~from ~~SEC,~~the ~~U.S.~~PRC ~~Department~~State Administration of ~~Justice,~~Foreign ~~and~~Exchange ~~other~~by complying ~~U.S.~~with ~~authorities~~certain ~~face~~procedural ~~substantial~~requirements. ~~challenges~~However, inapproval ~~bringing~~from ~~and~~appropriate ~~enforcing~~governmental ~~actions~~authorities ~~against~~is ~~China-based~~required ~~issuers~~where ~~and~~RMB ~~their~~is ~~officers~~to ~~and~~be ~~directors.~~converted Asinto aforeign ~~result,~~currency ~~investors~~and inremitted ~~our~~out ~~Company~~of ~~may~~PRC ~~not~~to ~~benefit~~pay ~~from~~capital aexpenses ~~regulatory~~such ~~environment~~as ~~that~~the ~~fosters~~repayment ~~effective~~of ~~enforcement~~bank ofloans ~~U.S.~~denominated ~~federal securities~~in ~~laws~~foreign currencies.

~~According~~The PRC togovernment ~~Article 177,~~also ~~there~~may ~~are~~at ~~uncertainties as~~its todiscretion restrict access in the ~~procedures~~future ~~and~~to ~~requisite~~foreign ~~timing~~currencies for ~~the~~current Uaccount transactions.S. ~~securities regulatory~~If ~~agencies~~the foreign toexchange ~~conduct~~control ~~investigations~~system ~~and~~prevents ~~collect~~us ~~evidence within~~from ~~the~~obtaining ~~territory of the PRC.~~sufficient Ifforeign ~~the~~currency ~~U.S. securities regulatory~~to ~~agencies~~satisfy ~~are~~our ~~unable~~currency todemands, ~~conduct~~we ~~such~~may ~~investigations,~~not be ~~there~~able ~~exists~~to apay ~~risk~~certain ~~that~~of ~~they~~our ~~may~~expenses ~~determine~~as tothey ~~suspend~~come ordue, ~~de-register~~finance our ~~registration~~cash ~~with~~requirements, ~~the~~service ~~SEC~~debt ~~and~~or ~~may~~make ~~also~~dividend ~~delist~~or ~~our securities from~~other distributions ~~OTC~~to ~~Markets~~our orshareholders, ~~other~~all ~~applicable~~of ~~trading~~which ~~market~~may ~~within~~adversely ~~the~~affect USyour investment.

~~Governmental control of currency conversion may affect the value of your investment.~~22

The ~~People’s Republic of China (PRC) government~~ ~~imposes~~fluctuation ~~controls on the convertibility~~ of ~~Renminbi (~~RMB) into foreign currencies and, in certain cases, the remittance of currency out of the PRC. We receive substantially all of our revenues in RMB, which is currently not a freely convertible currency. Shortages in the availability of foreign currency may ~~restrict~~materially our ability to remit sufficient foreign currency to pay dividends, or otherwise satisfy foreign currency dominated obligations. Under existing PRC foreign exchange regulations, payments of current account items, including profit distributions, interest payments and ~~expenditures~~adversely inaffect ~~connection~~your ~~with a commercial transaction, can be made in foreign currencies without prior approval from the PRC State Administration of Foreign Exchange by complying with certain procedural requirements~~investment. However, approval from appropriate governmental authorities is required where RMB is to be converted into foreign currency and remitted out of PRC to pay capital expenses such as the repayment of bank loans denominated in foreign currencies.

The value ~~PRC~~of ~~government~~the ~~also~~RMB against the U.S. dollar and other currencies may atfluctuate ~~its~~and ~~discretion restrict~~is ~~access~~affected by, among other things, changes in the ~~future~~PRC’s political toand ~~foreign~~economic ~~currencies~~conditions. ~~for~~As ~~current~~we ~~account~~rely ~~transactions.~~entirely Ifon revenues earned in the ~~foreign~~PRC, ~~exchange~~any ~~control~~significant ~~system~~revaluation ~~prevents~~of RMB may materially usand ~~from~~adversely ~~obtaining~~affect ~~sufficient~~our ~~foreign~~cash ~~currency~~flows, torevenues ~~satisfy~~and ~~our~~financial ~~currency~~condition. ~~demands~~For example, weto ~~may~~the ~~not~~extent bethat ~~able~~we need to ~~pay~~convert ~~certain~~U.S. dollars we receive from an offering of our ~~expenses~~securities asinto ~~they come~~RMB ~~due~~for our operations, ~~finance~~appreciation of the RMB against the U.S. dollar could have a material adverse effect on our ~~cash~~business, ~~requirements~~financial condition and results of operations. Conversely, ~~service~~if ~~debt~~we ordecide ~~make~~to convert our RMB into U.S. dollars for the purpose of making dividend payments on our common stock or for other ~~distributions~~business topurposes ~~our~~and ~~shareholders~~the U.S. dollar appreciates against the RMB, ~~all~~the U.S. dollar equivalent of ~~which~~the ~~may~~RMB ~~adversely~~we convert would be reduced. In addition, the depreciation of significant ~~affect~~U.S. ~~your~~dollar ~~investment~~denominated assets could result in a charge to our income statement and a reduction in the value of these assets.

22We may become subject to a variety of laws and regulations in the PRC regarding privacy, data security, cybersecurity, and data protection. We may be liable for improper use or appropriation of personal information provided by our customers.

We may become subject to a variety of laws and regulations in the PRC regarding privacy, data security, cybersecurity, and data protection. These laws and regulations are continuously evolving and developing. The ~~fluctuation~~scope and interpretation of ~~RMB~~the laws that are or may ~~materially~~be applicable to us are often uncertain and may be conflicting, particularly with respect to foreign laws. In particular, there are numerous laws and ~~adversely~~regulations ~~affect~~regarding ~~your~~privacy ~~investment~~and the collection, sharing, use, processing, disclosure, and protection of personal information and other user data. Such laws and regulations often vary in scope, may be subject to differing interpretations, and may be inconsistent among different jurisdictions.

~~The value of the RMB against the U.S. dollar and~~We ~~other~~expect ~~currencies~~to ~~may~~obtain ~~fluctuate~~information ~~and~~about isvarious ~~affected~~aspects ~~by, among other things, changes in the PRC’s political and economic conditions. As we rely entirely on revenues earned in the PRC, any significant revaluation~~ of ~~RMB~~our ~~may~~operations ~~materially~~as ~~and~~well ~~adversely~~as ~~affect~~regarding our ~~cash~~employees ~~flows, revenues~~ and ~~financial~~third ~~condition~~parties. ~~For~~We ~~example,~~also tomaintain information ~~the~~about ~~extent~~various ~~that~~aspects ~~we need to convert U.S. dollars we receive from an offering~~ of our ~~securities into RMB for our~~ operations, ~~appreciation~~as ofwell ~~the~~as ~~RMB~~regarding ~~against~~our ~~the U~~employees.S. ~~dollar~~The ~~could~~integrity ~~have~~and aprotection ~~material~~of ~~adverse effect on~~ our ~~business~~customer, ~~financial~~ ~~condition~~employee and ~~results~~company ofdata ~~operations.~~is ~~Conversely,~~critical ~~if we decide~~ to ~~convert~~ our ~~RMB into U~~business.S. ~~dollars~~Our ~~for~~customers ~~the~~and ~~purpose~~employees ofexpect ~~making~~that ~~dividend payments~~we onwill ~~our~~adequately ~~common~~protect ~~stock~~their orpersonal information. ~~for~~We ~~other~~are ~~business~~required ~~purposes~~by ~~and~~applicable ~~the~~laws ~~U.S.~~to ~~dollar~~keep ~~appreciates~~strictly ~~against~~confidential the ~~RMB,~~personal ~~the~~information ~~U.S.~~that ~~dollar equivalent of the RMB~~ we ~~convert would be reduced. In addition~~collect, ~~the~~and ~~depreciation~~to oftake ~~significant U.S. dollar denominated assets could result in a~~adequate ~~charge~~security measures to ~~our~~safeguard ~~income~~such ~~statement and a reduction in the value of these assets~~information.

WeThe PRC ~~may~~Criminal ~~become~~Law, ~~subject~~as toamended aby ~~variety~~its ofAmendment ~~laws~~ 7 (effective on February 28, 2009) and ~~regulations~~Amendment in9 ~~the~~(effective ~~PRC~~on ~~regarding~~November ~~privacy~~1, ~~data security~~2015), ~~cybersecurity~~prohibits institutions, companies and ~~data~~their ~~protection.~~employees Wefrom ~~may~~selling beor ~~liable~~otherwise ~~for~~illegally ~~improper~~disclosing ~~use~~a orcitizen’s personal information obtained ~~appropriation~~during the course of ~~personal~~performing duties or providing services or obtaining such information ~~provided~~through bytheft ~~our~~or ~~customers~~other illegal ways.

WeOn November ~~may~~7, ~~become~~2016, ~~subject~~the toStanding aCommittee ~~variety~~ of ~~laws and regulations in~~ the PRC ~~regarding~~National ~~privacy,~~People’s ~~data~~Congress ~~security,~~issued ~~cybersecurity,~~the ~~and~~Cyber ~~data~~Security ~~protection.~~Law ~~These~~of ~~laws~~the ~~and~~PRC, ~~regulations~~or ~~are continuously~~Cyber ~~evolving~~Security ~~and~~Law, ~~developing.~~which ~~The~~became ~~scope~~effective ~~and~~on ~~interpretation~~June of1, 2017. Pursuant to the ~~laws~~Cyber ~~that~~Security ~~are~~Law, ornetwork ~~may~~operators bemust ~~applicable~~not, towithout ususers’ consent, ~~are~~collect ~~often~~their ~~uncertain~~personal information, and may beonly ~~conflicting, particularly~~collect ~~with~~users’ ~~respect~~personal information necessary to ~~foreign~~provide ~~laws~~their services. Providers Inare ~~particular,~~also ~~there~~obliged ~~are~~to ~~numerous~~provide ~~laws~~security ~~and~~maintenance ~~regulations~~for ~~regarding~~their ~~privacy~~products and ~~the~~services ~~collection, sharing,~~and ~~use,~~shall ~~processing,~~comply ~~disclosure,~~with ~~and~~provisions regarding the protection of personal information ~~and~~as ~~other~~stipulated ~~user~~under ~~data.~~the ~~Such~~relevant laws and regulations. ~~often~~We ~~vary~~ believe that we are in ~~scope~~compliance with the Cyber Security Law, ~~may~~given bethat: ~~subject~~(i) toour ~~differing~~products ~~interpretations,~~and services are sold offline; and ~~may~~(ii) bewe ~~inconsistent~~do ~~among~~not ~~different~~have ~~jurisdictions~~an online platform.

WeThe Civil ~~expect~~Code toof ~~obtain~~the ~~information~~PRC ~~about~~(issued ~~various aspects~~by ofthe ~~our~~PRC ~~operations~~National asPeople’s ~~well~~Congress ason ~~regarding~~May ~~our~~28, ~~employees~~2020 and ~~third~~effective ~~parties.~~from WeJanuary ~~also~~1, ~~maintain~~2021) ~~information about various aspects of~~provides ~~our~~the ~~operations~~main aslegal ~~well~~basis asfor ~~regarding~~privacy ~~our employees. The integrity~~ and ~~protection~~personal ofinformation ~~our~~infringement ~~customer,~~claims ~~employee~~under ~~and~~the ~~company~~Chinese ~~data~~civil ~~is critical to our business~~laws. ~~Our~~PRC ~~customers~~regulators, ~~and~~including the ~~employees~~Cyberspace ~~expect~~Administration ~~that~~of weChina, ~~will~~MIIT, ~~adequately~~and ~~protect~~the ~~their~~Ministry ~~personal~~of ~~information.~~Public WeSecurity ~~are~~have ~~required~~been byincreasingly ~~applicable laws~~focused toon ~~keep~~regulation ~~strictly~~in ~~confidential~~ the areas ~~personal~~of ~~information~~data ~~that~~security ~~we collect,~~ and todata ~~take adequate security measures to safeguard such information~~protection.

The PRC ~~Criminal~~regulatory ~~Law~~requirements regarding cybersecurity are constantly evolving. For instance, asvarious ~~amended~~regulatory bybodies ~~its~~in ~~Amendment~~China, including 7the ~~(effective~~Cyberspace onAdministration ~~February~~of 28China, ~~2009)~~the ~~and~~Ministry ~~Amendment~~of 9Public ~~(effective~~Security onand ~~November~~the 1SAMR, ~~2015),~~have ~~prohibits~~enforced ~~institutions,~~data ~~companies~~privacy and ~~their~~protection ~~employees~~laws ~~from~~and ~~selling~~regulations orwith ~~otherwise~~varying ~~illegally~~and ~~disclosing~~evolving astandards ~~citizen’s~~and ~~personal~~interpretations. ~~information~~In ~~obtained~~April ~~during~~2020, the ~~course~~Chinese ofgovernment ~~performing~~promulgated ~~duties~~Cybersecurity orReview ~~providing~~Measures, ~~services~~which orcame ~~obtaining~~into ~~such~~effect on June 1, 2020. According to the Cybersecurity Review Measures, operators of critical information infrastructure ~~through~~must ~~theft~~pass a cybersecurity review when purchasing network products and services which do or ~~other~~may ~~illegal~~affect ~~ways~~national security.

On November 7, 2016, the Standing Committee of the PRC National People’s Congress issued the Cyber Security Law of the PRC, or Cyber Security Law, which became effective on June 1, 2017. Pursuant to the Cyber Security Law, network operators must not, without users’ consent, collect their personal information, and may only collect users’ personal information necessary to provide their services. Providers are also obliged to provide security maintenance for their products and services and shall comply with provisions regarding the protection of personal information as stipulated under the relevant laws and regulations. We believe that we are in compliance with the Cyber Security Law, given that: (i) our products and services are sold offline; and (ii) we do not have an online platform.23

~~The~~In November ~~Civil~~2016, ~~Code~~the Standing Committee of ~~the~~China’s ~~PRC~~National People’s Congress passed China’s first Cybersecurity Law (~~issued~~“CSL”), bywhich became effective in June 2017. The CSL is the first PRC ~~National People’s~~law ~~Congress~~that systematically lays out the regulatory requirements on ~~May~~cybersecurity 28and data protection, subjecting many previously under-regulated or unregulated activities in cyberspace to government scrutiny. The legal consequences of violation of the CSL include penalties of warning, confiscation of illegal income, suspension of related business, winding up for rectification, shutting down the websites, and revocation of business license or relevant permits. In April 2020, the Cyberspace Administration of China and certain other PRC regulatory authorities promulgated the Cybersecurity Review Measures, which became effective ~~from~~in ~~January~~June 12020. Pursuant to the Cybersecurity Review Measures, operators of critical information infrastructure must pass a cybersecurity review when purchasing network products and services which do or may affect national security. On July 10, 2021), ~~provides~~the Cyberspace Administration of China issued a revised draft of the ~~main~~Measures ~~legal~~for ~~basis~~Cybersecurity Review for ~~privacy~~public ~~and~~comments ~~personal~~(“Draft Measures”), which required that, in addition to “operator of critical information infrastructure,” any “data ~~infringement~~processor” ~~claims~~carrying ~~under~~out data processing activities that affect or may affect national security should also be subject to cybersecurity review, and further elaborated the ~~Chinese~~factors ~~civil~~to ~~laws.~~be ~~PRC~~considered ~~regulators~~when assessing the national security risks of the relevant activities, including, among others, (i) the ~~Cyberspace~~risk of core data, important data or a large amount of personal information being stolen, leaked, destroyed, and illegally used or exited the country; and (ii) the risk of critical information infrastructure, core data, important data or a large amount of personal information being affected, controlled, or maliciously used by foreign governments after listing abroad. The Cyberspace Administration of China has said that under the proposed rules companies holding data on more than 1,000,000 ~~MIIT~~users must now apply for cybersecurity approval when seeking listings in other nations because of the risk that such data and personal information could be “affected, controlled, and maliciously exploited by foreign governments,” The cybersecurity review will also investigate the ~~Ministry~~potential national security risks from overseas IPOs. We do not know what regulations will be adopted or how such regulations will affect us and the quotation of ~~Public~~our ~~Security~~securities ~~have~~on ~~been~~the ~~increasingly~~OTC ~~focused~~Pink Market. In the event that the Cyberspace Administration of China determines that we are subject to these regulations, quotation of our securities on ~~regulation~~the inOTC may be prohibited and we may be subject to fines and penalties. We believe that we will not be subject to the ~~areas~~cybersecurity review by the CAC, given that: (i) we are not an “operator of critical information infrastructure” or a “data processor” carrying out data processing activities that affect or may affect national security; (ii) we do not possess a large amount of personal information in our business operations; and (iii) data ~~protection~~processed in our business does not have a bearing on national security and thus may not be classified as core or important data by the authorities. However, there remains uncertainty as to how the 2021 Measures will be interpreted or implemented and whether the PRC regulatory agencies, including the CAC, may adopt new laws, regulations, rules, or detailed implementation and interpretation related to the 2021 Measures. If any such new laws, regulations, rules, or implementation and interpretation comes into effect, we will take all reasonable measures and actions to comply and to minimize the adverse effect of such laws on us.

~~The~~We cannot ~~PRC~~assure ~~regulatory~~you ~~requirements~~that ~~regarding~~PRC ~~cybersecurity are~~regulatory ~~constantly~~agencies, ~~evolving.~~including ~~For~~the ~~instance~~CAC, ~~various~~would ~~regulatory~~take ~~bodies~~the insame ~~China,~~view ~~including~~as ~~the~~we ~~Cyberspace~~do, ~~Administration~~and ofthere ~~China,~~is ~~the~~no ~~Ministry~~assurance that ofwe ~~Public~~can ~~Security~~fully ~~and~~or ~~the~~timely ~~SAMR,~~comply ~~have~~with ~~enforced~~such ~~data~~laws. ~~privacy~~In ~~and~~the ~~protection~~event ~~laws~~that ~~and~~we ~~regulations~~are ~~with~~subject ~~varying~~to ~~and~~any ~~evolving~~mandatory ~~standards~~cybersecurity review and other specific ~~interpretations.~~actions Inrequired ~~April~~by ~~2020~~PRC regulatory agencies, ~~the~~we ~~Chinese~~face ~~government~~uncertainty ~~promulgated~~as ~~Cybersecurity~~to ~~Review~~whether ~~Measures,~~any ~~which~~clearance ~~came~~or ~~into~~other ~~effect~~required onactions ~~June~~can 1,be ~~2020.~~timely ~~According~~completed, toor ~~the~~at ~~Cybersecurity~~all. ~~Review~~Given ~~Measures~~such uncertainty, ~~operators~~we ofmay ~~critical~~be ~~information~~further ~~infrastructure~~required ~~must~~to ~~pass~~suspend aour ~~cybersecurity~~relevant ~~review~~business, ~~when purchasing~~shut ~~network~~down ~~products~~our ~~and~~website, ~~services~~or face other penalties, which docould ormaterially ~~may~~and adversely affect ~~national~~our ~~security~~business, financial condition, and results of operations.

2324

~~In November 2016, the Standing Committee of China’s~~The ~~National~~Chinese ~~People’s~~government ~~Congress~~can ~~passed~~take ~~China’s first Cybersecurity Law (“CSL”), which became effective in June 2017. The CSL is the first PRC law that systematically lays out the~~ regulatory ~~requirements~~actions ~~on cybersecurity~~ and ~~data~~statements ~~protection,~~to ~~subjecting many~~regulate ~~previously~~business ~~under-regulated~~operations orin ~~unregulated~~China ~~activities~~with inlittle ~~cyberspace~~ to ~~government~~no ~~scrutiny.~~advance ~~The legal consequences of violation of~~notice ~~the~~at ~~CSL~~any ~~include~~time, ~~penalties~~including ofcracking ~~warning,~~down ~~confiscation~~on of illegal ~~income,~~activities ~~suspension~~in ~~of related business, winding up for rectification, shutting down~~ the ~~websites,~~securities ~~and revocation of business license or relevant permits. In April 2020~~market, ~~the~~enhancing ~~Cyberspace~~supervision ~~Administration~~over of China-based ~~and certain~~companies ~~other~~listed ~~PRC~~overseas ~~regulatory~~using ~~authorities~~variable ~~promulgated~~interest ~~the~~entity ~~Cybersecurity Review Measures~~structure, ~~which~~adopting ~~became~~new ~~effective~~measures ~~in June 2020. Pursuant~~ to ~~the~~extend Cybersecurity Review Measures, operators of critical information infrastructure must pass a cybersecurity review when purchasing network products and services which do or may affect national security. On July 10, 2021, the ~~Cyberspace~~scope ~~Administration~~ of China issued a revised draft of the Measures for Cybersecurity Review for public comments (“Draft Measures”), which required that, in addition to “operator of critical information infrastructure,” any “data processor” carrying out data processing activities that affect or may affect national security should also be subject to cybersecurity ~~review~~reviews, and ~~further elaborated the factors to be considered when~~expanding ~~assessing~~ the ~~national~~efforts ~~security~~in ~~risks~~anti-monopoly ofenforcement. ~~the~~Rules ~~relevant activities, including, among others, (i) the risk of core data, important data or a large amount of personal information being stolen, leaked, destroyed,~~ and ~~illegally~~regulations ~~used or exited the country;~~ and ~~(ii)~~ the ~~risk~~enforcement ~~of critical information infrastructure, core data, important data~~ or ainterpretation ~~large~~thereof ~~amount~~in ~~of personal information being affected, controlled, or maliciously used by foreign governments after listing abroad. The Cyberspace Administration of~~ China ~~has~~can said that under the proposed rules companies holding data on more than 1,000,000 users must now apply for cybersecurity approval when seeking listings in other nations because of the risk that such data and personal information could be “affected, controlled, and maliciously exploited by foreign governments,” The cybersecurity review will also ~~investigate the potential national security risks from overseas IPOs. We do not~~change ~~know~~with ~~what~~little regulations will be adopted or how such regulations will affect us and the quotation of our securities on the OTC Pink Market. In the event that the Cyberspace Administration of China determines that we are subject to ~~these~~no ~~regulations~~advance notice, ~~quotation of our securities on the OTC may be prohibited~~ and weactions ~~may~~related ~~be subject~~ to ~~fines~~oversight and ~~penalties.~~control Weover ~~believe~~offerings that ~~we will not be subject to the cybersecurity review by the CAC, given that: (i) we~~ are ~~not~~conducted anoverseas “operator of critical information infrastructure” or a “data processor” carrying out data processing activities that affect or may affect national security; (ii) we do not possess a large amount of personal information in our ~~business operations; and (iii) data processed in our business does not have a bearing on national security and thus~~China ~~may~~based ~~not~~entities becould ~~classified~~cause ~~as core or important data by~~ the ~~authorities.~~value ~~However,~~of ~~there~~Longduoduo’s ~~remains~~securities ~~uncertainty as~~ to ~~how~~significantly ~~the~~decline ~~2021~~or ~~Measures will~~ be interpreted or implemented and whether the PRC regulatory agencies, including the CAC, may adopt new laws, regulations, rules, or detailed implementation and interpretation related to the 2021 Measuresworthless. If any such new laws, regulations, rules, or implementation and interpretation comes into effect, we will take all reasonable measures and actions to comply and to minimize the adverse effect of such laws on us.

~~On July 10, 2021, the Cyberspace Administration~~The ofChinese ~~China~~government ~~(“CAC”)~~has ~~issued~~taken aand ~~revised~~continues ~~draft~~to oftake ~~the~~regulatory ~~Measures~~actions ~~for~~and ~~Cybersecurity~~statements ~~Review~~to ~~for~~regulate ~~public~~over ~~comments~~virtually ~~(“Draft~~every ~~Measures”), which~~sector ~~required that, in addition to “operator~~ of ~~critical~~the ~~information infrastructure,” any “data processor” carrying~~Chinese ~~out~~economy ~~data~~through ~~processing~~regulation ~~activities~~and ~~that~~state ~~affect~~ownership, orsometimes ~~may~~with ~~affect~~very ~~national~~little ~~security~~advance ~~should~~notice. ~~also~~Our beability ~~subject~~ to ~~cybersecurity~~operate ~~review,~~through ~~and~~our ~~further~~subsidiaries ~~elaborated~~in ~~the~~China ~~factors~~may to be ~~considered~~harmed ~~when~~by ~~assessing~~changes ~~the~~in ~~national~~its ~~security~~laws ~~risks~~and ~~of the relevant activities~~regulations, including, ~~among~~those ~~others, (i)~~relating ~~the~~to ~~risk~~taxation, ofenvironmental ~~core data~~regulations, ~~important~~land use ~~data or a large amount of personal information being stolen~~rights, ~~leaked~~cybersecurity, ~~destroyed,~~property and ~~illegally~~other ~~used or~~matters. ~~exited~~The ~~the~~central ~~country;~~or ~~and~~local ~~(ii)~~governments ~~the risk~~ of ~~critical~~these ~~information~~jurisdictions ~~infrastructure,~~may ~~core~~impose ~~data~~new, ~~important~~stricter regulations ~~data~~ or ainterpretations ~~large amount~~ of ~~personal information~~existing ~~being~~regulations ~~affected,~~that ~~controlled,~~would orrequire ~~maliciously~~additional ~~used~~expenditures byand ~~foreign~~efforts ~~governments~~on ~~after~~our ~~listing~~part ~~abroad.~~to ~~The~~ensure ~~Cyberspace Administration~~our ofcompliance ~~China~~with ~~has~~such ~~said~~regulations ~~that,~~or ~~under~~interpretations. ~~the proposed rules~~Accordingly, ~~companies~~government ~~holding~~actions ~~data~~in onthe ~~more than 1~~future,~~000,000~~ ~~users~~including ~~must~~any ~~now~~decision ~~apply~~not ~~for~~to ~~cybersecurity~~continue ~~approval~~to ~~when~~support ~~seeking~~recent ~~listings~~economic inreforms ~~other~~and ~~nations~~to ~~because~~return ofto ~~the~~a ~~risk~~more ~~that~~centrally ~~such~~planned ~~data~~economy ~~and~~or ~~personal~~regional ~~information~~or ~~could~~local bevariations ~~“affected, controlled,~~in ~~and~~the ~~maliciously~~implementation of ~~exploited~~economic ~~by foreign governments~~policies,” ~~The~~could ~~cybersecurity~~result ~~review~~in ~~will~~a ~~also~~material ~~investigate~~change ~~the~~in ~~potential~~our ~~national security~~operations ~~risks~~in ~~from~~China ~~overseas~~and ~~IPOs.~~could Welimit door ~~not~~completely ~~know~~hinder ~~what~~our ~~regulations~~ability ~~will~~to offer beor ~~adopted~~continue orto ~~how~~offer ~~such~~securities ~~regulations~~to ~~will~~investors ~~affect~~or require us ~~and~~to ~~the~~divest ~~quotation~~ ourselves of ~~our~~any ~~securities~~interest onwe ~~the~~then ~~OTC~~hold ~~Markets.~~in InChina ~~the~~properties or ~~event~~joint ~~that~~ventures. ~~the~~Any ~~Cyberspace~~such ~~Administration~~actions of(including ~~China~~divesture ~~determines~~or ~~that~~similar weactions) ~~are~~could ~~subject~~result toin ~~these regulations,~~a ~~quotation~~material ofadverse ~~our~~effect ~~securities~~ on ~~the~~us ~~OTC~~and ~~Markets~~on ~~may~~your investment bein ~~prohibited~~us and wecould ~~may~~render beour ~~subject~~securities toand ~~fines~~your ~~and~~investment ~~penalties~~in our securities worthless.

~~We cannot assure you that PRC regulatory agencies,~~As ~~including~~such, the ~~CAC,~~Company’s ~~would~~business ~~take~~segments ~~the~~and ~~same~~entities ~~view~~may asbe wesubject ~~do,~~to ~~and~~various ~~there~~government isand noregulatory ~~assurance~~interference ~~that~~in wethe ~~can~~provinces in ~~fully~~which orthey ~~timely~~operate. ~~comply~~The ~~with~~Company ~~such~~could ~~laws.~~be ~~In the~~subject ~~event~~to ~~that~~new weregulation ~~are~~by ~~subject~~various topolitical ~~any~~and ~~mandatory~~regulatory ~~cybersecurity~~entities, ~~review~~including various local and ~~other~~municipal ~~specific~~agencies ~~actions~~and ~~required~~government bysub-divisions. ~~PRC~~The ~~regulatory~~Company ~~agencies,~~may ~~we face~~incur ~~uncertainty~~increased ascosts necessary to ~~whether~~comply ~~any~~with ~~clearance~~existing orand newly ~~other~~adopted ~~required~~laws ~~actions~~and ~~can~~regulations beor ~~timely~~penalties ~~completed,~~for orany atfailure ~~all~~to comply. ~~Given~~As ~~such~~a ~~uncertainty~~result, ~~we may~~the befast-changing ~~further~~rules ~~required~~and toregulation ~~suspend~~could potentially impact our ~~relevant~~operation ~~business,~~and ~~shut~~profitability ~~down~~in ~~our~~China ~~website,~~and oras ~~face~~a ~~other penalties~~result, ~~which~~cause ~~could~~the ~~materially~~value ~~and~~of ~~adversely affect~~Longduoduo’s ~~our~~securities ~~business,~~to ~~financial~~significantly decline ~~condition,~~or ~~and~~even ~~results~~become ~~of operations~~worthless.

24We will require the approval of the CSRS before our common stock may become listed on the OTCQB, Nasdaq or any U.S. securities exchange. If we are unable to obtain CSRC’s approval, our ability to raise capital will be limited, which would likely limit the growth of our company.

~~The~~We intend ~~Chinese~~to ~~government~~fund ~~can~~the ~~take~~growth ~~regulatory actions~~of ~~and~~our ~~statements~~business toin ~~regulate~~large ~~business~~part ~~operations~~by raising capital in ~~China~~Longduoduo ~~with~~through ~~little~~its tosale noof ~~advance~~securities ~~notice~~outside atof ~~any~~the PRC. ~~time,~~The ~~including~~capital ~~cracking~~markets ~~down~~in the U.S. that we might access for financing will depend in large part on our ability to secure a listing on ~~illegal~~Nasdaq, ~~activities~~OTCQX inor one of the registered securities ~~market,~~exchanges. ~~enhancing~~The ~~supervision~~Trial ~~over~~Administrative ~~China-based~~Measures ~~companies~~adopted ~~listed~~on ~~overseas~~March ~~using~~31, ~~variable~~2023 ~~interest~~require that ~~entity~~at ~~structure,~~the ~~adopting~~time ~~new~~we ~~measures~~apply to ~~extend~~an ~~the~~exchange ~~scope~~(which offor ~~cybersecurity~~this ~~reviews~~purpose will include Nasdaq, ~~and~~OTCQB ~~expanding~~or ~~the~~OTCQX), ~~efforts~~we inmust ~~anti-monopoly~~file ~~enforcement.~~an extensive application ~~Rules~~with ~~and~~the ~~regulations~~CSRC and ~~the~~await ~~enforcement~~approval orby ~~interpretation~~CSRC ~~thereof~~of inthe ~~China~~listing. ~~can~~The ~~also~~CSRC ~~change~~has ~~with~~indicated ~~little~~an intent to nouse ~~advance~~these ~~notice,~~applications ~~and~~in ~~actions related~~order to ~~oversight~~protect the ~~and~~PRC from foreign control of (or significant influence over) ~~offerings~~important ~~that~~Chinese ~~are~~businesses. ~~conducted~~We ~~overseas~~cannot indetermine what criteria the CSRC will apply for this purpose. The regulations, therefore, create for our ~~China~~investors ~~based~~a ~~entities~~risk ~~could~~that ~~cause~~our ~~the~~efforts ~~value~~to offinance our Chinese subsidiaries by selling Longduoduo securities abroad will be restricted, delayed or eliminated by CSRC’s implementation of the listing requirements ~~securities~~in tothe ~~significantly~~Trial ~~decline~~Administrative Measures. That risk, if realized, could prevent us from expanding our Chinese subsidiaries’s business, which could reduce or beeliminate ~~worthless~~the value of Longduoduo common stock.

The Chinese government has taken and continues to take regulatory actions and statements to regulate over virtually every sector of the Chinese economy through regulation and state ownership, sometimes with very little advance notice. Our ability to operate through our subsidiaries in China may be harmed by changes in its laws and regulations, including those relating to taxation, environmental regulations, land use rights, cybersecurity, property and other matters. The central or local governments of these jurisdictions may impose new, stricter regulations or interpretations of existing regulations that would require additional expenditures and efforts on our part to ensure our compliance with such regulations or interpretations. Accordingly, government actions in the future, including any decision not to continue to support recent economic reforms and to return to a more centrally planned economy or regional or local variations in the implementation of economic policies, could result in a material change in our operations in China and could limit or completely hinder our ability to offer or continue to offer securities to investors or require us to divest ourselves of any interest we then hold in China properties or joint ventures. Any such actions (including divesture or similar actions) could result in a material adverse effect on us and on your investment in us and could render our securities and your investment in our securities worthless.25

~~As such, the Company’s business segments~~If ~~and~~Longduoduo ~~entities~~common ~~may~~stock bebecomes ~~subject~~listed toon ~~various government and regulatory interference in~~ the ~~provinces~~OTCQB inor ~~which~~an ~~they~~exchange, ~~operate.~~we ~~The~~will ~~Company could~~ be ~~subject~~required to ~~new~~obtain ~~regulation~~the byapproval ~~various~~of ~~political~~the ~~and~~PRC ~~regulatory entities, including various local and municipal agencies and~~ government ~~sub-divisions. The Company may incur increased costs necessary to comply with existing and newly adopted laws and regulations or penalties~~ for ~~any failure to comply. As~~ a ~~result~~business combination, the ~~fast-changing~~issuance ~~rules~~of ~~and~~our ~~regulation~~common ~~could~~stock, ~~potentially~~or ~~impact~~maintaining our ~~operation~~status ~~and profitability in China and~~ as a ~~result,~~publicly ~~cause~~listed ~~the~~company ~~value~~outside ~~of Longduoduo’s securities to significantly decline or even become worthless~~China.

WeOn February ~~will~~17, ~~require~~2023, the ~~approval~~CSRC promulgated the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies (the ~~CSRS~~“Trial ~~before~~Administrative Measures”), which took effect on March 31, 2023. On the same date, the CSRC published on CSRC’s ~~our~~official ~~common~~website ~~stock~~Supporting ~~may~~Guidance ~~become~~Rules ~~listed~~No. 1 through No. 5, Notes on the ~~OTCQB~~Trial Administrative Measures, ~~Nasdaq~~Notice on Administration Arrangements for the Filing of Overseas Listings by Domestic Enterprises and relevant CSRC Answers to Reporter Questions or, ~~any~~collectively, the U“Guidance Rules and Notice.S.” The Trial Administrative Measures, together with the Guidance Rules and Notice, mandate that issuers whose principal business activities occur in the PRC must, within three business days after filing with the offshore regulator an application for an offshore offering or listing of securities on an exchange, submit to CSRC an application for review. IfThe weTrial Administrative ~~are~~Measures ~~unable~~apply to ~~obtain~~overseas securities offerings and/or listings conducted by companies incorporated in the PRC, PRC domestic companies, and companies incorporated overseas with operations primarily in the PRC, indirect offerings. The Trial Administrative Measures require (1) the filing of the overseas offering and listing plan by the PRC domestic companies with the CSRC’s ~~approval~~under certain conditions, ~~our~~(2) ~~ability~~the filing by the underwriter with the CSRC under certain conditions and (3) the submission of an annual report to ~~raise~~the ~~capital~~CSRC within the required timeline. The Trial Administrative Measures include: (1) criteria to determine whether an issuer will be ~~limited~~required to go through the filing procedures under the Trial Administrative Measures; (2) exemptions from immediate filing requirements for issuers that have already been listed in foreign securities markets, ~~which~~including ~~would~~U.S. ~~likely~~markets, ~~limit~~prior to the ~~growth~~effective date of ~~our~~the ~~company~~Trial Administrative Measures; (3) a negative list of types of issuers banned from listing or offering overseas, such as issuers whose affiliates have been recently convicted of bribery and corruption; (4) issuers’ compliance with web security, data security, and other national security laws and regulations; (5) issuers’ filing and reporting obligations, such as obligation to file with the CSRC after it submits an application for initial public offering to overseas regulators, and obligation after offering or listing overseas to file with the CSRC after it completes subsequent offerings and to report to the CSRC material events including change of control or voluntary or forced delisting of the issuer; and (6) the CSRC’s authority to fine both issuers and their relevant shareholders for failure to comply with the Trial Administrative Measures, including failure to comply with filing obligations or committing fraud and misrepresentation. Fines of up to 10 million RMB (approximately US$1.4 million) for non-compliance are authorized.

WeLongduoduo plans ~~intend~~ to ~~fund~~apply ~~the~~for ~~growth~~listing ofon ~~our business in large part by raising capital in Longduoduo through its sale of securities outside of~~ the ~~PRC.~~OTCQB ~~The~~or ~~capital~~Nasdaq ~~markets~~as insoon ~~the~~as ~~U.S. that~~ we ~~might~~ ~~access~~are ~~for~~eligible; ~~financing~~if ~~will~~accepted, ~~depend~~we inwould ~~large~~then ~~part~~be onsubject ~~our ability~~ to ~~secure~~the ~~a listing on Nasdaq, OTCQX or one~~ requirements of the ~~registered securities exchanges. The~~ Trial Administrative Measures ~~adopted~~with onrespect ~~March~~to ~~31,~~any ~~2023~~future ~~require~~securities ~~that~~offerings atmade ~~the~~outside ~~time~~of weChina. ~~apply~~As tothe anTrial ~~exchange (which for this~~Administrative ~~purpose~~Measures ~~will~~are ~~include~~newly ~~Nasdaq~~issued, ~~OTCQB~~there orremain ~~OTCQX),~~uncertainties weregarding ~~must~~its ~~file~~interpretation ~~an extensive application with the CSRC~~ and ~~await~~implementation. ~~approval~~Therefore, bywe ~~CSRC~~cannot ofassure ~~the listing.~~you ~~The~~that ~~CSRC~~we ~~has~~will ~~indicated~~be anable ~~intent~~ to ~~use~~complete ~~these applications in order to protect~~ the ~~PRC~~filings ~~from~~for ~~foreign~~our ~~control~~future ofofferings ~~(or~~and ~~significant~~fully ~~influence over)~~comply ~~important~~with ~~Chinese~~the ~~businesses.~~relevant Wenew ~~cannot~~rules ~~determine~~on ~~what~~a ~~criteria~~timely ~~the~~basis, if ~~CSRC~~at ~~will apply for this purpose~~all. ~~The~~In ~~regulations~~addition, ~~therefore, create~~we ~~for~~face ~~our~~uncertainty ~~investors~~regarding athe ~~risk~~criteria that ~~our~~CSRS ~~efforts~~will toapply ~~finance~~when ~~Longduoduo~~reviewing ~~Health~~filings ~~Technology~~for byapproval, ~~selling~~and ~~Longduoduo securities abroad will~~cannot beassure ~~restricted,~~that ~~delayed~~the orprocess ~~eliminated~~will bynot ~~CSRC’s~~cause ~~implementation~~a ofsubstantial ~~the~~reduction ~~listing requirements~~ in ~~the~~our ~~Trial~~ability ~~Administrative~~to ~~Measures. That~~raise ~~risk,~~capital ifin ~~realized, could prevent us from expanding Longduoduo Health Technology’s business, which could reduce or eliminate~~ the ~~value of Longduoduo common stock~~U.S.

2526

~~If Longduoduo common stock becomes listed on~~Risks ~~the~~Relating ~~OTCQB or an exchange, we will be required~~ to ~~obtain~~Our ~~the~~Common ~~approval of the PRC government for a business combination, the issuance of our common stock, or maintaining our status as a publicly listed company outside China.~~Stock

~~On February 17, 2023, the CSRC promulgated the~~We ~~Trial~~are ~~Administrative~~an ~~Measures~~emerging ofgrowth ~~Overseas~~company ~~Securities Offering~~ and ~~Listing by Domestic Companies (the “Trial Administrative Measures”)~~, ~~which~~ ~~took~~as ~~effect~~a onresult March 31, 2023. On the same date, the CSRC published on CSRC’s official website Supporting Guidance Rules No. 1 through No. 5, Notes on the Trial Administrative Measures, Notice on Administration Arrangements for the Filing of ~~Overseas Listings by Domestic Enterprises and relevant CSRC Answers to Reporter Questions or, collectively,~~ the ~~“Guidance~~reduced ~~Rules~~disclosure and ~~Notice.” The~~governance ~~Trial~~requirements ~~Administrative~~applicable Measures, together with the Guidance Rules and Notice, mandate that issuers whose principal business activities occur in the PRC must, within three business days after filing with the offshore regulator an application for an offshore offering or listing of securities on an exchange, submit to ~~CSRC~~emerging angrowth ~~application for review. The Trial Administrative Measures apply to overseas securities offerings and/or listings conducted by~~ companies ~~incorporated in the PRC~~, ~~PRC domestic companies, and companies incorporated overseas~~ ~~with~~our ~~operations~~common ~~primarily~~stock inmay the PRC, indirect offerings. The Trial Administrative Measures require (1) the filing of the overseas offering and listing plan by the PRC domestic companies with the CSRC under certain conditions, (2) the filing by the underwriter with the CSRC under certain conditions and (3) the submission of an annual report to the CSRC within the required timeline. The Trial Administrative Measures include: (1) criteria to determine whether an issuer will be ~~required~~less toattractive go through the filing procedures under the Trial Administrative Measures; (2) exemptions from immediate filing requirements for issuers that have already been listed in foreign securities markets, including U.S. markets, prior to the effective date of the Trial Administrative Measures; (3) a negative list of types of issuers banned from listing or offering overseas, such as issuers whose affiliates have been recently convicted of bribery and corruption; (4) issuers’ compliance with web security, data security, and other national security laws and regulations; (5) issuers’ filing and reporting obligations, such as obligation to file with the CSRC after it submits an application for initial public offering to overseas regulators, and obligation after offering or listing overseas to file with the CSRC after it completes subsequent offerings and to report to the CSRC material events including change of control or voluntary or forced delisting of the issuer; and (6) the CSRC’s authority to fine both issuers and their relevant shareholders for failure to comply with the Trial Administrative Measures, including failure to comply with filing obligations or committing fraud and misrepresentationinvestors. ~~Fines of up to 10 million RMB (approximately US$1.4 million) for non-compliance are authorized.~~

~~Longduoduo~~We are ~~plans~~an emerging growth company, as defined in the JOBS Act, and we are eligible to ~~apply~~take ~~for~~advantage ~~listing~~of oncertain exemptions from various reporting requirements applicable to other public companies. We will remain an emerging growth company until the ~~OTCQB~~earliest to occur of: or(i) ~~Nasdaq~~the aslast ~~soon~~day asof the fiscal year in which we ~~are~~have ~~eligible~~at least $1.07 billion in annual revenue; if(ii) ~~accepted,~~the last day of the fiscal year in which we ~~would~~are ~~then~~deemed to be ~~subject~~a to“large accelerated filer,” as defined in Rule 12b-2 under the ~~requirements~~Exchange Act, which would occur if the market value of our Common Stock held by non-affiliates exceeded $700 million as of the ~~Trial~~last ~~Administrative~~business ~~Measures~~day ~~with~~of the second fiscal ~~respect~~quarter toof ~~any~~such ~~future~~year; (iii) the date on which we have issued more than $1.0 billion in nonconvertible debt securities ~~offerings~~during ~~made~~the ~~outside~~prior three-year period; and (iv) the last day of ~~China.~~the Asfiscal year ending after the ~~Trial~~fifth ~~Administrative~~anniversary ~~Measures~~of ~~are~~our ~~newly~~initial ~~issued,~~public ~~there~~offering. ~~remain~~The exemptions ~~uncertainties~~available ~~regarding~~to ~~its~~emerging ~~interpretation~~growth companies include the right to present only two years of audited financial statements in our registration statements and ~~implementation.~~annual ~~Therefore~~reports, wean ~~cannot~~exemption ~~assure~~from ~~you~~the ~~that~~auditor weattestation ~~will~~requirement beof ~~able~~Section to404 ~~complete~~of the ~~filings~~Sarbanes-Oxley Act relating ~~for~~to ~~our~~internal ~~future~~controls, ~~offerings~~reduced ~~and~~disclosure ~~fully~~about ~~comply~~executive ~~with~~compensation ~~the~~arrangements, ~~relevant~~and ~~new~~no ~~rules~~requirement to seek non-binding advisory votes on executive compensation or golden parachute arrangements. Some of these exemptions are also available to us as a ~~timely~~smaller ~~basis,~~reporting company if(i.e. ata ~~all~~company with less than $250 million of its voting equity held by non-affiliates). InWe ~~addition,~~have weelected ~~face~~to ~~uncertainty~~adopt ~~regarding~~these reduced ~~the~~disclosure ~~criteria~~requirements. ~~that~~We ~~CSRS~~cannot predict if investors will ~~apply~~find ~~when~~our ~~reviewing~~common ~~filings~~stock ~~for~~less ~~approval,~~attractive ~~and~~as ~~cannot~~a ~~assure~~result ~~that~~of ~~the~~our ~~process~~taking ~~will~~advantage of ~~not~~these ~~cause~~exemptions. If some investors find our common stock less attractive as a ~~substantial~~result of our choices, there may be a less active trading ~~reduction~~market infor our ~~ability~~common tostock ~~raise~~and ~~capital~~our instock ~~the~~price Umay be more volatile.S.

26Pursuant to Section 107(b) of the JOBS Act, we have elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(2) of The JOBS Act. This election allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result, our financial statements may not be comparable to companies that comply with public company effective dates. The decision to opt out is irrevocable.

~~Risks~~Because the ~~Relating~~worldwide market value of our common stock held by non-affiliates, or public float, was below $250 million on the last day of our second fiscal quarter, we are also a “smaller reporting company” as defined under the Exchange Act. Some of the foregoing reduced disclosure and other requirements are also available to ~~Our~~us ~~Common~~because ~~Stock~~we are a smaller reporting company and may continue to be available to us even after we are no longer an emerging growth company under the JOBS Act but remain a smaller reporting company under the Exchange Act. As a smaller reporting company, we are not required to:

We● ~~are~~have an ~~emerging~~auditor ~~growth~~report ~~company~~on ~~and,~~our ~~as a~~internal ~~result~~control ofover ~~the~~financial ~~reduced~~reporting ~~disclosure~~pursuant ~~and governance requirements applicable~~ to ~~emerging~~Section ~~growth~~404(b) ~~companies,~~of ~~our~~the ~~common~~Sarbanes-Oxley ~~stock may be less attractive to investors.~~Act;

We● ~~are~~present an emerging growth company, as defined in the JOBS Act, and we are eligible to take advantage of certain exemptions from various reporting requirements applicable to other public companies. We will remain an emerging growth company until the earliest to occur of: (i) the last day of the fiscal year in which we have at least $1.07 billion in annual revenue; (ii) the last day of the fiscal year in which we are deemed to be a “large accelerated filer,” as defined in Rule 12b-2 under the Exchange Act, which would occur if the market value of our Common Stock held by non-affiliates exceeded $700 million as of the last business day of the second fiscal quarter of such year; (iii) the date on which we have issued more than $1.0 billion in nonconvertible debt securities during the prior three-year period; and (iv) the last day of the fiscal year ending after the fifth anniversary of our initial public offering. The exemptions available to emerging growth companies include the right to present only two years of audited financial statements in our registration statements and annual reports, an exemption from the auditor attestation requirement of Section 404 of the Sarbanes-Oxley Act relating to internal controls, reduced disclosure about executive compensation arrangements, and no requirement to seek non-binding advisory votes on ~~executive~~Form compensation or golden parachute arrangements. Some of these exemptions are also available to us as a smaller reporting company (i.e. a company with less than $250 million of its voting equity held by non10-~~affiliates).~~K; We have elected to adopt these reduced disclosure requirements. We cannot predict if investors will find our common stock less attractive as a result of our taking advantage of these exemptions. If some investors find our common stock less attractive as a result of our choices, there may be a less active trading market for our common stock and our stock price may be more volatile.or

~~Pursuant~~● topresent ~~Section~~any ~~107(b)~~selected offinancial ~~the~~data ~~JOBS~~in ~~Act,~~such ~~we have~~registration ~~elected~~statements toand ~~use~~annual ~~the~~reports ~~extended~~filings ~~transition~~made ~~period~~by ~~for complying with new or revised accounting standards under Section 102(b)(2) of The JOBS Act. This election allows us to delay~~ the ~~adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies~~Company. ~~As a result, our financial statements may not be comparable to companies that comply with public company effective dates. The decision to opt out is irrevocable.~~

Because the worldwide market value of our common stock held by non-affiliates, or public float, was below $250 million on the last day of our second fiscal quarter, we are also a “smaller reporting company” as defined under the Exchange Act. Some of the foregoing reduced disclosure and other requirements are also available to us because we are a smaller reporting company and may continue to be available to us even after we are no longer an emerging growth company under the JOBS Act but remain a smaller reporting company under the Exchange Act. As a smaller reporting company, we are not required to: 27

●Shareholders do not have anpre-emptive ~~auditor~~rights, ~~report~~which onwill ~~our~~cause ~~internal~~them ~~control over financial reporting pursuant~~ to ~~Section~~experience ~~404(b)~~dilution ofif ~~the~~we ~~Sarbanes-Oxley~~issue ~~Act;~~additional securities.

●At any ~~present~~time ~~more~~or ~~than~~times, ~~two~~we ~~years~~may issue and sell additional shares of ~~audited~~our ~~financial~~authorized ~~statements~~but previously unissued shares of common stock, preferred stock, or common stock warrants on such terms and conditions as our Board of Directors, in its sole discretion, may determine without consent of our ~~registration~~shareholders. ~~statements~~Our shareholders do not have pre-emptive rights to acquire additional shares should we in the future issue or sell additional securities. Thus, we are not required to offer any existing shareholder the right to purchase his or her pro rata portion of any future issuance of securities and, ~~annual~~therefore, ~~reports~~upon onthe ~~Form~~issuance ~~10-K;~~of any additional securities by us hereafter, our shareholders will not be able to maintain their then existing pro rata ownership in our outstanding shares of common stock, preferred stock, or common stock warrants without additional purchases of securities at the price then set internally by us.

●We are ~~present~~unlikely ~~any~~to ~~selected~~pay ~~financial~~cash ~~data~~dividends in ~~such registration statements and annual reports filings made by~~ the ~~Company~~foreseeable future.

27We currently intend to retain any future earnings for use in the operation and expansion of our business. We do not expect to pay any cash dividends in the foreseeable future but will review this policy as circumstances dictate. Should we decide in the future to do so, as a holding company, our ability to pay dividends and meet other obligations depends upon the receipt of dividends or other payments from our operating subsidiaries. In addition, our operating subsidiaries, from time to time, may be subject to restrictions on their ability to make distributions to us, including as a result of restrictions on the conversion of local currency into U.S. dollars or other hard currency and other regulatory restrictions.

~~Shareholders~~Our insiders doown ~~not~~the ~~have~~majority ~~pre-emptive~~of ~~rights~~the outstanding shares of our stock, ~~which~~ ~~will~~and ~~cause~~accordingly, ~~them~~will tohave ~~experience~~control ~~dilution~~over ifstockholder wematters, ~~issue~~the ~~additional~~Company’s business ~~securities~~and management.

AtOne shareholder, ~~any~~Zhang ~~time or times~~Liang, ~~we may issue and sell additional shares of our authorized but previously unissued shares of common stock~~owns, ~~preferred~~in ~~stock~~aggregate, or common stock ~~warrants~~representing on51.30% ~~such terms and conditions as our Board~~ of ~~Directors,~~the inoutstanding ~~its~~shares ~~sole discretion, may determine without consent~~ of our ~~shareholders~~common stock. ~~Our~~While ~~shareholders do not have pre-emptive~~he ~~rights~~continues to ~~acquire~~hold ~~additional~~the ~~shares~~majority ~~should~~of ~~we in~~ the ~~future~~voting ~~issue~~power orin ~~sell~~our ~~additional securities. Thus~~Company, wehe ~~are~~will ~~not~~have ~~required~~effective tocontrol ~~offer~~over ~~any existing shareholder~~ the ~~right~~Company. toIn ~~purchase his or her pro rata portion of any future issuance of securities and~~particular, ~~therefore, upon the issuance~~he ~~of any additional securities by us hereafter, our shareholders~~ will ~~not~~have ~~be able to maintain their then existing pro rata ownership in our outstanding shares of common stock, preferred stock, or common stock warrants without additional purchases of securities at~~ the ~~price then~~ability ~~set internally by us.~~to:

We● ~~are~~Elect ~~unlikely~~or todefeat ~~pay~~the ~~cash~~election ~~dividends~~of ~~in the~~our ~~foreseeable future.~~ directors;

We● ~~currently~~Prevent ~~intend~~amendment ~~to retain any future earnings for use in the operation and expansion~~ of our ~~business.~~articles We do not expect to pay any cash dividends in the foreseeable future but will review this policy as circumstances dictate. Should we decide in the future to do so, as a holding company, our ability to pay dividends and meet other obligations depends upon the receipt of ~~dividends~~incorporation or other payments from our operating subsidiaries. In addition, our operating subsidiaries, from time to time, may be subject to restrictions on their ability to make distributions to us, including as a result of restrictions on the conversion of local currency into U.S. dollars or other hard currency and other regulatory restrictions.bylaws;

~~Our~~● ~~insiders~~Prevent ~~own~~a ~~the~~merger, ~~majority~~sale of ~~the~~assets ~~outstanding shares~~or ofother ~~our~~corporate ~~stock,~~transaction; and ~~accordingly, will have control over stockholder matters, the Company’s business and management.~~

~~One~~● ~~shareholder,~~Affect ~~Zhang Liang, owns, in aggregate, common stock representing 51.30% of~~ the ~~outstanding~~outcome ~~shares~~ of ~~our~~any ~~common~~other ~~stock.~~matter ~~While~~submitted ~~he continues~~ to ~~hold~~ the ~~majority~~shareholders offor ~~the voting power in our Company, he will have effective control over the Company~~vote. ~~In particular, he will have the ability to:~~

●Moreover, because ~~Elect~~of orthe ~~defeat~~significant ~~the~~ownership ~~election~~position ofheld by our ~~directors;~~insiders, new investors will not be able to affect a change in the Company’s business or management, and therefore, shareholders would be subject to decisions made by management and the majority shareholder.

●In addition, ~~Prevent~~sales ~~amendment~~of significant amounts of shares held by our ~~articles~~directors and executive officers, or the prospect of ~~incorporation~~these sales, could adversely affect the market price of our common stock. Management’s stock ownership may discourage a potential acquirer from making a tender offer or ~~bylaws;~~otherwise attempting to obtain control of us, which in turn could reduce our stock price or prevent our shareholders from realizing a premium over our stock price.

~~● Prevent a merger, sale of assets or other corporate transaction; and~~28

●Item 1B. ~~Affect~~Unresolved ~~the~~Staff ~~outcome of any other matter submitted to the shareholders for vote.~~Comments

~~Moreover, because of the significant ownership~~Not position held by our insiders, new investors will not be able to affect a change in the Company’s business or management, and therefore, shareholders would be subject to decisions made by management and the majority shareholderapplicable.

InItem ~~addition, sales of significant amounts of shares held by our directors and executive officers, or the prospect of these sales, could adversely affect the market price of our common stock~~1C. ~~Management’s~~ stock ownership may discourage a potential acquirer from making a tender offer or otherwise attempting to obtain control of us, which in turn could reduce our stock price or prevent our shareholders from realizing a premium over our stock price.Cybersecurity

28We have established certain processes for identifying, evaluating, and managing material risks from cybersecurity threats as a part of our overall technology management strategy. These processes are designed and reassessed on a periodic basis to help protect our technology assets and operations from internal and external security threats.

~~Item~~The 1BCompany’s employees are required to sign confidentiality agreements in an effort to, among other things, help to ensure cybersecurity. ~~Unresolved~~The ~~Staff~~Company ~~Comments~~has taken measures to better ensure that key employees are aware of data security threats (including cybersecurity threats), and Company security policies and procedures, as appropriate. Improper or illegitimate use of the Company’s information system resources or violation of the Company’s information security policies and procedures may result in disciplinary action.

~~Not~~In ~~applicable~~the last two fiscal years, we have not identified cybersecurity threats that have materially affected, or are reasonably likely to materially affect, our business, results of operations, or financial condition. Although we proactively attempt to prevent all threats, we are unable to eliminate all risk from cybersecurity threats or provide assurance that we have not experienced an undetected cybersecurity incident. For more information about these risks, please see Item 1A.

Item 2. Properties.

The Company does not own any real property. We believe the premises we now have under lease will be adequate for our operations for the foreseeable future.

Office Leases

OnIn ~~August~~October of 312020, ~~2023,~~Longduoduo ~~Qingguo~~Health ~~leased~~Technology ~~office~~entered ~~space (approximately 482 square~~into ~~meters) under~~ an operating ~~lease~~cooperation agreement with ~~Inner~~Baotou ~~Mongolia~~Jinshi ~~Chuangfuhui~~Traditional ~~Enterprise~~Chinese ~~Management~~Medicine Nephropathy Hospital Co., Ltd. Under the terms, ofLongduoduo ~~the~~Health ~~agreement,~~Technology ~~Qingguo~~ is ~~committed~~able to ~~make~~use ~~lease~~its ~~payments~~office ofspace (approximately ~~$30,510 (RMB 220,000)~~1000 ~~for~~square meters) free of charge during the period between ~~September~~October 1015, ~~2023~~2020 and ~~September~~October 1015, ~~2024~~2025. On March 18, 2021, Longduoduo Health Technology entered into an assignment agreement with Rongbin, pursuant to which Longduoduo Health Technology transferred all the rights and obligations under the cooperation agreement to Rongbin, which has been confirmed by Baotou Jin’s Traditional Chinese Medicine Nephropathy Hospital Co., Ltd.

On ~~June~~March 11 1,of ~~2024~~2025, ~~Chengheng~~Longduoduo ~~leased~~Health anTechnology leased office space (approximately ~~451~~ 160 square meters) under an operating lease agreement with ~~from~~Liu ~~Ding Jun~~Libao. Under the terms of the agreement, ~~Chengheng~~Longduoduo Health Technology is committed to make lease payments of approximately $24,~~774~~ 160 (~~RMB20~~RMB30,000) for the period between ~~June~~March 111, ~~2024~~2025 and ~~May~~March 3110, ~~2025~~2026.

On ~~March~~April 1 10 of 2024, ~~Longduoduo~~Tianju ~~Health Technology~~ leased office space (approximately ~~150~~595 square meters) under an operating lease agreement with ~~Liu~~Sun ~~Libao~~Xueqin. Under the terms of the agreement, ~~Longduoduo~~Tianju ~~Health Technology~~ is committed to make lease payments of approximately $419,~~160~~000 (~~RMB30~~RMB137,000) ~~for~~annually for the period between ~~March~~April 101, 2024 and March 1031, ~~2025~~2027.

On ~~April~~September 119, ~~of 2024~~2025, ~~Tianju~~Qingguo leased office ~~space~~ space (approximately ~~595~~ 482 square meters) under an operating lease agreement with ~~Han~~Chen ~~Ruijun~~Mingyue. Under the terms of the agreement, ~~Tianju~~Qingguo is committed to make lease payments of approximately $1930,~~000~~ 695 (~~RMB137~~RMB 220,000) ~~annually~~ for the period between ~~April~~September 110, ~~2024~~2025 and ~~March 31,~~September ~~2027~~9, 2026.

~~Item~~On 3November 20, 2024, Chengheng leased an office space (approximately 611 square meters) under an operating lease agreement from Dongsheng District Baiyan Health Consultation Department. ~~Legal~~Under ~~Proceedings~~the terms of the agreement, Chengheng is committed to make lease payments of approximately $16,720 (RMB120,000) for the period between November 20, 2024 and November 20, 2025.

~~From time to time, we may become involved in legal~~Item ~~proceedings or be subject to claims arising in the ordinary course of our business~~3. WeLegal are not presently a party to any legal proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flowsProceedings.

~~Item~~From time 4to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. ~~Mine~~We are ~~Safety~~not ~~Disclosure~~presently a party to any legal proceedings that in the opinion of our management, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, financial condition, or cash flows.

~~Not applicable~~Item 4. Mine Safety Disclosure

29Not applicable.

~~PART II~~29

~~Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.~~PART II

Item 5. Market ~~Information~~for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.

~~The Company’s common stock is quoted on the OTC Pink~~ Market ~~under the symbol “LDDD”. The quotations reported on the OTC Pink Market reflect inter-dealer prices without~~ ~~retail markup, markdown or commissions, and may not necessarily represent actual transactions.~~Information

The Company’s common stock is ~~thinly traded. The~~ quoted ~~bid~~on ~~and~~the ~~asked~~OTCID ~~prices~~Market ~~for~~under the ~~Common~~symbol ~~Stock vary significantly from week to week~~“LDDD”. AnThe ~~investor~~quotations ~~holding~~reported ~~shares~~on of the ~~Company’s~~OTCID ~~Common~~Market ~~Stock~~reflect ~~may~~inter-dealer ~~find~~prices itwithout ~~difficult~~retail tomarkup, ~~sell~~markdown ~~the~~or ~~shares~~commissions, and may ~~find~~not itnecessarily ~~impossible~~represent toactual ~~sell more than a small number of shares at the quoted bid price~~transactions.

~~Holders~~The Company’s common stock is thinly traded. The quoted bid and asked prices for the Common Stock vary significantly from week to week. An investor holding shares of ~~Securities~~the Company’s Common Stock may find it difficult to sell the shares and may find it impossible to sell more than a small number of shares at the quoted bid price.

~~As of the date of filing of this report, we had~~Holders ~~50 shareholders~~ of ~~record and 30,005,016 outstanding shares of common stock, par value $0.001.~~Securities

~~There~~As of ~~are~~the ~~currently~~date ~~effective~~of ~~prospectuses~~filing ~~that will~~of ~~permit~~this ~~the~~report, ~~public~~we ~~resale~~had 50 shareholders of 14record and 30,~~607~~015,~~993~~036 outstanding shares of ~~our~~ common stock, ~~now~~par ~~held~~value ~~by shareholders~~$0.001.

Dividends

We have not declared or paid any cash dividends on our common stock since our inception, and our board of directors currently intends to retain all earnings for use in the business for the foreseeable future. Any future payment of dividends will depend upon our results of operations, financial condition, cash requirements and other factors deemed relevant by our board of directors. There are currently no restrictions that limit our ability to declare cash dividends on our common stock.

The PRC government imposes controls on the convertibility of the RMB into foreign currencies and, in certain cases, the remittance of currency out of China. In addition, each of our subsidiaries in China is required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory reserve until such reserve reaches 50% of its registered capital. Each of such entities in China is also required to further set aside a portion of its after-tax profits to fund the employee welfare fund, although the amount to be set aside, if any, is determined at the discretion of its board of directors. Although the statutory reserves can be used, among other ways, to increase the registered capital and eliminate future losses in excess of retained earnings of the respective companies, the reserve funds are not distributable as cash dividends except in the event of liquidation.

Securities Authorized for Issuance Under Equity Compensation Plans

We have no equity compensation plans.

Sales of Unregistered Securities

The Company did not have any unregistered sales of equity securities during the fourth quarter of the fiscal year ended June 30, ~~2024~~2025.

Repurchase of Equity Securities

The Company did not repurchase any of its equity securities that were registered under Section 12 of the Securities Act during the fiscal quarter ended June 30, ~~2024~~2025.

Item 6. [Reserved]

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements and the notes thereto included elsewhere in this Annual Report on Form 10-K, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of such financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses. On an ongoing basis, we evaluate these estimates, including those related to useful lives of real estate assets, bad debts, impairment, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There can be no assurance that actual results will not differ from those estimates. The analysis set forth below is provided pursuant to applicable SEC regulations and is not intended to serve as a basis for projections of future events. See “Cautionary Statement Regarding Forward Looking Statements” above.

Results of Operations for the Years Ended June 30, ~~2024~~2025 and ~~2023~~2024

The following table shows key components of the results of operations during the years ended June 30, ~~2024~~2025 and ~~2023~~2024:

	For the Years Ended June 30,						Change
	2024			2023			$			%
	2025			2024			$			%
Total revenue	$	74,~~389~~262,~~842~~663		$	37,~~818~~389,~~560~~842		$	(3,~~571~~127,~~282~~179	)		94(42	)%
Cost of revenue		~~173~~91,~~349~~099			~~591~~173,~~885~~349			(~~418~~82,~~536~~250	)		(7147	)%
Gross Profit		74,~~216~~171,~~493~~564			37,~~226~~216,~~675~~493			(3,~~989~~044,~~818~~929	)		~~124~~(42	)%
Total operating expenses		53,~~190~~618,~~352~~885			35,~~197~~190,~~437~~352			(1,~~992~~571,~~915~~467	)		62(30	)%
Income from operations		2552,~~026,141~~679			292,~~238~~026,141			(1,~~996~~473,~~903~~462	)		~~6,830~~(73	)%
Other income (expense)		~~(139~~161,~~656~~849	)		2(139,~~093~~656	)		~~(141~~301,~~749~~505	)		(~~6,773~~216	)%
Income before income taxes		1714,~~886,485~~528			311,~~331~~886,485			(1,~~855~~171,~~154~~957	)		~~5,921~~(62	)%
Income taxes		~~523~~222,~~207~~268			10523,~~246~~207			~~512~~(300,~~961~~939	)		~~5,006~~(58	)%
Net income		1492,~~363,278~~260			211,~~085~~363,278			1(871,~~342,193~~018	)		~~6,366~~(64	)%

During the year ended June 30, ~~2024~~2025, our total revenue was $74,~~389~~262,~~842~~663, of which $~~327~~120,~~599~~866 was attributable to the sale of healthcare services, primarily derived from sales of “Immunological Ozonated Autohemotherapy”, “Meridian-regulating and Consciousness-restoring Iatrotechnics”, “Assay”, “PRP” and other healthcare services. The remaining $74,~~062~~141,~~243~~797 of revenue was attributable to commissions earned by the Company from its service as sales agent for Honghai. In June of 2023, the Company began to engage in the sales agent business and focused on the sales of preventive healthcare solutions administered by Honghai, with whom we have a Sales Agency Agreement. As of June 30, ~~2024~~2025, we operate through five entities: Longduoduo Health Technology, Tianju, Qingguo, Rongbin and Chengheng, which are established in ~~Ordos~~Huhhot, Ulanqab, Huhhot, Baotou and Ordos, respectively, which include four of the largest cities in Inner Mongolia, China.

~~Cost~~Annual to ofannual revenue ~~relates~~fell ~~solely~~by to42% ~~our~~as ~~service~~ compared with the operating revenue of $7,389,842 ~~and~~for ~~mainly~~the ~~consists~~year ofended ~~our~~June ~~payments~~30, 2024. The decrease was primarily attributable to the ~~third-party~~fact ~~healthcare~~that ~~service~~Inner ~~providers~~Mongolia ~~who~~was ~~perform~~emerging ~~healthcare~~from the pandemic during the year ended June 30, 2024. A large number of customers received services during that period that they had earlier paid for ~~our~~but ~~customers~~could not receive. This resulted in a surge in revenue ~~During~~during the year ended June 30, 2024,. ~~our~~One ~~cost~~other ofimportant ~~revenue~~factor ~~was~~influencing ~~$173,349,~~revenue ~~with~~in the ~~result~~recent ~~that~~year ~~our~~is ~~gross~~the ~~profit~~impact ~~from~~of ~~service~~the ~~revenue was~~economic ~~$154~~environment,~~250~~ (which has led to a ~~gross~~decrease ~~margin~~in ofcustomer ~~47%)~~health expenditures. ByManagement ~~comparison~~believes that the government has recently introduced policies to promote economic recovery, ~~our~~but ~~gross~~it ~~profit~~may ~~from~~take ~~service~~some ~~revenue~~time for the ~~year~~situation ~~ended~~to ~~June~~truly 30improve. Meanwhile, ~~2023~~as ~~was~~we ~~$1,208,046,~~wait for the economy ~~representing~~to ~~67%~~revive, ofthe ~~service~~Company ~~revenue~~is ~~for~~implementing ~~that~~plans ~~year~~to improve its operations by adjusting its operational policies.

~~When~~Cost of ~~our net service~~ revenue inrelates ~~fiscal~~solely ~~year~~to ~~2024 was~~our ~~combined~~healthcare ~~with~~service ~~commission~~ revenue, ~~(for~~and ~~which~~mainly ~~there~~consists ~~is no cost~~ of ~~revenue),~~our wepayments ~~achieved~~to ~~gross~~the ~~profit~~third-party ofhealthcare ~~$7,216,493.~~service providers ~~However,~~who weperform ~~realized only~~healthcare ~~$2,026,141~~services infor ~~income~~our ~~from~~customers. ~~operations~~During ~~for~~ the year ended June 30, ~~2024~~2025, ~~because~~our ~~the~~cost ~~Company~~of ~~incurred~~revenue ~~significant~~was ~~marketing~~$91,099, ~~expense~~with inthe ~~connection~~result ~~with~~that ~~establishing~~our ~~its~~gross ~~brand~~profit asfrom aservice ~~new~~revenue ~~company.~~was ~~The~~$29,767 ~~Company~~(a ~~will~~gross ~~continue~~margin toof ~~invest~~25%). ~~heavily~~By incomparison, ~~advertising~~our ~~and~~gross ~~promotion~~profit ~~expenses~~from healthcare inservice revenue for the ~~near~~year ~~future~~ended asJune it30, ~~continues~~2024 towas ~~establish~~$154,250, ~~and~~representing ~~expand~~47% ~~its~~of ~~brand~~service ~~and~~revenue ~~products~~for ~~and~~that ~~services~~year.

~~Our~~When our ~~operating~~net ~~expenses~~service ~~consist~~revenue ~~primarily~~in fiscal year 2025 was combined with commission revenue (for which there is no cost of ~~advertising~~revenue), we achieved ~~and~~gross ~~promotion~~profit ~~expenses~~of $4,171,564. ~~salaries~~However, ~~and~~we ~~benefits~~realized only $552,679 ~~office~~in ~~expenses~~income from operations for the year ended June 30, ~~professional~~2025 ~~fees~~because ~~and~~the Company ~~depreciation~~incurred ~~and~~significant ~~amortization~~marketing expense in connection with establishing its brand as a new company. ~~Our~~The ~~operating~~Company ~~expenses~~will continue to invest heavily in ~~fiscal~~advertising ~~year~~and ~~2024~~promotion ~~increased~~expenses byin ~~$1,992,915,~~the ~~primarily~~near ~~attributable~~future as it continues to: establish and expand its brand and products and services.

●Our operating ~~$3,338,737~~expenses inconsist primarily of advertising and promotion expenses, ~~incurred~~salaries inand ~~the year ended June 30~~benefits, ~~2024,~~office ~~compared to $1~~expenses,~~464,450~~ ~~recorded~~professional infees and ~~the~~depreciation ~~year~~and ~~ended June 30, 2023~~amortization. ~~The~~Our ~~increase~~operating ~~was~~expenses ~~primarily~~in ~~attributable~~fiscal toyear ~~the~~2025 ~~growth~~decreased inby ~~revenue~~$1,571,467, ~~which~~primarily weattributable ~~intend~~ to ~~roll over into expanded advertising and promotion expense for the purpose of achieving a broader market.~~:

31● $1,942,661 in advertising and promotion expenses incurred in the year ended June 30, 2025, compared to $3,338,737 recorded in the year ended June 30, 2024. The decrease was primarily attributable to the decline in revenue, which we intend to roll over into expanded advertising and promotion expense for the purpose of achieving a broader market.

● $172,337 in professional fees in the year ended June 30, 2024, compared to $142,447 in recorded in the year ended June 30, 2023. In both cases, the expense was primarily related to the costs incurred by the Company to establish and sustain its status as an SEC-reporting company in the United States.31

● $~~642~~182,~~094~~198 in ~~salaries~~professional ~~and~~fees ~~benefits expenses~~ in the year ended June 30, ~~2024~~2025, compared to $~~756~~172,~~913~~337 in recorded in the year ended June 30, ~~2023~~2024. ~~The~~In ~~decrease~~both incases, ~~our~~the ~~labor~~expense ~~costs~~ was primarily ~~caused~~related byto the ~~company~~costs ~~decreasing~~incurred by the ~~number~~Company ofto ~~employees~~establish ~~due~~and tosustain ~~adjustments~~its status as an SEC-reporting company in ~~its~~the ~~operational~~United ~~policies~~States.

● $~~878~~580,~~968~~370 in ~~office~~salaries and benefits expenses in the year ended June 30, ~~2024~~2025, compared to $~~701~~642,~~862~~094 in the year ended June 30, ~~2023~~2024. The ~~increase~~decrease in our labor costs was ~~mainly~~primarily ~~attributable~~caused toby the ~~growth~~Company indecreasing ~~revenue,~~the ~~which~~number ~~required~~of ~~additional~~employees ~~administrative~~due ~~services~~to adjustments in its operational policies.

~~Our~~● ~~net~~$722,447 ~~income~~in ~~for~~office expenses in the year ended June 30, ~~2024 was $1~~2025,~~363,278,~~ compared to ~~a net income of~~ $21878,~~085~~968 in the year ended June 30, ~~2023~~2024. The decrease was mainly attributable to the decline in revenue, which reduced additional administrative services.

~~Each of the four subsidiaries of Longduoduo Health~~Our ~~Technology has a minority shareholder holding from 10% of its equity (Qingguo) to 49% of its equity (Tianju). For that reason, we allocate to non-controlling interests the portion of~~ net income ~~corresponding to the minority interest. After that allocation of $107,830, the net income attributable to common stockholders~~ for the year ended June 30, ~~2024~~2025 was $1492,~~255~~260,~~448~~ ~~(i.e.~~compared ~~$0.042~~to ~~per~~a ~~share).~~net Byincome ~~comparison~~of $1, ~~for~~363,278 in the year ended June 30, ~~2023 we recorded a net loss attributable to common stockholders of ($39,089)~~2024.

~~Our~~Each of ~~reporting currency is~~ the ~~U.S.~~four ~~dollar.~~subsidiaries ~~Our local~~of ~~currency,~~Longduoduo ~~the~~Health ~~Renminbi~~Technology ~~(RMB),~~has isa ~~our~~minority ~~functional~~shareholder ~~currency.~~holding ~~Results~~from 10% of ~~operations~~its ~~and~~equity ~~cash~~(Qingguo) ~~flow~~to ~~are~~49% ~~translated at average exchange~~of ~~rates~~its ~~during~~equity ~~the~~(Tianju). ~~period~~For ~~being~~that ~~reported upon~~reason, ~~and~~we ~~assets~~allocate ~~and~~to ~~liabilities~~non-controlling ~~are~~interests ~~translated at~~ the ~~unified~~portion ~~exchange~~of ~~rate~~net asincome ~~quoted~~corresponding byto ~~OANDA on~~ the ~~balance sheet date~~minority interest. ~~Translation~~After ~~adjustments~~that ~~resulting~~allocation ~~from~~of ~~this~~$31,825, ~~process~~the ~~are~~net ~~included~~income inattributable ~~other~~to ~~comprehensive~~common ~~income~~stockholders ~~(loss).~~for ~~For~~ the ~~years~~ year ended June 30, ~~2024~~2025 ~~and~~was ~~2023~~$460,435 (i.e. ~~foreign~~$0.015 ~~currency~~per ~~translation adjustments of $(11,772~~share). ~~and~~By ~~$46~~comparison,~~099,~~ ~~respectively,~~for ~~have~~the ~~been reported~~year asended ~~other~~June ~~comprehensive~~30, ~~income~~2024 inwe ~~the~~recorded ~~consolidated~~a ~~statement~~net ofincome ~~operations~~attributable ~~and~~to ~~comprehensive~~common ~~income~~stockholders of ~~(loss)~~$1,255,448.

~~Liquidity~~Our reporting currency is the U.S. dollar. Our functional currency is the local currency, which is the Renminbi (RMB) for our Chinese subsidiaries, the Hong Kong Dollar (HKD) for our Hong Kong subsidiaries, and ~~Capital~~the ~~Resources~~U.S. Dollar (USD) for our BVI subsidiary. Results of operations and cash flow for RMB and HKD are translated at average exchange rates during the period being reported upon, and assets and liabilities are translated at the unified exchange rate as quoted by OANDA on the balance sheet date. Translation adjustments resulting from this process are included in other comprehensive income (loss). For the years ended June 30, 2025 and 2024, foreign currency translation adjustments of $22,921 and $(11,722), respectively, have been reported as other comprehensive income in the consolidated statement of operations and comprehensive income.

~~As of June 30, 2024, the Company had $1,404,042~~Liquidity ~~in cash~~ and ~~cash~~Capital equivalents. On the same date, we had a working capital of only $395,609, primarily because we had received $713,360 from customers as prepayment for future services and products but used the majority of the deposited sum to pay ongoing expenses and so had only $124,427 in prepayments on our June 30, 2024 balance sheet. Going forward, we will strive to achieve a better balance of customer deposits and prepayments; but we will achieve that better balance only when profits from operations and funds from financing are adequate to support the expansion effort that will be necessary for successful operations.Resources

WeAs of ~~anticipate~~June ~~that~~30, ~~our~~2025, ~~future~~the ~~liquidity~~Company ~~requirements will~~had ~~arise~~$1,642,721 ~~from~~in ~~the~~cash ~~need~~and tocash ~~fund~~equivalents. ~~our~~On ~~growth,~~the ~~pay~~same ~~current~~date, ~~obligations~~we ~~and~~had ~~future~~a working capital ~~expenditures. The primary sources~~ of ~~funding~~only ~~for~~$983,123, ~~such~~primarily ~~requirements~~because ~~are~~we ~~expected~~received to$335,484 beof ~~cash~~deferred ~~generated~~revenue from ~~operations~~customers ~~and~~as ~~raising~~prepayment ~~additional~~for ~~funds~~future ~~from~~services aand ~~public~~products ~~offering~~but ~~and/or~~used ~~debt financing.~~the Wemajority ~~expect~~of ~~Zhang~~the ~~Liang,~~deposited ~~our~~sum ~~majority~~to ~~shareholder,~~pay toongoing ~~continue~~expenses toand ~~provide~~so ~~support~~had only $133,610 in ~~the~~prepayments ~~future~~on our June 30, if2025 ~~needed~~balance sheet. ~~However~~Going forward, we ~~can~~will ~~provide~~strive noto ~~assurances that~~achieve a better balance of customer deposits and prepayments; but we will beachieve ~~able~~that tobetter ~~generate~~balance ~~sufficient~~only when ~~cash~~profits ~~flows~~ from operations and~~/or~~ ~~obtain~~funds ~~additional~~from financing onare ~~terms~~adequate ~~satisfactory~~ to ~~us, if~~support atthe ~~all,~~expansion toeffort ~~remain~~that awill ~~going~~be ~~concern~~necessary for successful operations.

32We anticipate that our future liquidity requirements will arise from the need to fund our growth, pay current obligations and future capital expenditures. The primary sources of funding for such requirements are expected to be cash generated from operations and raising additional funds from a public offering and/or debt financing. We expect Zhang Liang, our majority shareholder, to continue to provide support in the future, if needed. However, we can provide no assurances that we will be able to generate sufficient cash flows from operations and/or obtain additional financing on terms satisfactory to us, if at all, to remain a going concern.

~~Cash Flows~~32

~~The following table summarizes our cash flows~~Cash ~~for the years ended June 30, 2024 and 2023.~~Flows

	For the Years Ended June 30,						Change
	2024			2023			$
Net cash provided by operating activities	$	582,282		$	965,337		$	(383,055	)
Net cash used in investing activities		(305,495	)		(125,880	)		(179,615	)
Net cash provided by (used in) financing activities		-			(143,333	)		143,333
Effect of exchange rate fluctuation on cash and cash equivalents		(9,307	)		83,766			(93,073	)
Net increase in cash and cash equivalents		267,480			779,890			(512,410	)
Cash and cash equivalents, beginning of year		1,136,562			356,672			779,890
Cash and cash equivalents, end of year	$	1,404,042		$	1,136,562		$	267,480

The following table summarizes our cash flows for the years ended June 30, 2025 and 2024.

Net Cash Provided by Operating Activities

	For the Years Ended June 30,						Change
	2025			2024			$
Net cash provided by operating activities	$	277,365		$	582,282		$	(304,917	)
Net cash used in investing activities		(59,375	)		(305,495	)		246,120
Net cash provided by (used in) financing activities		-			-			-
Effect of exchange rate fluctuation on cash and cash equivalents		20,689			(9,307	)		29,996
Net increase in cash and cash equivalents		238,679			267,480			(28,801	)
Cash and cash equivalents, beginning of year		1,404,042			1,136,562			267,480
Cash and cash equivalents, end of year	$	1,642,721		$	1,404,042		$	238,679

~~For the year ended June 30, 2024, we had cash~~Net ~~provided by operating activities of $582,282, compared to $965,337 for the year ended June 30, 2023.~~ Cash ~~provided~~Provided by ~~operations~~Operating during the year ended June 30, 2024 was primarily due to recording net income of $1,363,278 and receiving $126,980 in deposits by customers for future services, from which we used $689,296 to reduce accounts payable and $100,092 to pay off loans made to us by related parties.Activities

~~Net~~For the year ended June 30, 2025, we had cash provided by operating activities of $277,365, compared to $582,282 for the year ended June 30, 2024. Cash ~~Used~~provided inby ~~Investing~~operations ~~Activities~~during the year ended June 30, 2025 was primarily due to recording net income of $492,260, which was partially offset by deferred revenue.

Net Cash ~~cash~~Used ~~used~~ in ~~investing~~Investing ~~activities for the year ended June 30, 2024 was $305,495, compared to $125,880 for the year ended June 30, 2023. The cash was used for the purchase of fixed assets and office decoration.~~Activities

Net cash ~~Cash~~used ~~Provided~~in byinvesting ~~Financing~~activities ~~Activities~~for the year ended June 30, 2025 was $59,375, compared to $305,495 for the year ended June 30, 2024. In both periods, the cash was used for the purchase of fixed assets and office decoration.

Net ~~cash used in financing activities for the~~ ~~year~~Cash ~~ended~~Provided ~~June~~by ~~30,~~Financing ~~2024 was $0 compared to $143,333 in cash used in financing activities during the year ended June 30, 2023, which represented the sum we repaid on a short-term loan.~~Activities

~~Critical~~Net cash ~~Accounting~~used ~~Policies~~in financing activities for the years ended June 30, 2025 and 2024 was $0.

~~The discussion and analysis of the Company’s~~Critical ~~financial~~Accounting condition and results of operations is based upon its consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of these financial statements requires us to make significant estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These items are monitored and analyzed by management for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate.Policies

InThe discussion ~~our~~and ~~preparation~~analysis of the Company’s financial condition and results of operations is based upon its consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of these ~~for~~financial statements requires us to make significant estimates and judgments that affect the ~~year~~reported ~~ended~~amounts ~~June~~of 30assets, ~~2024~~liabilities, revenues ~~there~~and ~~was~~expenses, noand ~~estimate~~related ~~made~~disclosure ~~which~~of ~~was~~contingent ~~(a)~~assets ~~subject~~and toliabilities. aThese ~~high~~items ~~degree~~are ofmonitored ~~uncertainty~~and analyzed by management for changes in facts and ~~(b)~~circumstances, and material tochanges in these estimates could occur in the future. Changes in estimates are recorded ~~our~~in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate.

33In our preparation of the financial statements for the year ended June 30, 2025, there was no estimate made which was (a) subject to a high degree of uncertainty and (b) material to our results.

~~Trends, Events and Uncertainties~~33

~~The U.S. government~~Trends, ~~including the SEC, has made~~ ~~statements~~Events and taken actions that have led to changes in relations between the U.S. and China, and will impact companies with connections to the United States or China. Those actions by the U.S. government included imposing several rounds of tariffs affecting certain products manufactured in China and imposing sanctions and restrictions in relation to China. Actions by the SEC included issuing statements indicating that it would make enhanced review of companies with significant China-based operations. It is unknown whether and to what extent new legislation, executive orders, tariffs, laws or regulations will be adopted, or the effect that any such actions would have on U.S.-domiciled companies with significant connections to China, our industry or on us. Any unfavorable government policies on cross-border relations, including increased scrutiny on companies with significant China-based operations, capital controls or tariffs, may affect our ability to raise capital and the market price of our shares. If any new legislation, executive orders, tariffs, laws and/or regulations are implemented, if existing trade agreements are renegotiated or if the U.S. or Chinese governments take retaliatory actions due to the recent U.S.-China tensions, such changes could have an adverse effect on our business, financial condition and results of operations, our ability to raise capital and the market price of our shares. Changes in United States and China relations and/or regulations may adversely impact our business, our operating results, our ability to raise capital and the market price of our shares.Uncertainties

~~Other~~The U.S. ~~than~~government, including the ~~factors~~SEC, ~~listed~~has ~~above~~made westatements doand ~~not~~taken actions that have led to changes in relations between the U.S. and ~~know~~China, and will impact companies with connections to the United States or China. Those actions by the U.S. government included imposing several rounds of ~~any~~tariffs ~~trends~~affecting certain products manufactured in China and imposing sanctions and restrictions in relation to China. Actions by the SEC included issuing statements indicating that it would make enhanced review of companies with significant China-based operations. It is unknown whether and to what extent new legislation, ~~events~~executive orders, tariffs, laws or ~~uncertainties~~regulations will be adopted, or the effect that any such actions would have ~~had~~on U.S.-domiciled companies with significant connections to China, our industry or on us. Any unfavorable government policies on cross-border relations, including increased scrutiny on companies with significant China-based operations, capital controls or tariffs, may affect our ability to raise capital and the market price of our shares. If any new legislation, executive orders, tariffs, laws and/or regulations are ~~reasonably~~implemented, ~~expected~~if existing trade agreements are renegotiated or if the U.S. or Chinese governments take retaliatory actions due to the recent U.S.-China tensions, such changes could have aan ~~material~~adverse ~~impact~~effect on our ~~net~~business, financial ~~sales~~condition orand ~~revenues~~results of operations, our ability to raise capital and the market price of our shares. Changes in United States and China relations and/or ~~income~~regulations ~~from~~may ~~continuing~~adversely ~~operations~~impact our business, our operating results, our ability to raise capital and the market price of our shares.

~~Recent~~Other than ~~Accounting~~the ~~Pronouncements~~factors listed above we do not know of any trends, events or uncertainties that have had or are reasonably expected to have a material impact on our net sales or revenues or income from continuing operations.

~~There were no recent accounting pronouncements~~Recent ~~that~~Accounting ~~we expect to have a material effect on the Company’s financial position or results of operations. Please refer to Note 2 of our consolidated financial statements included in this annual report.~~Pronouncements

~~Item~~There were 7Ano recent accounting pronouncements that we expect to have a material effect on the Company’s financial position or results of operations. ~~Quantitative~~Please ~~and~~refer ~~Qualitative~~to ~~Disclosures~~Note ~~about~~2 ~~Market~~of ~~Risk~~our consolidated financial statements included in this annual report.

~~Not~~Item 7A. ~~applicable~~Quantitative and Qualitative Disclosures about Market Risk.

34Not applicable.

~~Item 8. Financial Statements and Supplementary Data.~~34

~~INDEX~~Item TO8. Financial ~~CONSOLIDATED~~Statements ~~FINANCIAL~~and ~~STATEMENTS~~Supplementary Data.

~~LONGDUODUO~~INDEX TO ~~COMPANY~~CONSOLIDATED ~~LIMITED~~FINANCIAL ~~AND SUBSIDIARIES~~STATEMENTS

~~TABLE~~LONGDUODUO COMPANY OFLIMITED ~~CONTENTS~~AND SUBSIDIARIES

		Page
Years Ended June 30, 2024 and 2023
Report of Independent Registered Public Accounting Firm (PCAOB ID 6797) – year ended June 30, 2024		F - 2
Report of Independent Registered Public Accounting Firm (PCAOB ID 822) – year ended June 30, 2023		F - 3
Consolidated Balance Sheets as of June 30, 2024 and 2023		F - 5
Consolidated Statements of Operations and Comprehensive Income for the years ended June 30, 2024 and 2023		F - 6
Consolidated Statement of Changes in shareholders’ Equity (Deficit) for the years ended June 30, 2024 and 2023		F - 7
Consolidated Statements of Cash Flows for the years ended June 30, 2024 and 2023		F - 8
Notes to Consolidated Financial Statements		F - 9

TABLE OF CONTENTS

F-1

		Page

Years Ended June 30, 2025 and 2024

Report of Independent Registered Public Accounting Firm (PCAOB ID 6797)		F-2

Consolidated Balance Sheets as of June 30, 2025 and 2024		F-3

Consolidated Statements of Operations and Comprehensive Income for the years ended June 30, 2025 and 2024		F-4

Consolidated Statement of Changes in Shareholders’ Equity (Deficit) for the years ended June 30, 2025 and 2024		F-5

Consolidated Statements of Cash Flows for the years ended June 30, 2025 and 2024		F-6

Notes to Consolidated Financial Statements		F-7

~~REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM~~F-1

ToREPORT OF ~~the~~INDEPENDENT ~~Shareholders~~REGISTERED ~~and~~PUBLIC ~~the~~ACCOUNTING ~~Board of Directors of~~FIRM

~~Longduoduo~~To ~~Co.~~the ~~Ltd.~~Board of Directors and Shareholders of

~~OPINION~~Longduoduo ONCompany ~~THE FINANCIAL STATEMENTS~~Limited

WeOPINION ~~have~~ON ~~audited~~THE ~~the~~FINANCIAL accompanying consolidated balance sheet of Longduoduo Co. Ltd. (the “Company”) as of June 30, 2024, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2024, and the results of its operations and its cash flows for the year then ended in conformity with accounting principles generally accepted in the United States of America.STATEMENTS

~~BASIS~~We ~~FOR~~have ~~OPINION~~audited the accompanying consolidated balance sheets of Longduoduo Company Limited and its subsidiaries (the “Company”) as of June 30, 2025 and 2024, and the related consolidated statements of operations and comprehensive loss, stockholders’ equity and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2025 and 2024, and the results of its operations and its cash flows for the years then ended in conformity with accounting principles generally accepted in the United States of America.

~~These~~BASIS ~~financial~~FOR statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.OPINION

WeThese ~~conducted~~financial ~~our~~statements ~~audit~~are ~~in accordance with~~ the ~~standards~~responsibility of the ~~PCAOB~~Company’s management. ~~Those~~ ~~standards~~Our ~~require~~responsibility ~~that~~is ~~we plan and perform the audit~~ to ~~obtain~~express ~~reasonable~~an ~~assurance~~opinion ~~about~~on ~~whether the~~ these financial statements ~~are~~based ~~free of~~on ~~material~~our ~~misstatement, whether due to error or fraud~~audit. ~~The~~We ~~Company~~are isa ~~not~~public ~~required~~accounting tofirm ~~have,~~registered ~~nor~~with ~~were~~the wePublic ~~engaged~~Company toAccounting ~~perform,~~Oversight ~~an audit~~Board of(United ~~its~~States) ~~internal~~(“PCAOB”) ~~control~~and ~~over financial reporting. As part of our audits, we~~ are required to ~~obtain~~be anindependent ~~understanding~~with ofrespect ~~internal~~to ~~control over~~the ~~financial~~Company ~~reporting~~in ~~but~~accordance ~~not~~with ~~for~~ the ~~purpose~~U.S. offederal securities ~~expressing~~laws anand ~~opinion~~the onapplicable ~~the~~rules ~~effectiveness~~and regulations of the ~~Company’s~~Securities ~~internal~~and ~~control over~~Exchange ~~financial~~Commission ~~reporting.~~and ~~Accordingly,~~the ~~we express no such opinion~~PCAOB.

~~Our~~We ~~audit~~conducted ~~included~~our ~~performing~~audit ~~procedures~~in toaccordance ~~assess~~with the ~~risks~~standards of ~~material~~the PCAOB. Those standards require that we plan and perform the audit to obtain ~~misstatement~~reasonable ofassurance about whether the financial statements are free of material misstatement, whether due to error or fraud,. ~~and~~The ~~performing~~Company is ~~procedures~~not ~~that~~required ~~respond~~ to ~~those~~have, ~~risks.~~nor ~~Such~~were ~~procedures included~~we ~~examining,~~engaged onto ~~a test basis~~perform, ~~evidence~~an ~~regarding~~audit ~~the~~of ~~amounts~~its ~~and~~internal ~~disclosures~~control inover ~~the~~ financial ~~statements~~reporting. ~~Our~~As ~~audits~~part ~~also~~of ~~included~~our audits, ~~evaluating~~we ~~the~~are ~~accounting~~required ~~principles~~to ~~used~~obtain ~~and~~an ~~significant~~understanding ~~estimates~~of ~~made~~internal bycontrol ~~management,~~over asfinancial ~~well~~reporting asbut ~~evaluating~~not for the ~~overall~~purpose ~~presentation~~ of expressing an opinion on the ~~financial~~effectiveness ~~statements.~~of Wethe ~~believe~~Company’s ~~that~~internal ~~our~~control ~~audit~~over ~~provides~~financial areporting. ~~reasonable~~Accordingly, ~~basis~~we ~~for~~express ~~our~~no such opinion.

~~CRITICAL~~Our ~~AUDIT~~audit ~~MATTERS~~included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.

~~Critical~~/s/ ~~audit~~Bush ~~matters~~& ~~are~~Associates ~~matters~~CPA arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgements. We determined that there are no critical audit matters.LLC

~~/s/~~We ~~Bush~~have &served ~~Associates~~as ~~CPA~~the ~~LLC~~Company’s auditor since 2024.

WeHenderson, ~~have served as the Company’s auditor since 2024.~~Nevada

~~Henderson~~September 26, ~~Nevada~~2025

~~October~~PCAOB ID ~~15,~~Number ~~2024~~6797

~~PCAOB ID Number 6797~~F-2

~~F-2~~LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

~~REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING~~CONSOLIDATED ~~FIRM~~BALANCE SHEETS

To the Board of Directors and Stockholders of Longduoduo Company Limited:

	As of June 30,
	2025			2024

Assets
Current Assets:
Cash and cash equivalents	$	1,642,721		$	1,404,042
Other receivables		37,256			131,376
Prepayments		133,610			124,427
Total current assets		1,813,587			1,659,845
Property and equipment, net		280,003			353,486
Right-of-use assets		32,906			50,070
Total assets	$	2,126,496		$	2,063,401

Liabilities and Equity (Deficit)
Current Liabilities:
Accounts payable	$	399,906		$	358,613
Deferred revenue		335,484			713,360
Accrued expenses		50,027			50,107
Due to related parties		408			2,233
Other payables		-			35,660
Operating lease liabilities, current		18,570			17,618
Other current liabilities		26,069			86,645
Total current liabilities		830,464			1,264,236
Operating lease liabilities, less current portion		-			18,314
Total liabilities		830,464			1,282,550

Equity (Deficit):
Preferred stock; $0.001 par value, 30,000,000 shares authorized, no shares issued and outstanding at June 30, 2025 and 2024		-			-
Common stock; $0.001 par value, 500,000,000 shares authorized; 30,015,036 and 30,005,016 shares issued and outstanding at June 30, 2025 and 2024, respectively		30,015			30,005
Additional paid-in capital		7,246,719			7,246,729
Accumulated deficit		(6,169,197	)		(6,629,632	)
Accumulated other comprehensive income		77,028			55,413
Total stockholders’ equity		1,184,565			702,515
Non-controlling interests		111,467			78,336
Total stockholders’ equity attributable to the common stockholders		1,296,032			780,851
Total liabilities and equity	$	2,126,496		$	2,063,401

~~Opinion~~The accompanying onnotes ~~the~~are ~~Financial~~an ~~Statements~~integral part of these consolidated financial statements.

We have audited the accompanying consolidated balance sheet of Longduoduo Company Limited (the “Company”) as of June 30, 2023 and the related consolidated statements of operations and comprehensive income, changes in deficit, and cash flows for the year then ended, and the related notes (collectively referred to as the “financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of June 30, 2023 and the results of its operations and cash flows for the year then ended in conformity with accounting principles generally accepted in the United States.F-3

~~Explanatory~~LONGDUODUO COMPANY ~~Paragraph~~LIMITED AND ~~Regarding Going Concern~~SUBSIDIARIES

~~The accompanying financial statements have been~~CONSOLIDATED ~~prepared~~STATEMENTS ~~assuming~~OF ~~that~~OPERATIONS ~~the~~AND ~~Company~~COMPREHENSIVE will continue as a going concern. As described in Note 2 to the consolidated financial statements, the Company’s present financial situation raises substantial doubt about its ability to continue as a going concern. Management’s plans in regard to this matter are also described in Note 2. These financial statements do not include any adjustments that might result from the outcome of this uncertainty.INCOME

Basis for Opinion

	For the Years Ended June 30,
	2025		2024

Revenues:
Service revenue	$	120,866	$	327,599
Commission revenue		4,141,797		7,062,243
Total revenues		4,262,663		7,389,842
Cost of revenue:
Cost of service revenue		91,099		173,349
Total cost of revenues		91,099		173,349
Gross profit		4,171,564		7,216,493

Selling, general and administrative expenses		3,618,885		5,190,352
Income from operations		552,679		2,026,141
Other income (expense)		161,849		(139,656	)
Income before provision for income taxes		714,528		1,886,485
Provision for income taxes		222,268		523,207
Net income		492,260		1,363,278
Less: net income attributable to non-controlling interests		31,825		107,830
Net income attributable to common stockholders	$	460,435	$	1,255,448

Comprehensive income:
Net income	$	492,260	$	1,363,278
Foreign currency translation adjustment		22,921		(11,772	)
Comprehensive income		515,181		1,351,506
Less: comprehensive income attributable to non-controlling interests		33,131		107,034
Comprehensive income attributable to the common stockholders	$	482,050	$	1,244,472

Basic and diluted income per share	$	0.015	$	0.042
Weighted average number of shares outstanding - basic and diluted		30,009,878		30,005,016

~~These~~The accompanying ~~financial~~notes ~~statements~~ are ~~the responsibility of the Company’s management. Our responsibility is to express~~ an ~~opinion~~integral onpart ~~the~~of ~~Company’s~~these consolidated financial statements ~~based on our audit~~. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.F-4

~~Our audit included performing procedures to assess~~LONGDUODUO ~~the~~COMPANY ~~risks~~LIMITED ofAND material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.SUBSIDIARIES

~~F-3~~CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT)

~~Critical~~FOR THE ~~Audit~~YEARS ~~Matter~~ENDED JUNE 30, 2025 AND JUNE 30, 2024

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit maters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

	Common stock				Additional						Accumulated Other			Total Stockholder’			Non-			Total
	Number of Shares		Amount		Paid-in Capital			Accumulated Deficit			Comprehensive Income			Equity (Deficit)			controlling Interests			Equity (Deficit)
Balance at June 30, 2023		30,005,008	$	30,005	$	7,246,729		$	(7,885,080	)	$	66,389		$	(541,957	)	$	(28,698	)	$	(570,655	)
Adjustment for the reverse stock split		8		-		-			-			-			-			-			-
Net income		-		-		-			1,255,448			-			1,255,448			107,830			1,363,278
Foreign currency translation adjustment		-		-		-			-			(10,976	)		(10,976	)		(796	)		(11,772	)
Balance at June 30, 2024		30,005,016	$	30,005	$	7,246,729		$	(6,629,632	)	$	55,413		$	702,515		$	78,336		$	780,851
Stock issued and exchanged for shares of LDD		10,020		10		(10	)		-			-			-			-			-
Net income		-		-		-			460,435			-			460,435			31,825			492,260
Foreign currency translation adjustment		-		-		-			-			21,615			21,615			1,306			22,921
Balance at June 30, 2025		30,015,036	$	30,015	$	7,246,719		$	(6,169,197	)	$	77,028		$	1,184,565		$	111,467		$	1,296,032

~~Commission~~The accompanying ~~Revenue~~notes are an integral part of these consolidated financial statements

The Company’s consolidated statement of operations for the year ended June 30, 2023 includes commission revenue of $2,010,045. Substantially all of the commission revenue was derived from a contract executed in June 2023 with a thirdF-party healthcare provider. Under the contract, the Company refers customers to the third-party provider, which is wholly responsible for fulfillment of the services to the customer. The Company has no performance commitment or liability to the customer. The Company recognizes commission revenue upon acceptance of the customer contract by the third-party provider in an amount equal to the net of the gross amount received from the customer less the amount payable to the third-party provider.5

~~The principal considerations for our determination~~LONGDUODUO ~~that~~COMPANY ~~performing~~LIMITED ~~procedures~~AND relating to commission revenue is a critical audit matter are (i) the significant judgement by management to determine whether to account for the transactions in an agent or principal capacity and (ii) a high degree of auditor judgement, subjectivity, and effort in performing procedures relating to commission revenue.SUBSIDIARIES

~~Addressing the matter involved performing procedures~~CONSOLIDATED ~~and~~STATEMENTS ~~evaluating~~OF ~~audit~~CASH evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included, among other things, evaluating the conclusions reached by management and reviewing both contracts with customers and the contract between the Company and the third-party provider.FLOWS

/s/ Michael T. Studer CPA P.C. Michael T. Studer CPA P.C.

	For the Years Ended June 30,
	2025			2024
Cash Flows from Operating Activities
Net income	$	492,260		$	1,363,278
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		137,290			102,032
Loss on disposal of fixed assets		-			10,070
Operating lease expense		63,345			58,790
Changes in operating assets and liabilities:
Other receivables		95,330			(24,702	)
Prepayments		(53,139	)		(114,643	)
Inventories		-			830
Due from related parties		20,092			(5,016	)
Accounts payable		36,036			(689,296	)
Deferred revenue		(385,316	)		126,980
Accrued expenses		(776	)		(40,922	)
Due to related parties		(11,462	)		(100,902	)
Security deposits		-			(54,992	)
Other payables		(35,922	)		(48,940	)
Payment of operating lease liabilities		(18,990	)		(14,250	)
Other current liabilities		(61,383	)		13,965
Net cash provided by operating activities		277,365			582,282

Cash Flows from Investing Activities
Purchase of property, plant and equipment		(59,375	)		(305,495	)
Net cash used in investing activities		(59,375	)		(305,495	)

Cash Flows from Financing Activities
Proceeds from short-term borrowing from third party		-			-
Net cash (used in) Financing Activities		-			-

Effect of exchange rate fluctuation on cash and cash equivalents		20,689			(9,307	)
Net increase in cash and cash equivalents		238,679			267,480

Cash and cash equivalents, beginning of year		1,404,042			1,136,562
Cash and cash equivalents, end of year	$	1,642,721		$	1,404,042

Supplemental Non-Cash Investing and Financing Activities
Share issuance for acquisition	$	-		$	-
Share issuance in exchange for equipment	$	-		$	-
Right-of-use assets obtained in exchange for new operating lease liabilities	$	-		$	-

Supplemental disclosure of cash flow information
Cash paid for income taxes	$	231,580		$	523,207
Cash paid for interest expense	$	-		$	-

~~Freeport,~~The accompanying ~~New~~notes ~~York~~are an integral part of these consolidated financial statements.

~~November 14, 2023~~F-6

WeLONGDUODUO COMPANY ~~have~~LIMITED ~~served~~AND ~~as the Company’s auditor since 2023.~~SUBSIDIARIES

~~F-4~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

~~LONGDUODUO~~FOR THE ~~COMPANY~~YEARS ~~LIMITED~~ENDED JUNE 30, 2025 AND ~~SUBSIDIARIES~~JUNE 30, 2024

~~CONSOLIDATED~~NOTE 1. ~~BALANCE~~NATURE ~~SHEETS~~OF OPERATIONS AND BASIS OF PRESENTATION

	As of June 30,
	2024			2023
Assets
Current Assets:
Cash and cash equivalents	$	1,404,042		$	1,136,562
Other receivables		131,376			107,042
Prepayments		124,427			68,341
Inventories		-			820
Total current assets		1,659,845			1,312,765
Property and equipment, net		353,486			152,719
Intangible asset, net		-			3,828
Right-of-use assets		50,070			13,470
Total assets	$	2,063,401		$	1,482,782
Liabilities and Equity (Deficit)
Current Liabilities:
Accounts payable	$	358,613		$	1,044,247
Deferred revenue		713,360			588,335
Accrued expenses		50,107			90,858
Due to related parties		2,233			104,611
Security deposits		-			54,992
Other payables		35,660			84,015
Operating lease liabilities, current		17,618			6,579
Other current liabilities		86,645			72,909
Total current liabilities		1,264,236			2,046,546
Operating lease liabilities, less current portion		18,314			6,891
Total liabilities		1,282,550			2,053,437
Equity (Deficit):
Preferred stock; $0.001 par value, 30,000,000 shares authorized,no shares issued and outstanding at June 30, 2024 and 2023		-			-
Common stock; $0.001 par value, 500,000,000 shares authorized; 30,005,016 and 30,000,008 shares issued and outstanding at June 30, 2024 and 2023, respectively		30,005			30,005
Additional paid-in capital		7,246,729			7,246,729
Accumulated deficit		(6,629,632	)		(7,885,080	)
Accumulated other comprehensive income		55,413			66,389
Total stockholders’ equity (deficit)		702,515			(541,957	)
Non-controlling interests		78,336			(28,698	)
Total stockholders’ equity (deficit) attributable to the common stockholders		780,851			(570,655	)
Total liabilities and equity (deficit)	$	2,063,401		$	1,482,782

Longduoduo Company Limited (“Longduoduo”, together as a group with Longduoduo’s subsidiaries referred to as the “Company” or “we”) was incorporated in the State of Nevada on October 25, 2021. Acting in a principal capacity, the Company provides customers comprehensive and high-quality preventive healthcare solutions including a wide range of preventive healthcare services, including disease screening healthcare treatment, healthcare products and other services through a network of third-party healthcare service providers. In June 2023, the Company began to engage in agent sales of preventive healthcare solutions on behalf of a third-party provider and earn commissions revenue.

~~The~~On September ~~accompanying~~21, ~~notes~~2023, ~~are~~the anCompany ~~integral~~implemented ~~part~~ a 1-for-10 reverse split of ~~these~~its ~~consolidated~~outstanding common stock, effective at the close of business on September 26, 2023. The accompanying financial statements have been adjusted to retroactively reflect this reverse stock split.

~~F-5~~Longduoduo’s subsidiaries include:

~~LONGDUODUO~~● ~~COMPANY~~Longduoduo ~~LIMITED AND~~Company ~~SUBSIDIARIES~~Limited (Hong Kong) (“Longduoduo HK”), was established on July 26, 2021 under the laws of Hong Kong. On October 26, 2021, Longduoduo issued 30,000,000 shares of its common stock to the original shareholders of Longduoduo HK, in exchange for 100% of the outstanding shares of Longduoduo HK.

~~CONSOLIDATED~~● ~~STATEMENTS~~LDD OFTechnology ~~OPERATIONS~~Limited ~~AND~~(“LDD”) ~~COMPREHENSIVE INCOME~~was established on March 18, 2024 under the laws of British Virgin Islands. On February 19, 2025, Longduoduo issued 10,020 shares of its common stock to the original shareholders of LDD, in exchange for 100% of the outstanding shares of LDD .

	For the Years Ended June 30,
	2024			2023
Revenues:
Service revenue	$	327,599		$	1,799,901
Product revenue		-			8,614
Commission revenue		7,062,243			2,010,045
Total revenues		7,389,842			3,818,560
Cost of revenue:
Cost of service revenue		173,349			591,574
Cost of product revenue		-			311
Total cost of revenues		173,349			591,885
Gross profit		7,216,493			3,226,675
Selling, general and administrative expenses		5,190,352			3,197,437
Income from operations		2,026,141			29,238
Other income (expense)		(139,656	)		2,093
Income before provision for income taxes		1,886,485			31,331
Provision for income taxes		523,207			10,246
Net income		1,363,278			21,085
Less: net income attributable to non-controlling interests		107,830			60,174
Net income (loss) attributable to common stockholders	$	1,255,448		$	(39,089	)
Comprehensive income:
Net income	$	1,363,278		$	21,085
Foreign currency translation adjustment		(11,772	)		46,099
Comprehensive income		1,351,506			67,184
Less: comprehensive income attributable to non-controlling interests		107,034			64,855
Comprehensive income attributable to the common stockholders	$	1,244,472		$	2,329
Basic and diluted income(loss) per share	$	0.042		$	(0.001	)
Weighted average number of shares outstanding - basic and diluted		30,005,016			30,001,806

●

LDDJK Hong Kong Limited (“LDDJK”) was established on April 9, 2024 under the laws of Hong Kong. LDD has controlled 100% of LDDJK since its inception.

~~The~~● ~~accompanying~~Beijing ~~notes~~Julong ~~are~~Health anConsulting ~~integral~~Co., ~~part~~ Limited (“Julong”) was established in Beijing, China on July 23, 2024. LDDJK has controlled 100% of ~~these~~Julong ~~consolidated~~since ~~financial~~its ~~statements~~inception.

~~F-6~~● Beijing Yihua Health Consulting Co., Limited (“Yihua”) was established in Beijing, China on March 14, 2024. On January 7, 2025, Julong acquired all the shares held by the original shareholders of Yihua, and controlled 100% ownership of Yihua.

~~LONGDUODUO~~● ~~COMPANY~~Longduoduo ~~LIMITED~~Health ~~AND~~Technology ~~SUBSIDIARIES~~Company Limited (“Longduoduo Health Technology”) is a privately held Limited Company, registered in Inner Mongolia, China on August 20, 2020. On August 16, 2021, Longduoduo HK acquired 100% of Longduoduo Health Technology from the original shareholders of Longduoduo Health Technology. On April 2, 2025, Julong acquired 100% of Longduoduo Health Technology from Longduoduo HK.

~~CONSOLIDATED~~● ~~STATEMENTS~~Inner OFMongolia ~~CHANGES~~Qingguo INHealth ~~EQUITY~~ Consulting Company Limited (~~DEFICIT~~“Qingguo”) is a privately held Limited Company, registered in Inner Mongolia, China on June 18, 2020. On September 8, 2020, Longduoduo Health Technology acquired 90% of Qingguo from the original shareholders of Qingguo.

~~FOR~~● ~~THE~~Inner ~~YEARS~~Mongolia ~~EDNED~~Rongbin ~~JUNE~~Health 30Consulting Company Limited (“Rongbin”) is a privately held Limited Company, ~~2024~~registered ~~AND~~in ~~JUNE~~Inner 30Mongolia, ~~2023~~ China on March 18, 2021. Longduoduo Health Technology has controlled 80% of Rongbin since its inception.

	Common stock				Additional					Accumulated Other			Total Stockholder’			Non-			Total
	Number of Shares		Amount		Paid-in Capital		Accumulated Deficit			Comprehensive Income			Equity (Deficit)			controlling Interests			Equity (Deficit)
Balance at June 30, 2022		30,000,008	$	30,000	$	6,862,234	$	(7,845,991	)	$	24,971		$	(928,786	)	$	(93,553	)	$	(1,022,339	)
Stock-based compensation		5,000		5		384,495		-			-			384,500			-			384,500
Net loss		-		-		-		(39,089	)		-			(39,089	)		60,174			21,085
Foreign currency translation adjustment		-		-		-		-			41,418			41,418			4,681			46,099
Balance at June 30, 2023		30,005,008	$	30,005	$	7,246,729	$	(7,885,080	)	$	66,389		$	(541,957	)	$	(28,698	)	$	(570,655	)
Adjustment for the reverse stock split		8						-			-						-
Net income		-		-		-		1,255,448			-			1,255,448			107,830			1,363,278
Foreign currency translation adjustment		-		-		-		-			(10,976	)		(10,976	)		(796	)		(11,772	)
Balance at June 30, 2024		30,005,016	$	30,005	$	7,246,729	$	(6,629,632	)	$	55,413		$	702,515		$	78,336		$	780,851

●

Inner Mongolia Chengheng Health Consulting Company Limited (“Chengheng”) is a privately held Limited Company, registered in Inner Mongolia, China on April 9, 2021. Longduoduo Health Technology has controlled 80% of Chengheng since its inception.

~~The~~● ~~accompanying~~Inner ~~notes~~Mongolia ~~are~~Tianju anHealth ~~integral~~Consulting ~~part of~~Company ~~these~~Limited ~~consolidated~~(“Tianju”) ~~financial~~is ~~statements~~a privately held Limited Company registered in Inner Mongolia, China on July 5, 2021. Longduoduo Health Technology has controlled 51% of Tianju since inception.

FThe transactions summarized above are treated in the Company’s financial statements as a corporate restructuring (reorganization) of entities under common control, as each of the eleven entities have at all times been under the control of Mr. Zhang Liang. Therefore, in accordance with ASC 805-750-45-5, the current capital structure has been retroactively presented in prior periods as if such structure existed at that time, and the entities under common control are presented on a combined basis for all periods. Since all of the subsidiaries were under common control for all periods presented, the results of these subsidiaries are included in the Company’s financial statements for all periods presented.

~~LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES~~F-7

~~CONSOLIDATED~~LONGDUODUO COMPANY ~~STATEMENTS~~LIMITED OFAND ~~CASH FLOWS~~SUBSIDIARIES

	For the Years Ended June 30,
	2024			2023
Cash Flows from Operating Activities
Net income	$	1,363,278		$	21,085
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation		102,032			67,738
Loss on disposal of fixed assets		10,070			-
Operating lease expense		58,790			64,604
Stock compensation expense		-			384,500
Changes in operating assets and liabilities:
Other receivables		(24,702	)		(78,477	)
Prepayments		(114,643	)		(43,997	)
Inventories		830			1,826
Due from related parties		(5,016	)		(56,663	)
Accounts payable		(689,296	)		1,050,336
Deferred revenue		126,980			(145,760	)
Accrued expenses		(40,922	)		(32,595	)
Due to related parties		(100,902	)		77,564
Security deposits		(54,992	)		(274,188	)
Other payables		(48,940	)		(122,792	)
Payment of operating lease liabilities		(14,250	)		(21,575	)
Other current liabilities		13,965			73,731
Net cash provided by operating activities		582,282			965,337
Cash Flows from Investing Activities
Purchase of property, plant and equipment		(305,495	)		(120,127	)
Purchase of intangible asset		-			(5,753	)
Net cash used in investing activities		(305,495	)		(125,880	)
Cash Flows from Financing Activities
Proceeds from short-term borrowing from third party		-			(143,333	)
Net cash (used in) Financing Activities		-			(143,333	)
Effect of exchange rate fluctuation on cash and cash equivalents		(9,307	)		83,766
Net increase in cash and cash equivalents		267,480			779,890
Cash and cash equivalents, beginning of year		1,136,562			356,672
Cash and cash equivalents, end of year	$	1,404,042		$	1,136,562
Supplemental Non-Cash Investing and Financing Activities
Share issuance for lease payment	$	-		$	-
Share issuance in exchange for equipment	$	-		$	-
Right-of-use assets obtained in exchange for new operating lease liabilities	$	-		$	-
Supplemental disclosure of cash flow information
Cash paid for income taxes	$	523,207		$	10,246
Cash paid for interest expense	$	-		$	-

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

~~The~~FOR THE ~~accompanying~~YEARS ~~notes~~ENDED ~~are~~JUNE an30, ~~integral~~2025 ~~part of~~AND ~~these~~JUNE ~~consolidated~~30, ~~financial statements.~~2024

~~F-8~~NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

~~LONGDUODUO~~A. Basis ~~COMPANY~~of ~~LIMITED AND SUBSIDIARIES~~presentation

~~NOTES~~The accompanying TOconsolidated ~~CONSOLIDATED~~financial ~~FINANCIAL~~statements ~~STATEMENTS~~are expressed in U.S. Dollars and have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

~~FOR~~B. Principles ~~THE~~of ~~YEARS ENDED JUNE 30, 2024 AND JUNE 30, 2023~~consolidation

~~NOTE~~The 1consolidated financial statements include the accounts of Longduoduo and its subsidiaries. ~~NATURE~~All OFsignificant ~~OPERATIONS~~inter-company ~~AND~~accounts ~~BASIS~~and OFtransactions ~~PRESENTATION~~have been eliminated. The consolidated financial statements include 100% of assets, liabilities, and net income of these subsidiaries.

~~Longduoduo~~LDD ~~Company~~Technology Limited ~~(“Longduoduo”,~~was established on March ~~together~~18, as2024 under the laws of British Virgin Islands. LDD is a ~~group~~holding company with no business operations of its own. On February 19, 2025, Longduoduo’s ~~subsidiaries~~issued ~~referred~~10,020 toshares asof its common stock to the ~~“Company”~~original orshareholders ~~“we”)~~of ~~was~~LDD, ~~incorporated~~and assumed all the original shareholders' capital contribution obligations of LDD, in ~~the~~exchange ~~State~~for 100% of ~~Nevada~~the onoutstanding ~~October~~shares ~~25,~~of ~~2021~~LDD. ~~Acting~~This intransaction ais ~~principal~~treated ~~capacity,~~in the Company’s financial ~~provides~~statements ~~customers~~as ~~comprehensive~~a corporate restructuring (reorganization) of entities under common control, as LDD and ~~high-quality preventive~~Longduoduo ~~healthcare~~have ~~solutions~~at ~~including~~all times abeen ~~wide~~under ~~range~~the control of ~~preventive~~Mr. ~~healthcare~~Zhang ~~services~~Liang. Therefore, ~~including~~this ~~disease~~transaction ~~screening~~is ~~healthcare~~accounted ~~treatment,~~for by the carry-over basis method (also referred ~~healthcare~~to ~~products~~as the pooling-of-interests method or historical-cost method). The assets and ~~other~~liabilities ~~services~~transferred ~~through~~are arecorded ~~network~~by the receiving entity at their historical carrying amounts in the consolidated financial statements of ~~third-party~~the ~~healthcare~~controlling ~~service~~parent, ~~providers~~not at fair value. No new goodwill is recognized, and no gain or loss is recorded. In ~~June~~accordance ~~2023~~with ASC 805-50-45-5, the ~~Company~~current ~~began~~capital structure has been toretroactively ~~engage~~presented in ~~agent~~prior ~~sales~~periods ofas ~~preventive~~if ~~healthcare~~such ~~solutions~~structure onexisted ~~behalf~~at ofthat time, and the entities under common control are presented on a ~~third-party~~combined ~~provider~~basis for all periods. Since LDD and ~~earn~~Longduoduo ~~commissions~~were ~~revenue~~under common control for all periods presented, the results of LDD are included in the Company’s financial statements for all periods presented.

~~On September 21, 2023, the Company implemented~~Longduoduo’s asubsidiaries ~~1-for-10~~as ~~reverse split~~ of ~~its~~June ~~outstanding common stock~~30, ~~effective~~2025 atare ~~the~~listed ~~close~~as ~~of business on September 26, 2023. The accompanying financial statements have been adjusted to retroactively reflect this reverse stock split.~~follows:

Longduoduo’s subsidiaries include:

Name	Place of Incorporation	Attributable equity interest %		Authorized capital
Longduoduo Company Limited	Hong Kong		100	HK$	10,000
LDD Technology Limited	British Virgin Islands		100	$	100,000
LDDJK Hong Kong Limited	Hong Kong		100	HK$	10,000
Beijing Julong Health Consulting Co., Limited	China		100		0
Beijing Yihua Health Consulting Co., Limited	China		100		0
Longduoduo Health Technology Company Limited	China		100		0
Inner Mongolia Qingguo Health Consulting Company Limited	China		90		0
Inner Mongolia Rongbin Health Consulting Company Limited	China		80		0
Inner Mongolia Chengheng Health Consulting Company Limited	China		80		0
Inner Mongolia Tianju Health Consulting Company Limited	China		51		0

~~● Longduoduo Company Limited (Hong Kong) (“Longduoduo HK”), which was established on July 26, 2021 under the laws of Hong Kong~~C. Use ~~On October 26, 2021, Longduoduo issued 30,000,008 shares~~ of ~~its common stock to the original shareholders of Longduoduo HK, in exchange for 100% of the outstanding shares of Longduoduo HK (the “Share Exchange”).~~estimates

●The preparation ~~Longduoduo~~of ~~Health~~consolidated ~~Technology~~financial ~~Company~~statements ~~Limited~~in ~~(“Longduoduo~~conformity ~~Health~~with ~~Technology”),~~U.S. aGAAP ~~privately~~requires ~~held~~management ~~Limited~~to ~~Company~~make ~~registered~~estimates inand ~~Inner~~assumptions ~~Mongolia,~~that affect ~~China~~the onreported ~~August~~amounts 20of assets and liabilities, ~~2020.~~disclosure Onof ~~August~~contingent ~~16,~~assets ~~2021,~~and ~~Longduoduo~~liabilities HKat ~~acquired~~the ~~100%~~date of the ~~ownership~~financial statements, and the reported amounts of ~~Longduoduo~~revenue ~~Health~~and ~~Technology~~expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however, actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the ~~original~~inventory ~~shareholders~~valuation allowance and the treatment of ~~Longduoduo~~the ~~Health~~shares ~~Technology~~issued. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.

~~● Inner Mongolia Qingguo Health Consulting Company Limited (“Qingguo”), a privately held Limited Company registered in Inner Mongolia, China on June 18, 2020. On September~~ F-8~~, 2020, Longduoduo Health Technology acquired 90% of the ownership of Qingguo from the original shareholders of Qingguo.~~

●LONGDUODUO COMPANY ~~Inner~~LIMITED ~~Mongolia~~AND Rongbin Health Consulting Company Limited (“Rongbin”), a privately held Limited Company registered in Inner Mongolia, China on March 18, 2021. Longduoduo Health Technology has controlled 80% of the ownership of Rongbin since established.SUBSIDIARIES

●NOTES TO ~~Inner~~CONSOLIDATED ~~Mongolia~~FINANCIAL Chengheng Health Consulting Company Limited (“Chengheng”), a privately held Limited Company registered in Inner Mongolia, China on April 9, 2021. Longduoduo Health Technology has controlled 80% of the ownership of Chengheng since established.STATEMENTS

●FOR THE ~~Inner~~YEARS ~~Mongolia~~ENDED ~~Tianju~~JUNE ~~Health Consulting Company Limited (“Tianju”)~~30, a2025 ~~privately~~AND ~~held~~JUNE ~~Limited Company registered in Inner Mongolia~~30, ~~China on July 5, 2021. Longduoduo Health Technology has controlled 51% of Tianju since inception.~~2024

The transactions summarized above are treated in the Company’s financial statements as a corporate restructuring (reorganization) of entities under common control, as each of the seven entities have at all times been under the control of MrD. ~~Zhang Liang. Therefore, in accordance with ASC 805-50-45-5, the current~~ ~~capital~~Functional ~~structure~~currency ~~has been retroactively presented in prior periods as if such structure existed at that time,~~ and ~~the~~foreign ~~entities~~currency under common control are presented on a combined basis for all periods. Since all of the subsidiaries were under common control for all periods presented, the results of these subsidiaries are included in the Company’s financial statements for all periods presented. translation

FAn entity’s functional currency is the currency of the primary economic environment in which it operates, normally that is the currency of the environment in which the entity primarily generates and expends cash. Management’s judgment is essential to determine the functional currency by assessing various indicators, such as cash flows, sales price and market, expenses, financing and inter-9company transactions and arrangements. The functional currency of the Company is the Chinese Renminbi (“RMB’), except the functional currency of Longduoduo HK and LDDJK is the Hong Kong Dollar and the functional currency of Longduoduo and LDD is the United States Dollar (“US Dollars” or “$”). The reporting currency of these consolidated financial statements is in US Dollars.

~~LONGDUODUO~~The financial ~~COMPANY~~statements ~~LIMITED~~of ~~AND~~Longduoduo’s ~~SUBSIDIARIES~~subsidiaries, which are prepared using the RMB and HKD, are translated into the Company’s reporting currency, the US Dollar. Assets and liabilities are translated using the exchange rate at each reporting period end date. Revenue and expenses are translated using weighted average rates prevailing during each reporting period, and stockholders’ equity (deficit) is translated at historical exchange rates. Adjustments resulting from the translation are recorded as a separate component of accumulated other comprehensive income or expense.

~~NOTES~~Transactions denominated TOin ~~CONSOLIDATED~~currencies ~~FINANCIAL~~other ~~STATEMENTS~~than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transactions. Foreign currency exchange gains and losses resulting from these transactions are included in operations.

~~FOR~~The exchange ~~THE~~rates ~~YEARS~~used ~~ENDED~~for ~~JUNE~~foreign ~~30,~~currency ~~2024~~translation ~~AND~~are ~~JUNE~~as ~~30, 2023~~follows:

NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

		For the Years Ended June 30,
		2025		2024
		(USD to RMB/ USD to HKD)		(USD to RMB/ USD to HKD)
Assets and liabilities	period end exchange rate		7.1672/7.8499		7.2675/7.8081
Revenue and expenses	period weighted average		7.2145/7.7895		7.2107/7.8190

AE. Concentration ~~Going~~of ~~concern~~credit risk

The ~~accompanying consolidated financial statements~~ ~~have been prepared assuming that the~~ Company ~~will~~maintains ~~continue~~cash asin astate-owned ~~going~~banks ~~concern, which contemplates the realization of assets and liquidation of liabilities~~ in ~~the normal course of business~~China. AtIn ~~June 30~~China, ~~2023,~~ the ~~Company~~insurance ~~had~~coverage ~~cash~~ of ~~$1,136,562,~~each ~~negative~~bank ~~working~~is ~~capital of $733~~RMB500,~~781,~~000 (approximately ~~and a stockholders’ deficit of~~ USD$~~570~~70,~~655~~000). ~~For~~As ~~the~~of ~~year ended~~ June 30, ~~2023~~2025 and 2024, the Company had ~~net~~$1,130,547 and ~~income of~~ $21826,~~085.~~853 cash ~~The Company’s independent auditor included a going concern emphasis paragraph~~ in ~~its~~excess ~~audit~~of ~~report for~~ the ~~years~~insured ~~ended June 30~~amount, ~~2023 and June 30, 2022~~respectively.

~~Commencing~~For each ~~in the last quarter~~ of the ~~fiscal~~years ~~year~~ ended June 30, ~~2023,~~2025 ~~the~~and ~~Company changed its business plan to focus on resale of health care services offered by its contractor. At June 30,~~ 2024, ~~the~~one ~~Company~~customer ~~had~~accounted ~~cash~~for 97.2% ~~of $1,404,042, working capital of $395,609,~~ and ~~stockholders’ equity of $780,851~~95.6% ~~For the years ended June 30, 2024, the Company had net income~~ of ~~$1,363,278~~revenue. Although we cannot guarantee that we will continue to achieve profits in our operations, the initial results of the change in our business plan have reduced our doubts concerning the ability of the Company to continue as a going concern.

B.For the ~~Basis~~years ended June 30, 2025 and 2024, the Company had two and three major suppliers, respectively, that accounted for over 10% of ~~presentation~~its total cost of revenue.

The accompanying consolidated financial statements are expressed in U.S. Dollars and have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”).

	Year ended June 30, 2025					Year ended June 30, 2024
	Cost of revenue		Percentage of Cost of revenue			Cost of revenue		Percentage of Cost of revenue

Supplier A	$	29,666		33	%	$	57,358		33	%
Supplier B		38,502		42	%		31,216		18	%
Supplier C		-		-			63,663		37	%

CF. Cash ~~Principles~~and ofcash ~~consolidation~~equivalents

~~The~~Cash consists ~~consolidated~~of ~~financial~~cash ~~statements~~on ~~include~~hand and bank deposits, which are unrestricted as to withdrawal and use. All highly liquid investments with original ~~the~~stated ~~accounts~~maturity of ~~Longduoduo~~three months or less are classified as cash and ~~its~~cash ~~subsidiaries~~equivalents. ~~All~~Cash ~~significant~~equivalents ~~inter-company~~approximate ~~accounts~~or ~~and~~equal ~~transactions~~fair ~~have~~value due ~~been~~to ~~eliminated~~their short-term nature. The ~~consolidated financial~~Company’s ~~statements~~cash ~~include 100%~~and cash equivalents consist of ~~assets,~~cash ~~liabilities,~~on hand and ~~net~~cash ~~income~~in orbank ~~loss~~as of ~~these~~June ~~subsidiaries~~30, 2025 and 2024.

~~Longduoduo’s subsidiaries as of June 30, 2024 are listed as follows:~~F-9

Name	Place of Incorporation	Attributable equity interest %		Authorized capital
Longduoduo Company Limited	Hong Kong		100		HK$10,000
Longduoduo Health Technology Company Limited	China		100		0
Inner Mongolia Qingguo Health Consulting Company Limited	China		90		0
Inner Mongolia Rongbin Health Consulting Company Limited	China		80		0
Inner Mongolia Chengheng Health Consulting Company Limited	China		80		0
Inner Mongolia Tianju Health Consulting Company Limited	China		51		0

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

D.NOTES TO ~~Use~~CONSOLIDATED ofFINANCIAL ~~estimates~~STATEMENTS

~~The preparation of consolidated financial statements~~FOR inTHE ~~conformity~~YEARS ~~with~~ENDED ~~U.S.~~JUNE ~~GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities~~30, ~~disclosure~~ of2025 ~~contingent~~AND ~~assets~~JUNE ~~and liabilities at the date of the financial statements~~30, and the reported amounts of revenue and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however, actual results could differ from those estimates. Significant items subject to such estimates and assumptions include the inventory valuation allowance and the treatment of the shares issued. These estimates are often based on complex judgments and assumptions that management believes to be reasonable but are inherently uncertain and unpredictable. Actual results could differ from these estimates.2024

~~F-10~~G. Property and equipment

~~LONGDUODUO~~Property and ~~COMPANY~~equipment ~~LIMITED~~are ~~AND~~stated ~~SUBSIDIARIES~~at cost. Expenditures for maintenance and repairs are charged to operations when incurred, while additions and betterments are capitalized. Depreciation is recorded on a straight-line basis over the useful lives of the assets. When assets are retired or disposed, the asset’s original cost and related accumulated depreciation are eliminated from those accounts and any gain or loss is reflected in income.

~~NOTES~~The Company TOcapitalizes ~~CONSOLIDATED~~certain ~~FINANCIAL~~costs ~~STATEMENTS~~associated with the acquisition of software. Once the software is ready for its intended use, these costs are amortized on a straight-line basis over the software’s expected useful life.

~~FOR~~The estimated ~~THE~~useful ~~YEARS~~lives ~~ENDED~~for ~~JUNE~~property ~~30,~~and ~~2024~~equipment ~~AND~~categories ~~JUNE~~are ~~30, 2023~~as follows:

E. Functional currency and foreign currency translation

Office equipment and furniture		3 years
Leasehold Improvements		1-5 years

An entity’s functional currency is the currency of the primary economic environment in which it operates, normally that is the currency of the environment in which the entity primarily generates and expends cashH. ~~Management’s judgment is essential to determine the functional currency by assessing various indicators,~~ ~~such~~Intangible as cash flows, sales price and market, expenses, financing and inter-company transactions and arrangements. The functional currency of the Company is the Chinese Renminbi (“RMB’), except the functional currency of Longduoduo HK is the Hong Kong Dollar and the functional currency of Longduoduo is the United States Dollar (“US Dollars” or “$”). The reporting currency of these consolidated financial statements is in US Dollars.Assets

~~The~~Intangible assets ~~financial~~consist ~~statements~~ of ~~Longduoduo’s subsidiaries,~~software. ~~which~~Intangible assets are ~~prepared~~initially ~~using~~recognized ~~the~~at ~~RMB,~~their ~~are~~respective ~~translated~~acquisition ~~into~~costs. All of the Company’s ~~reporting currency, the US Dollar. Assets and~~ ~~liabilities~~intangible ~~are~~assets ~~translated~~have ~~using~~been ~~the~~determined ~~exchange~~to ~~rate~~have atfinite ~~each~~useful ~~reporting~~lives ~~period end date. Revenue~~ and ~~expenses~~ are, ~~translated using weighted average rates prevailing during each reporting period~~therefore, ~~and~~amortized ~~stockholders’~~using ~~equity~~the ~~(deficit)~~straight-line ismethod ~~translated at historical exchange rates.~~over ~~Adjustments~~their ~~resulting~~estimated ~~from~~useful ~~the translation are recorded as a separate component of accumulated other comprehensive income or expense.~~lives:

~~Transactions~~Software ~~denominated~~3 in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transactions. Foreign currency exchange gains and losses resulting from these transactions are included in operations.years

~~The exchange rates used for foreign currency translation~~I. ~~are~~Fair asvalue ~~follows:~~measurements

		For the Years Ended June 30,
		2024		2023
		(USD to RMB/ USD to HKD)		(USD to RMB/ USD to HKD)
Assets and liabilities	period end exchange rate		7.2675/7.8081		7.2556/7.8361
Revenue and expenses	period weighted average		7.2107/7.8190		6.9526/7.8370

The Company applies the provisions of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Section 820, Fair Value Measurements (“ASC 820”), for fair value measurements of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the financial statements. ASC 820 also establishes a framework for measuring fair value and expands disclosures about fair value measurements.

FFair value is defined as the price that would be received when selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ~~Concentration~~In ofdetermining ~~credit~~the ~~risk~~fair value for the assets and liabilities required or permitted to be recorded, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

~~The~~ASC 820 ~~Company~~establishes ~~maintains~~a ~~cash~~fair invalue ~~state-owned~~hierarchy ~~banks in~~that ~~China.~~requires Inan ~~China,~~entity to maximize the ~~insurance~~use ~~coverage~~of observable inputs and minimize the use of ~~each~~unobservable inputs ~~bank~~when ismeasuring ~~RMB500,000 (approximately~~fair ~~USD$69,000)~~value. AsASC 820 establishes three levels of ~~June~~inputs ~~30,~~that ~~2024~~may ~~and~~be ~~2023,~~used ~~the~~to measure fair value. The hierarchy gives ~~Company~~the ~~had~~highest ~~$826,853 and~~priority ~~$606,483 cash~~to unadjusted quoted prices in ~~excess~~active ofmarkets for identical assets or liabilities (Level 1 measurements) and the lowest ~~insured~~priority ~~amount,~~to ~~respectively~~measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:

~~For~~Level 1: ~~each~~Unadjusted ofquoted ~~the~~prices ~~years~~in ~~ended~~active ~~June~~markets ~~30,~~that ~~2024~~are ~~and 2023,~~accessible ~~one~~at ~~customer~~the ~~accounted~~measurement date for ~~99.9%~~ ofidentical, ~~commission~~unrestricted ~~revenue.~~assets or liabilities;

~~For~~Level 2: ~~the~~Quoted ~~years~~prices, ~~ended~~other ~~June~~than ~~30,~~those ~~2024~~in ~~and~~Level ~~2023~~1, ~~the Company~~in ~~had~~markets ~~three~~that ~~major~~are ~~suppliers~~not active, or inputs that ~~accounted~~are ~~for~~observable, ~~over 10%~~either ofdirectly ~~its~~or ~~total~~indirectly, for ~~cost~~substantially the full term of ~~revenue.~~the asset or liability,

	Year ended June 30, 2024					Year ended June 30, 2023
	Cost of revenue		Percentage of Cost of revenue			Cost of revenue		Percentage of Cost of revenue
Supplier A	$	57,358		33	%	$	263,812		45	%
Supplier B		31,216		18	%		90,380		15	%
Supplier C		63,663		37	%		120,646		20	%

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).

G.There were ~~Cash~~no ~~and~~transfers ~~cash~~between ~~equivalents~~level 1, level 2 or level 3 measurements for the years ended June 30, 2025 and 2024.

~~Cash~~Financial assets ~~consists~~and liabilities of ~~cash~~the onCompany ~~hand and bank deposits, which~~ are ~~unrestricted~~primarily ascomprised toof ~~withdrawal~~cash and ~~use.~~cash ~~All~~equivalents, ~~highly~~other ~~liquid~~receivables, ~~investments~~prepayments, ~~with~~due ~~original~~from related ~~stated~~parties, ~~maturity~~accounts ofpayable, ~~three~~deferred ~~months~~revenue, oraccrued ~~less~~expenses, ~~are classified~~due asto ~~cash~~related parties and ~~cash~~other ~~equivalents~~payables. ~~Cash~~As ~~equivalents~~of ~~approximate~~June or30, ~~equal fair value due to their short-term nature. The Company’s~~2025 ~~cash~~ and ~~cash~~2024, ~~equivalents~~the ~~consist~~carrying values of ~~cash~~these onfinancial ~~hand~~instruments ~~and~~approximated ~~cash~~their infair ~~bank~~values asdue ofto ~~June~~the ~~30,~~short-term ~~2024~~maturity ~~and~~of ~~2023~~these instruments.

F-1110

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, ~~2024~~2025 AND JUNE 30, ~~2023~~ 2024

HJ. Segment ~~Property~~information and ~~equipment~~geographic data

~~Property~~The Company ~~and~~is ~~equipment~~operating ~~are~~in ~~stated~~one atsegment ~~cost.~~in ~~Expenditures for~~accordance ~~maintenance~~with ~~and~~the ~~repairs~~accounting ~~are~~guidance ~~charged~~in toFASB ~~operations~~ASC ~~when~~Topic ~~incurred~~280, Segment ~~while additions and betterments are capitalized~~Reporting. ~~Depreciation is~~ ~~recorded~~The oncompany’s arevenues ~~straight-line~~are ~~basis~~from ~~over~~customers in the ~~useful~~People’s ~~lives~~Republic of ~~the~~China ~~assets~~(“PRC”). ~~When~~Substantially all assets of ~~are retired or disposed,~~ the ~~asset’s~~Company ~~original cost and related accumulated depreciation~~ are ~~eliminated~~located ~~from those accounts and any gain or loss is reflected~~ in ~~income~~the PRC.

~~The Company capitalizes certain costs associated with the acquisition of software~~K. ~~Once the software is ready for its intended use, these costs are amortized on a straight-line basis~~ ~~over~~Revenue ~~the software’s expected useful life.~~recognition

The Company ~~estimated~~adopted ~~useful~~FASB ~~lives~~ASC ~~for~~Section ~~property~~606 ~~and~~— ~~equipment~~Revenue from Contracts with Customers. Under ASC 606, the Company recognizes revenue from ~~categories~~the ~~are~~sales asof ~~follows~~products and services by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

Office equipment and furniture		3 years
Leasehold Improvements		1-5 years

The Company recognizes revenue when the amount of revenue can be reliably measured, it is probable that economic benefits will flow to the entity, and specific criteria have been met for each of the Company’s activities as described below.

~~I. Intangible Assets~~Service Revenue

~~Intangible~~The Company ~~assets~~sells ~~consist~~healthcare ofservice ~~software.~~packages ~~Intangible assets~~to ~~are~~customers, ~~initially~~which ~~recognized~~represent atthe ~~their~~rights ~~respective~~to ~~acquisition~~services ~~costs~~purchased by the Company. ~~All~~The delivery of ~~the~~a healthcare service package to a customer represents a separate performance obligation. The Company’s ~~intangible~~policy ~~assets~~is ~~have~~to recognize service revenue at that time when the healthcare service package has been ~~determined to~~sold, ownership and risk of loss have ~~finite~~been ~~useful~~transferred ~~lives~~to the customer, and ~~are,~~the ~~therefore~~service has been provided. Accordingly, ~~amortized~~revenue ~~using~~is recognized at the ~~straight-line~~point ~~method~~in ~~over~~time ~~their~~when ~~estimated~~the ~~useful~~service ~~lives:~~is provided. Service revenue is recognized when the healthcare service package has been delivered to the customer and there are no remaining performance obligations.

~~Software~~Management regularly 3reviews the sales returns and allowances based on historical experience. Any subsequent sales returns and cancellations are recognized upon notification from the customers. The liability for sales returns and allowances relating to the sale of healthcare service packages amounted to $208 and $923 as of June 30, 2025 and June 30, 2024, respectively. Management’s provision for sales returns and allowances was 1.60% and 1.13%, respectively, of the total service revenue for the years ended June 30, 2025 and 2024.

JThe Company typically collects fees before delivery of healthcare packages. ~~Fair~~Amounts ~~value~~received ~~measurements~~from a customer before the delivery of the healthcare package are recorded as deferred revenue on the Consolidated Balance Sheets.

~~The Company applies the provisions of the Financial~~Commission Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Section 820, Fair Value Measurements (“ASC 820”), for fair value measurements of financial assets and financial liabilities and for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the financial statements. ASC 820 also establishes a framework for measuring fair value and expands disclosures about fair value measurements.Revenue

~~Fair~~Commencing in ~~value~~the isthree ~~defined~~months asended June 30, 2023, the ~~price~~Company ~~that~~started ~~would be~~offering ~~received~~in ~~when~~a ~~selling~~sales anagent ~~asset~~capacity orhealthcare ~~paid~~service toand ~~transfer~~product packages of a ~~liability~~third-party inprovider. anThe ~~orderly~~third ~~transaction~~party ~~between~~is ~~market~~responsible ~~participants~~for atfulfillment of the ~~measurement date.~~services Into ~~determining~~ the ~~fair~~customer ~~value~~and ~~for~~ the ~~assets~~Company ~~and~~has ~~liabilities~~no ~~required~~performance commitment or ~~permitted~~liability to bethe ~~recorded,~~customer. ~~the~~The Company ~~considers~~receives deposits from the ~~principal or~~customers, ~~most~~remits ~~advantageous~~to ~~market~~the inthird-party ~~which~~provider itthe ~~would~~provider’s contracted ~~transact~~amounts, and itretains ~~considers~~the ~~assumptions~~remaining ~~that~~amounts ~~market~~as ~~participants~~commission ~~would~~revenue. ~~use~~The ~~when~~commission ~~pricing~~revenue ~~the~~is recognized upon acceptance of ~~asset~~the orcustomer ~~liability~~contract by the third-party provider and is presented on a net basis in the Statement of Operations and Comprehensive Income.

~~ASC 820 establishes a fair value hierarchy that~~Cost ~~requires an entity to maximize the use~~ of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes three levels of inputs that may be used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows:Revenues

~~Level~~Cost of 1:service ~~Unadjusted~~revenue ~~quoted~~consists ~~prices~~primarily inof ~~active~~the ~~markets that~~cost ~~are~~of ~~accessible~~healthcare atservice ~~the~~packages ~~measurement~~purchased ~~date~~from ~~for~~third ~~identical,~~party ~~unrestricted~~healthcare ~~assets~~service orproviders to ~~liabilities;~~fulfill contracts with customers.

~~Level~~Cost of 2:product ~~Quoted~~revenue ~~prices,~~consists ~~other~~primarily ~~than~~of ~~those~~the incost ~~Level 1,~~of inhealthcare ~~markets~~products ~~that~~purchased ~~are~~from ~~not~~suppliers. ~~active,~~Cost orof ~~inputs~~product ~~that~~revenue ~~are~~is ~~observable,~~recognized when ~~either~~the ~~directly~~product orhas ~~indirectly,~~been ~~for~~delivered ~~substantially~~to the ~~full term of the asset or liability,~~customer.

~~Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (supported by little or no market activity).~~F-11

~~There were no transfers between level 1, level~~LONGDUODUO 2COMPANY orLIMITED ~~level~~AND ~~3 measurements for the years ended June 30, 2024 and 2023.~~SUBSIDIARIES

~~Financial assets and liabilities of the Company~~NOTES ~~are~~TO ~~primarily~~CONSOLIDATED ~~comprised~~FINANCIAL of cash and cash equivalents, other receivables, accounts payable, accrued expenses, due to related parties, loan from third party, security deposits and other payables. As of June 30, 2024 and 2023, the carrying values of these financial instruments approximated their fair values due to the short-term maturity of these instruments.STATEMENTS

~~F-12~~FOR THE YEARS ENDED JUNE 30, 2025 AND JUNE 30, 2024

~~LONGDUODUO~~L. Income ~~COMPANY LIMITED AND SUBSIDIARIES~~taxes

~~NOTES~~The Company TOfollows ~~CONSOLIDATED~~FASB ~~FINANCIAL~~ASC ~~STATEMENTS~~Section 740, Income Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

~~FOR~~ASC 740-10-30 ~~THE~~requires ~~YEARS~~income ~~ENDED~~tax ~~JUNE~~positions ~~30,~~to ~~2024~~meet ~~AND~~a ~~JUNE~~more-likely-than-not recognition threshold to be recognized in the financial statements. Under ASC 740-10-30, tax positions that previously failed to meet the more-likely-than-not threshold should be recognized in the first ~~2023~~subsequent financial reporting period in which that threshold is met.

KThe application of tax laws and regulations is subject to legal and factual interpretation, judgment and uncertainty. ~~Segment~~Tax ~~information~~laws and ~~geographic~~regulations themselves ~~data~~are subject to change as a result of changes in fiscal policy, changes in legislation, the evolution of regulations and court rulings. Therefore, the actual liability may be materially different from our estimates, which could result in the need to record additional tax liabilities or potentially reverse previously recorded tax liabilities or the deferred tax asset valuation allowance.

~~The~~As a ~~Company~~result isof ~~operating~~the inimplementation ~~one~~of ~~segment~~ASC in740-10, ~~accordance with~~ the ~~accounting~~Company ~~guidance~~made ina ~~FASB~~comprehensive ~~ASC~~review ~~Topic~~of ~~280, Segment~~its ~~Reporting.~~portfolio ~~The~~of ~~company’s~~tax ~~revenues~~positions ~~are from customers~~ in accordance ~~the~~with ~~People’s~~recognition ~~Republic~~standards ofestablished ~~China~~by ~~(“PRC”)~~ASC 740-10. ~~Substantially~~The ~~all~~Company ~~assets~~recognized ofno ~~the~~material ~~Company~~adjustments ~~are~~to ~~located~~liabilities inor shareholder’s equity as a result of the ~~PRC~~implementation.

LM. Earnings ~~Revenue~~(loss) ~~recognition~~per share

The Company ~~adopted~~computes ~~FASB~~earnings ~~ASC~~(loss) ~~Section~~per ~~606~~share ~~— Revenue~~(“EPS”) ~~from~~in ~~Contracts~~accordance with ~~Customers. Under~~ ASC ~~606~~260, Earnings ~~the~~Per ~~Company~~Share. ~~recognizes~~ASC ~~revenue~~260 ~~from~~requires companies ~~the~~with ~~sales~~complex ofcapital ~~products~~structures ~~and~~to ~~services~~present bybasic ~~applying the~~and ~~following~~diluted ~~steps:~~EPS. ~~(1)~~Basic ~~identify~~EPS ~~the~~is ~~contract~~measured ~~with~~as anet ~~customer;~~income (2loss) ~~identify~~divided ~~the~~by ~~performance obligations in~~ the ~~contract; (3) determine~~ ~~the~~weighted ~~transaction~~average ~~price;~~common ~~(4)~~shares ~~allocate~~outstanding ~~the~~during ~~transaction price to each performance obligation in~~ the ~~contract; and (5) recognize revenue when each performance obligation is satisfied~~period.

~~The~~Diluted EPS ~~Company~~is ~~recognizes~~similar ~~revenue~~to ~~when~~basic EPS but presents the ~~amount~~ dilutive effect on a per share basis of ~~revenue~~contracts ~~can~~to beissue ~~reliably~~common ~~measured~~shares (e.g., itconvertible securities, isoptions ~~probable~~and ~~that~~warrants) ~~economic~~as ~~benefits~~if ~~will~~they ~~flow~~had tobeen converted at the ~~entity~~beginning of the periods presented, ~~and~~or ~~specific~~issuance ~~criteria~~date, ~~have~~if ~~been~~later. The ~~met~~computation of diluted EPS includes the estimated impact of the exercise of contracts to purchase common stock using the treasury ~~for~~stock ~~each~~method and the potential shares of converted common stock associated with the ~~Company’s~~convertible ~~activities~~debt asusing ~~described~~the ~~below~~if-converted method. Potential common shares that have an anti-dilutive effect (i.e., those that increase earnings per share or decrease loss per share) are excluded from the calculation of diluted EPS.

~~Service~~On February ~~Revenue~~19, 2025, Longduoduo issued 10,020 shares of its common stock to the original shareholders of LDD, in exchange for 100% of the outstanding shares of LDD.

~~The Company sells healthcare service packages to customers, which represent the rights to services purchased by the Company~~N. ~~The delivery of a healthcare service package to a customer~~ ~~represents~~Recently aadopted ~~separate~~accounting performance obligation. The Company’s policy is to recognize service revenue at that time when the healthcare service package has been sold, ownership and risk of loss have been transferred to the customer, and the service has been provided. Accordingly, revenue is recognized at the point in time when the service is provided. Service revenue is recognized when the healthcare service package has been delivered to the customer and there are no remaining performance obligations.pronouncements

~~Management regularly reviews the sales returns~~We ~~and~~do ~~allowances~~not ~~based~~believe onthat ~~historical~~any ~~experience.~~recently ~~Any~~issued ~~subsequent~~but ~~sales~~not ~~returns~~yet ~~and~~effective ~~cancellations~~accounting ~~are recognized upon notification from the customers. The liability for sales returns and allowances relating to the sale of healthcare service packages amounted to $923 and $15~~standards,~~406 as~~ ofif ~~June~~currently 30adopted, ~~2024~~would ~~and~~have ~~June~~a ~~30,~~material ~~2023,~~effect on ~~respectively.~~the ~~Management~~Company’s ~~provision~~consolidated ~~for~~financial ~~sales returns and allowances was 1.13% and 1.85%~~position, ~~respectively,~~statements of ~~the~~operations ~~total service revenue for the years ended June 30, 2024~~ and ~~2023~~cash flows.

~~For a brief period during the year ended June~~NOTE ~~30, 2023, the Company also sold healthcare products in packages with healthcare services~~3. Product revenue resulted from the sale of healthcare and nutritional products, including Collagen peptide, Calcium tablets and other products. The Company recognized revenue when the product had been delivered and ownership and risk of loss had been transferred to the customer. The Company accepts returns provided the products are well packaged and can be resold. Management regularly reviews the sales returns and allowances based on historical experience. The liability for sales returns and allowances relating to the sale of healthcare products amounted to $0 and $229 as of June 30, 2024 and June 30, 2023, respectively. Management’s provision for sales returns and allowances was 0% and 1.26%, respectively, of the total product revenue for the year ended June 30, 2024 and 2023. The Company terminated its sales of healthcare products during the year ended June 30, 2023.PREPAYMENTS

~~The~~Prepayments primarily ~~Company~~include ~~typically~~prepaid ~~collects~~expenses, ~~fees~~equipment, ~~before~~leasing ~~delivery of~~and ~~healthcare~~products ~~packages.~~in ~~Amounts~~advance ~~received~~to ~~from~~suppliers. aAs ~~customer before the delivery~~ of ~~the~~June ~~healthcare~~30, ~~package~~2025 ~~are~~and ~~recorded~~2024, asprepayments and deferred ~~revenue on~~expenses ~~the~~were ~~Consolidated~~$133,610 and ~~Balance~~$124,427, ~~Sheets~~respectively.

~~Commission Revenue~~F-12

~~Commencing in the three months ended June 30,~~LONGDUODUO ~~2023,~~COMPANY ~~the~~LIMITED ~~Company~~AND started offering in a sales agent capacity healthcare service and product packages of a third-party provider. The third party is responsible for fulfillment of the services to the customer and the Company has no performance commitment or liability to the customer. The Company receives deposits from the customers, remits to the third-party provider the provider’s contracted amounts, and retains the remaining amounts as commission revenue. The commission revenue is recognized upon acceptance of the customer contract by the third-party provider and is presented on a net basis in the Statement of Operations and Comprehensive Income (Loss).SUBSIDIARIES

~~Cost~~NOTES TO ofCONSOLIDATED ~~Revenues~~FINANCIAL STATEMENTS

~~Cost of service revenue consists primarily of~~FOR ~~the~~THE ~~cost~~YEARS ofENDED ~~healthcare~~JUNE ~~service~~30, ~~packages~~2025 ~~purchased~~AND ~~from~~JUNE ~~third~~30, ~~party healthcare service providers to fulfill contracts with customers.~~2024

~~Cost of product revenue consists primarily of~~NOTE ~~the cost of healthcare products purchased from suppliers~~4. ~~Cost~~PROPERTY ofAND ~~product revenue is recognized when the product has been delivered to the customer.~~EQUIPMENT

~~F-13~~At June 30, 2025 and 2024, property and equipment, at cost, consisted of:

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

	June 30,		June 30,
	2025		2024

Office equipment and furniture	$	452,187	$	461,562
Leasehold improvement		70,404		40,506
Total		522,591		502,068
Accumulated depreciation		242,588		148,582
Total property and equipment, net	$	280,003	$	353,486

~~NOTES~~The Company TOrecorded ~~CONSOLIDATED~~depreciation ~~FINANCIAL~~expense ~~STATEMENTS~~of $137,290 for the year ended June 30, 2025, of which $127,864 was recorded as operating expense and $9,426 was recorded as cost of revenue.

~~FOR~~The Company ~~THE~~recorded ~~YEARS~~depreciation ~~ENDED~~expense ~~JUNE~~of 30$102,032 for ~~2024~~the ~~AND~~year ~~JUNE~~ended June 30, 2024, of which $92,492 was recorded ~~2023~~as operating expense and $9,540 was recorded as cost of revenue.

M.The Company ~~Income~~disposed ~~taxes~~of fully depreciated assets with a total value of $46,271 for the year ended June 30, 2025.

~~The Company follows FASB ASC Section 740, Income~~NOTE ~~Taxes, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements or tax returns~~5. ~~Under~~RELATED ~~this~~PARTY method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.TRANSACTIONS

~~ASC 740-10-30 requires income tax positions to~~Due ~~meet a more-likely-than-not recognition threshold~~ to berelated recognized in the financial statements. Under ASC 740-10-30, tax positions that previously failed to meet the more-likely-than-not threshold should be recognized in the first subsequent financial reporting period in which that threshold is met.parties

~~The application of tax laws and regulations is~~Due ~~subject~~ to ~~legal~~related ~~and~~parties ~~factual~~consists ~~interpretation, judgment and uncertainty. Tax laws and regulations themselves are subject to change as a result~~ of ~~changes in fiscal policy, changes in legislation,~~ the evolution of regulations and court rulings. Therefore, the actual liability may be materially different from our estimates, which could result in the need to record additional tax liabilities or potentially reverse previously recorded tax liabilities or the deferred tax asset valuation allowance.following:

As a result of the implementation of ASC 740-10, the Company made a comprehensive review of its portfolio of tax positions in accordance with recognition standards established by ASC 740-10. The Company recognized no material adjustments to liabilities or shareholder’s equity as a result of the implementation.

Name of related party	June 30, 2025		June 30, 2024
Zhang Liang	$	408	$	2,233
Total	$	408	$	2,233

NUntil November 29, 2023, Zhang Liang was the President and Chairman of the Board of Longduoduo. ~~Earnings~~Mr. ~~(loss)~~Zhang ~~per~~Liang ~~share~~controls approximately 51.3% of Longduoduo’s issued and outstanding common stock. These advances due to related parties are unsecured, repayable on demand, and bear no interest.

~~The~~Related ~~Company~~parties’ computes earnings (loss) per share (“EPS”) in accordance with ASC 260, Earnings Per Share. ASC 260 requires companies with complex capital structures to present basic and diluted EPS. Basic EPS is measured as net income (loss) divided by the weighted average common shares outstanding during the period.transactions

~~Diluted~~Related ~~EPS~~parties’ istransactions ~~similar~~consists ~~to basic EPS but presents the dilutive effect on a per share basis~~ of ~~contracts to issue common shares (e.g., convertible securities, options and warrants) as if~~ ~~they had been converted at~~ the beginning of the periods presented, or issuance date, if later. The computation of diluted EPS includes the estimated impact of the exercise of contracts to purchase common stock using the treasury stock method and the potential shares of converted common stock associated with the convertible debt using the if-converted method. Potential common shares that have an anti-dilutive effect (i.e., those that increase earnings per share or decrease loss per share) are excluded from the calculation of diluted EPS. As of June 30, 2024 and 2023, the Company was not party to any contract to issue shares.following:

O. Recently adopted accounting pronouncements

	For the year ended June 30,
Name of related parties	2025		2024
Zhang Liang	$	8,630	$	(105,918	)
Total	$	8,630	$	(105,918	)

~~We do not believe that any recently issued but~~NOTE ~~not~~6. ~~yet~~INCOME ~~effective accounting standards, if currently adopted, would have a material effect on the Company’s consolidated financial position, statements of operations and cash flows.~~TAXES

~~NOTE 3. PREPAYMENTS~~United States

~~Prepayments primarily include prepaid expenses,~~Longduoduo ~~equipment,~~is ~~leasing~~subject ~~and products in advance~~ to ~~suppliers~~the U.S. Ascorporation oftax ~~June~~rate ~~30, 2024 and 2023, prepayments and deferred expenses were $124,427~~of ~~and $68,341, respectively~~21%.

~~F-14~~British Virgin Islands

~~LONGDUODUO~~The ~~COMPANY~~Company’ ~~LIMITED~~subsidiary, ~~AND~~LDD, ~~SUBSIDIARIES~~is incorporated in the BVI and is not subject to tax on income or capital gain. In addition, payments of dividends by LDD to its shareholders are not subject to withholding tax in the BVI.

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~Hong Kong

~~FOR~~Longduoduo ~~THE~~HK ~~YEARS~~and ~~ENDED~~LDDJK ~~JUNE~~are 30incorporated in Hong Kong and are subject to Hong Kong profits tax. They are subject to Hong Kong taxation on its activities conducted in Hong Kong and income arising in or derived from Hong Kong. From year of assessment of 2019/2020 onwards, ~~2024~~Hong ~~AND~~Kong ~~JUNE~~profits 30tax rates are 8.25% on assessable profits up to HK$2,000,000, and 16.5% on any part of assessable profits over HK$2,000,000. The Company did not have any income (loss) ~~2023~~subject to the Hong Kong profits tax.

~~NOTE 4. PROPERTY AND EQUIPMENT~~F-13

~~At June 30, 2024 and 2023, property and equipment,~~LONGDUODUO atCOMPANY ~~cost,~~LIMITED ~~consisted~~AND ~~of:~~SUBSIDIARIES

	June 30,		June 30,
	2024		2023
Office equipment and furniture	$	461,562	$	204,645
Leasehold improvement		40,506		72,026
Total		502,068		276,671
Accumulated depreciation		148,582		123,952
Total property and equipment, net	$	353,486	$	152,719

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

~~The Company recorded depreciation expense of $102,032 for~~FOR ~~the~~THE ~~year~~YEARS ~~ended~~ENDED ~~June~~JUNE 30, ~~2024, of which~~2025 ~~$92,492 was~~AND ~~recorded~~JUNE ~~as operating expense and $9~~30,~~540 was~~ ~~recorded as cost of revenue.~~2024

~~The Company recorded depreciation expense of $67,738 for the year ended June 30, 2023, of which $59,745 was recorded as operating expense and $7,993 was recorded as cost of revenue.~~China

~~NOTE~~Julong 5and its subsidiaries are subject to a 25% standard enterprise income tax in the PRC. ~~RELATED~~If ~~PARTY~~the ~~TRANSACTIONS~~taxable income in the calendar year does not exceed RMB 3 million, only 25% of the taxable income will be included in the tax base, which is then subject to a preferential tax rate of 20%. The Company accrued $222,268 and $523,207 of PRC income tax for the years ended June 30, 2025 and 2024.

~~Due~~A summary toof ~~related~~income ~~parties~~(loss) before income taxes for domestic and foreign locations for the years ended June 30, 2025 and 2024 is as follows:

Due to related parties consists of the following:

	For the year ended June 30,
	2025			2024
United States	$	(219,614	)	$	(200,515	)
Foreign		934,142			2,087,000
Total Income before income taxes	$	714,528		$	1,886,485

Name of related party	June 30, 2024		June 30, 2023
Zhang Liang	$	2,233	$	69,419
Zhou Hongxiao		-		35,192
Total	$	2,233	$	104,611

The difference between the U.S. federal statutory income tax rate and the Company’s effective tax rate was as follows:

Until November 29, 2023, Zhang Liang was the President and Chairman of the Board of Longduoduo. Mr. Zhang Liang controls approximately 51% of Longduoduo’s issued and outstanding common stock. Zhou Hongxiao is the CEO and a director of Longduoduo. These advances due to related parties are unsecured, repayable on demand, and bear no interest.

	For the year ended
	June 30,			June 30,
	2025			2024
Income tax (benefit) at USA statutory rate		21	%		21	%
U.S. valuation allowance		(21	)%		(21	)%
Income tax (benefit) at USA effective rate		0	%		0	%

~~NOTE~~The difference 6.between ~~INCOME~~the ~~TAXES~~PRC statutory income tax rate and the PRC effective tax rate was as follows:

United States

	For the year ended June 30,
	2025			2024
Income tax (benefit) at PRC statutory rate		25	%		25	%
Utilization of net operating loss carry forward		-			(1	)%
Tax preference		(10.2	)%		-
PRC valuation allowance		3	%		1	%
Income tax (benefit) at PRC effective rate		17.8	%		25	%

~~Longduoduo~~The Company did not recognize deferred tax assets since it is ~~subject~~not more likely than not that it will realize such deferred taxes. The deferred tax would apply to Longduoduo in the U.S. ~~corporation~~ ~~tax~~and ~~rate~~Julong ~~of 21%~~and subsidiaries in China.

~~Hong~~As ~~Kong~~of June 30, 2025, Julong and its subsidiaries had total net operating loss carry forwards of approximately $414,846 in the PRC that expire through 2030. Due to the uncertainty of utilizing these carry forwards, the Company provided a 100% allowance on all deferred tax assets of approximately $103,712 and $9,696 related to its operations in the PRC as of June 30, 2025 and 2024, respectively. The PRC valuation allowance has increased by $ 94,016 and decreased by $77,798 for the years ended June 30, 2025 and 2024, respectively.

~~Longduoduo~~The Company ~~HK was~~incurred ~~incorporated~~losses infrom ~~Hong~~its ~~Kong and~~United isStates ~~subject~~operations toduring ~~Hong~~the ~~Kong~~year ~~profits~~ended ~~tax~~June 30, 2025 of approximately $219,614. ~~Longduoduo~~The HKCompany’s United isStates ~~subject~~operations toconsist ~~Hong~~solely ~~Kong~~of ~~taxation~~ownership onof its ~~activities~~foreign ~~conducted~~subsidiaries, inand ~~Hong~~the ~~Kong~~losses ~~and~~arise ~~income~~from administration expenses. ~~arising~~Accordingly, inmanagement orprovided ~~derived~~a 100% ~~from~~valuation ~~Hong~~allowance ~~Kong.~~of approximately $259,555 ~~The~~and ~~applicable~~$199,817 against ~~statutory~~the deferred tax ~~rate~~assets ~~is 16.5%.~~related ~~The~~to the Company’s ~~did~~United ~~not~~States ~~have~~operations ~~any~~as ~~income~~of ~~(loss)~~June 30, 2025 and 2024, respectively, because the deferred tax ~~subject~~benefits of the net operating loss carry forwards in the United States are not likely to be utilized. The US valuation allowance has increased by approximately $59,738 and $28,490 for the ~~Hong~~years ~~Kong~~ended ~~profits~~June ~~tax~~30, 2025, and 2024, respectively.

The Company is subject to examination by the Internal Revenue Service (IRS) in the United States as well as by the taxing authorities in China, where the Company has significant business operations. The table below presents the earliest tax year that remains subject to examination by major jurisdiction.

Longduoduo Health Technology and subsidiaries are subject to a 25% standard enterprise income tax in the PRC. The Company accrued $523,207 and $10,246 of PRC income tax for the year ended June 30, 2024 and 2023.

		Earliest tax year that remains subject to examination
U.S. Federal		June 30, 2021
China		June 30, 2020

~~F-15~~NOTE 7. LEASES

~~LONGDUODUO~~On April ~~COMPANY~~1 ~~LIMITED~~of ~~AND~~2024, ~~SUBSIDIARIES~~Tianju leased office space (approximately 595 square meters) under an operating lease agreement with Sun Xueqin. Under the terms of the agreement, Tianju is committed to make lease payments of approximately $19,000 (RMB137,000) annually for the period between April 1, 2024 and March 31, 2027.

~~NOTES TO CONSOLIDATED FINANCIAL STATEMENTS~~F-14

~~FOR~~LONGDUODUO COMPANY ~~THE~~LIMITED ~~YEARS ENDED JUNE 30, 2024~~ AND ~~JUNE 30, 2023~~SUBSIDIARIES

~~A summary of income (loss) before income taxes~~NOTES ~~for~~TO ~~domestic~~CONSOLIDATED ~~and~~FINANCIAL ~~foreign locations for the years ended June 30, 2024 and 2023 is as follows:~~STATEMENTS

	For the year ended June 30,
	2024			2023
United States	$	(200,515	)	$	(586,688	)
Foreign		2,087,000			618,019
Total Income before income taxes	$	1,886,485		$	31,331

FOR THE YEARS ENDED JUNE 30, 2025 AND JUNE 30, 2024

~~The~~On ~~difference~~August ~~between~~14, ~~the~~2024, UQingguo leased office space (approximately 482 square meters) under an operating lease agreement with Inner Mongolia Chuangfuhui Enterprise Management Co.S, Ltd. ~~federal~~Under ~~statutory~~the terms of the agreement, Qingguo was committed to make lease payments of approximately $30,700 (RMB 220,000) ~~income~~for ~~tax~~the ~~rate~~period between September 10, 2024 and September 9, 2025. On September 19, 2025, Qingguo with Chen Mingyue signed an agreement leased this office space under non-cancellable operating lease agreements. Under terms of the ~~Company’s~~lease ~~effective~~agreement, ~~tax~~from ~~rate~~September ~~was~~10, as2025, Qingguo ~~follows:~~is committed to make lease payments of approximately $30,695 per year for 1 year.

	For the year ended
	June 30,			June 30,
	2024			2023
Income tax (benefit) at USA statutory rate		(21	)%		(21	)%
U.S. valuation allowance		21	%		21	%
Income tax (benefit) at USA effective rate		(0	)%		(0	)%

On November 20, 2024, Chengheng leased an office space (approximately 611 square meters) under an operating lease agreement from Dongsheng District Baiyan Health Consultation Department. Under the terms of the agreement, Chengheng is committed to make lease payments of approximately $16,700 (RMB120,000) for the period between November 20, 2024 and November 20, 2025.

~~The~~On March ~~difference~~11 ~~between~~of ~~the~~2025, ~~PRC~~Longduoduo ~~statutory~~Health ~~income~~Technology leased office space (approximately 160 square meters) under an operating lease agreement ~~tax~~with ~~rate~~Liu ~~and~~Libao. Under the ~~PRC~~terms ~~effective~~of ~~tax~~the ~~rate~~agreement, ~~was~~Longduoduo asHealth ~~follows:~~Technology is committed to make lease payments of approximately $4,200 (RMB30,000) for the period between March 11, 2025 and March 10, 2026.

	For the year ended June 30,
	2024			2023
Income tax (benefit) at PRC statutory rate		25	%		(25	)%
Utilization of net operating loss carry forward		(1	)%		(23	)%
PRC valuation allowance		1	%		-
Income tax (benefit) at PRC effective rate		25	%		2	%

Leases with an initial term of 12 months or less are not recorded on the balance sheet. Operating lease cost is recognized as a single lease cost on a straight-line basis over the lease term and is recorded in selling, general and administrative expenses. For lease agreements entered into or reassessed after the adoption of Topic 842, the Company did not combine lease and non-lease components.

~~The~~Most ~~Company~~leases ~~did~~do not ~~recognize~~include ~~deferred~~options ~~tax~~to ~~assets~~renew. ~~since~~The itexercise isof ~~not~~lease ~~more~~renewal ~~likely~~options ~~than~~has ~~not~~to ~~that~~be itagreed ~~will~~to ~~realize~~by ~~such~~the ~~deferred taxes~~lessors. The ~~deferred~~depreciable ~~tax~~life ~~would~~of ~~apply~~assets toand ~~Longduoduo~~leasehold inimprovements are limited by the Uterm of leases, unless there is a transfer of title or purchase option reasonably certain of exercise.S. Lease expense is ~~and~~recognized ~~Longduoduo~~on ~~Health~~a ~~Technology~~straight-line basis over the term of the lease. Lease expense related to these noncancelable operating leases was $63,345 and $58,790 for ~~subsidiaries~~the inyears ~~China~~ended June 30, 2025 and 2024, respectively.

~~As of June 30, 2024, Longduoduo Health Technology~~Balance ~~and~~sheet ~~its~~information ~~subsidiaries~~related ~~have total net operating loss carry forwards of approximately $430,356 in the PRC that expire through 2029. Due~~ to the ~~uncertainty of utilizing these carry forwards, the~~ Company’s ~~provided~~leases ~~a 100%~~is ~~allowance~~presented on all deferred tax assets of approximately $9,696 and $87,494 related to its operations in the PRC as of June 30, 2024 and 2023, respectively. The PRC valuation allowance has decreased by $77,798 and decreased by $151,427 for the years ended June 30, 2024 and 2023, respectively.below:

The Company has incurred losses from its United States operations during the year ended June 30, 2024 of approximately $200,515. The Company’s United States operations consist solely of ownership of its foreign subsidiaries, and the losses arise from administration expenses. Accordingly, management provided a 100% valuation allowance of approximately $199,817 and $171,327 against the deferred tax assets related to the Company’s United States operations as of June 30, 2024 and 2023, respectively, because the deferred tax benefits of the net operating loss carry forwards in the United States are not likely to be utilized. The US valuation allowance has increased by approximately $28,490 and $123,204 for the years ended June 30, 2024, and 2023, respectively.

	June 30, 2025		June 30, 2024
Assets
Operating lease right of use assets	$	32,906	$	50,070
Liabilities
Operating lease liabilities – current	$	18,570	$	17,618
Operating lease liabilities – non-current		-		18,314
Total Operating lease liabilities	$	18,570	$	35,932

~~The Company is subject to examination by the Internal~~Other ~~Revenue~~information ~~Service~~related ~~(IRS) in the United States as well as by the taxing authorities in China, where the Company has significant business operations. The table below presents the earliest tax year that remains subject~~ to ~~examination~~leases byis ~~major~~presented ~~jurisdiction.~~ below:

	Earliest tax year that remains subject to examination
	For the year ended June 30,
U.S. Federal	June 30, 2021
	2025			2024
China	June 30, 2020
Cash Paid for Amounts Included in Measurement of Liabilities:
Operating cash flows used in operating leases	$	18,990		$	14,250
Weighted Average Remaining Lease Term:
Operating leases		1.75 years			2.75 years
Weighted Average Discount Rate
Operating leases		3.95	%		3.95	%

~~NOTE~~As most 7of the Company’s leases do not provide an implicit rate, the Company uses 1-5 years borrowing rate from bank of 3.95% based ~~LEASES~~on the information available at commencement date in determining the present value of lease payments.

~~On August 31, 2023, Qingguo leased office space~~Maturities ~~(approximately 482 square meters) under an operating lease agreement with Inner Mongolia Chuangfuhui Enterprise Management Co., Ltd. Under the terms~~ of ~~the agreement, Qingguo is committed to make~~ lease ~~payments~~liabilities ofare ~~approximately~~as ~~$30,510 (RMB 220,000) for the period between September 10, 2023 and September 10, 2024.~~follows:

On June 1, 2024, Chengheng leased an office space (approximately 451 square meters) under an operating lease agreement from Ding Jun. Under the terms of the agreement, Chengheng is committed to make lease payments of approximately $2,774 (RMB20,000)for the period between June 1, 2024 and May 31, 2025.

For the year ending June 30:
2026	$	19,115
Total lease payments		19,115
Less: imputed interest		(545	)
Total lease liabilities	$	18,570

F-1615

LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEARS ENDED JUNE 30, ~~2024~~2025 AND JUNE 30, ~~2023~~ 2024

~~On March 10 of 2024, Longduoduo Health Technology~~NOTE ~~leased office space (approximately 150 square meters) under an operating lease agreement with Liu Libao~~8. ~~Under the terms of the agreement, Longduoduo Health Technology is committed to make lease payments of approximately $4,160 (RMB30,000) for the period between March 10, 2024 and March 10, 2025.~~CONTINGENCIES

On April 1 of 2024, Tianju leased office space (approximately 595 square meters) under an operating lease agreement with Han Ruijun. Under the terms of the agreement, Tianju is committed to make lease payments of approximately $19,000 (RMB137,000) annually for the period between April 1, 2024 and March 31, 2027.Contingencies

~~Leases~~Certain conditions ~~with~~may anexist ~~initial~~as ~~term~~ of 12the ~~months~~date orthe ~~less~~ consolidated financial statements are ~~not~~issued ~~recorded~~which onmay result in a loss to the ~~balance~~Company ~~sheet.~~but ~~Operating~~which will ~~lease~~only ~~cost~~be isresolved ~~recognized~~when asone aor ~~single~~more ~~lease~~future ~~cost~~events onoccur aor ~~straight-line~~fail ~~basis~~to ~~over~~occur. ~~the~~The ~~lease term~~Company’s management and islegal ~~recorded~~counsel inassess such ~~selling~~contingent liabilities, ~~general~~ and ~~administrative~~such ~~expenses~~assessment inherently involves an exercise of judgment. ~~For~~In ~~lease~~assessing ~~agreements~~loss ~~entered~~contingencies ~~into~~related to legal proceedings that are pending against the Company or ~~reassessed~~unasserted ~~after~~claims that may result in such proceedings, the ~~adoption~~Company’s legal counsel evaluates the perceived merits of ~~Topic~~any ~~842,~~legal proceedings or unasserted claims as well as the ~~Company~~perceived ~~did~~merits ~~not~~of ~~combine~~the ~~lease~~amount of ~~and~~relief ~~non-lease~~sought ~~components~~or expected to be sought.

~~Most~~If the ~~leases~~assessment doof ~~not~~a ~~include~~contingency ~~options~~indicates tothat ~~renew.~~it ~~The exercise~~is ofprobable ~~lease~~that ~~renewal~~a ~~options~~material loss has tobeen beincurred ~~agreed~~and tothe byamount of the ~~lessors.~~liability can ~~The~~be ~~depreciable~~estimated, ~~life~~then ofthe ~~assets~~estimated ~~and~~liability ~~leasehold~~would ~~improvements~~be ~~are~~accrued ~~limited by~~in the ~~term~~Company’s offinancial ~~leases,~~statements. ~~unless~~If ~~there~~the isassessment indicates that a ~~transfer~~potential ofmaterial ~~title~~loss orcontingency ~~purchase~~is ~~option~~not ~~reasonably~~probable ~~certain~~but ofis ~~exercise.~~reasonably ~~Lease~~possible, ~~expense~~or is ~~recognized on~~probable abut ~~straight-line~~cannot ~~basis~~be ~~over~~estimated, then the nature ~~term~~ of the ~~lease.~~contingent ~~Lease~~liability, ~~expense~~together ~~related~~with toan ~~these~~estimate ~~noncancelable~~of ~~operating~~the ~~leases~~range ~~was~~of ~~$65,724 and $73,147 for~~possible ~~the~~loss ~~years~~if ~~ended~~determinable ~~June~~and ~~30,~~material ~~2024~~would ~~and~~be ~~2023, respectively~~disclosed.

~~Balance~~Loss contingencies ~~sheet~~considered ~~information~~to ~~related~~be toremote by management are generally not disclosed unless they involve guarantees, in which case the ~~Company’s~~guarantee ~~leases~~would isbe ~~presented below:~~disclosed.

	June 30, 2024		June 30, 2023
Assets
Operating lease right of use assets	$	50,070	$	13,470
Liabilities
Operating lease liabilities – current	$	17,618	$	6,579
Operating lease liabilities – non-current		18,314		6,891
Total Operating lease liabilities	$	35,932	$	13,470

The Company was not subject to any material loss contingency as of June 30, 2025 and 2024.

~~Other~~NOTE 9. ~~information~~STOCKHOLDERS’ ~~related to leases is presented below:~~EQUITY

	For the year ended June 30,
	2024			2023
Cash Paid for Amounts Included in Measurement of Liabilities:
Operating cash flows used in operating leases	$	14,250		$	21,575
Weighted Average Remaining Lease Term:
Operating leases		2.75 years			2 years
Weighted Average Discount Rate
Operating leases		3.95	%		4.75	%

On September 21, 2023, the Company filed with the Nevada Secretary of State a Certificate of Change Pursuant to NRS 78.209. The Certificate of Change provided for a 1-for-10 reverse split of the Registrant’s outstanding common stock effective at the close of business on September 26, 2023. The Certificate of Change did not change the number of authorized shares of Common Stock, which remains 500,000,000 shares. No fractional shares were issued in connection with the reverse stock split; any fractional shares that resulted from the reverse split were rounded up to the nearest whole share. The accompanying financial statements have been adjusted to retroactively reflect this reverse stock split.

~~As most of the Company’s leases do not provide~~Share anexchange ~~implicit~~under ~~rate,~~common ~~the Company uses 1-5 years borrowing rate from bank of 3.95% and 4.75% based on the information available at commencement date in determining the present value of lease payments.~~control

~~Maturities~~On February 19, 2025, Longduoduo issued 10,020 shares of ~~lease~~its ~~liabilities~~common ~~are~~stock to the original shareholders of LDD, in exchange for 100% of the outstanding shares of LDD. This transaction is treated as ~~follows:~~a corporate restructuring (reorganization) of entities under common control, as each of the entities have at all times been under the control of Mr. Zhang Liang.

For the year ending June 30:
2025	$	18,851
2026		18,851
Total lease payments		37,702
Less: imputed interest		(1,770	)
Total lease liabilities	$	35,932

F-16

~~F-17~~LONGDUODUO COMPANY LIMITED AND SUBSIDIARIES

~~LONGDUODUO~~NOTES TO ~~COMPANY~~CONSOLIDATED ~~LIMITED~~FINANCIAL ~~AND SUBSIDIARIES~~STATEMENTS

~~NOTES~~FOR THE TOYEARS ~~CONSOLIDATED~~ENDED ~~FINANCIAL~~JUNE ~~STATEMENTS~~30, 2025 AND JUNE 30, 2024

~~FOR~~NOTE 10. ~~THE~~BASIC ~~YEARS~~AND ~~ENDED~~DILUTED ~~JUNE~~EARNINGS ~~30,~~PER ~~2024 AND JUNE 30, 2023~~SHARE

~~NOTE~~Basic 8net income per share is computed using the weighted average number of common shares outstanding during the period. ~~CONTINGENCIES~~Diluted net income per share is computed using the weighted average number of common shares and, if dilutive, potential common shares outstanding during the period. Potential common shares comprise shares issuable upon the exercise of share-based awards, using the treasury stock method. The reconciliation of the numerators and denominators of the basic and diluted earnings per share computations is shown as follows:

Contingencies

	For the year ended June 30,
	2025		2024
Numerator:
Net income attributable to common stockholders	$	460,435	$	1,255,448
Denominator:
Basic and diluted weighted-average number of shares outstanding		30,009,878		30,005,016
Net income per share:
Basic and diluted	$	0.015	$	0.042

~~Certain conditions may exist as of the date the~~NOTE ~~consolidated financial statements are issued which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur~~11. ~~The~~NON-CONTROLLING Company’s management and legal counsel assess such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or unasserted claims that may result in such proceedings, the Company’s legal counsel evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.INTERESTS

~~If the assessment of a contingency indicates that~~Qingguo, itChengheng, isRongbin ~~probable that a material loss has been incurred~~ and ~~the~~Tianju ~~amount~~are of the ~~liability~~Company’s ~~can~~majority-owned besubsidiaries ~~estimated,~~which ~~then~~are ~~the~~consolidated ~~estimated liability would be accrued~~ in the Company’s financial statements. Ifwith ~~the~~non-controlling ~~assessment~~interests ~~indicates~~recognized. ~~that~~The aCompany ~~potential material loss contingency is not probable but is reasonably possible~~holds 90%, ~~or is probable but cannot be estimated~~ 80%, 80% ~~then~~and 51% ~~the~~interest ~~nature~~ of ~~the contingent liability~~Qingguo, ~~together with~~ anChengheng, ~~estimate~~Rongbin ofand ~~the~~Tianju ~~range~~as of ~~possible~~June ~~loss~~30, if2025, ~~determinable and material would be disclosed~~respectively.

~~Loss contingencies considered to be remote by~~As ~~management~~of ~~are~~June ~~generally~~30, ~~not~~2025 ~~disclosed~~and ~~unless~~2024, ~~they~~the ~~involve~~non-controlling ~~guarantees,~~interests in ~~which~~the ~~case~~consolidated ~~the~~balance ~~guarantee~~sheet ~~would~~was be$111,467 ~~disclosed~~and $78,336, respectively.

~~The~~For year ~~Company~~ended ~~was~~June ~~not~~30, ~~subject~~2025, tothe ~~any~~comprehensive ~~material~~income ~~loss contingency~~attributable asto ofcommon ~~June~~stockholders ~~30,~~and ~~2024~~non-controlling interests were $482,050 and $33,131, ~~2023~~respectively.

~~NOTE~~For year 9.ended ~~STOCKHOLDERS’~~June ~~EQUITY~~30, 2024, the comprehensive income attributable to common stockholders and non-controlling interests were $1,244,472 and $107,034, respectively.

~~On February 20, 2023, the Company issued 5,000~~NOTE ~~common~~12. ~~shares~~SUBSEQUENT ~~(valued at $384,500) to Kang Liping (Chief Financial Officer of the Company) as compensation.~~EVENTS

OnManagement ~~September~~has ~~21,~~evaluated ~~2023,~~subsequent ~~the~~events ~~Company~~through ~~filed with~~ the ~~Nevada~~date ~~Secretary~~which ofthe ~~State~~consolidated afinancial ~~Certificate~~statements ofwere ~~Change~~available ~~Pursuant~~ to ~~NRS~~be 78issued.~~209.~~ ~~The~~All ~~Certificate~~subsequent ofevents ~~Change~~requiring ~~provided~~recognition ~~for~~as ~~a 1-for-10 reverse split~~ of ~~the~~June ~~Registrant’s outstanding~~30, ~~common~~2025 ~~stock~~have ~~effective~~been atincorporated ~~the~~into ~~close~~these ofconsolidated ~~business~~financial

Filing Compare · Longduoduo Co Ltd